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CHAPTER 1: INTRODUCTION 
Osteoarthritis (OA) remains one of the most prevalent medical conditions in the world. 
Though the exact worldwide incidence of OA is difficult to calculate, the World Health 
Organization (WHO) estimates that worldwide, 9.6% of men and 18.0% of women are affected 
by OA.(Woolf and Pfleger, 2003) Based on 2008 studies by Helmick(Helmick et al., 2008) and 
Lawrence(Lawrence et al., 2008), the Center for Disease Control (CDC) estimates that in the 
U.S.,  ~13.9% of adults 25 years of age and older, and ~33.6% of adults older than 65 years are 
affected by OA. Other studies have reported much higher incidences, and this variability has 
been attributed to extensive variability in symptoms and their associated severities.(Haugen et 
al., 2011) In addition to causing pain, disorder, and dysfunction, it is also one of the highest 
global causes of economic loss.(Brown et al., 2006) 
The exact pathogenesis of OA remains unknown. While it is documented that age, 
gender, obesity, diabetes, and other musculoskeletal injuries or conditions are associated with the 
progression of OA, precise trigger mechanisms and their temporal relationships to OA have yet 
to be elucidated. To date, the only property of OA that is truly understood is its perpetuity and 
seemingly self-accelerating nature. This was recognized as early as 1743, when Dr. William 
Hunter, a Scottish surgeon and anatomist, stated that “ulcerated cartilage is a troublesome thing 
and that, once destroyed, is not repaired.”(Hunter, 1995)  
Post-traumatic osteoarthritis (PTOA) is the onset and progression of OA-like symptoms 
following trauma due to sporting injury, motor vehicle accidents, or other injurious events. It has 
been estimated that PTOA constitutes ~12% of all OA cases, (Brown et al., 2006) and there is a 
20 – 50% risk of developing PTOA following any joint injury.(Dirschl et al., 2004) The severity 
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and rate of onset is directly related to the severity of trauma, and few interventional clinical 
treatments have shown repeatable success. PTOA is most prevalent in the tibiofemoral and 
tibiotalar joints, and intraarticular fractures with displacement of cartilage fragments cause a 
more rapid onset and, ultimately, more severe PTOA than destabilization of the joints due to 
capsule, tendon, ligament, and/or meniscus damage.(Brown et al., 2006)  
Rupture of the Anterior Cruciate Ligament (ACL) is a well-described injury leading to 
the onset of PTOA. As the major stabilizer of anterior translation of the tibiofemoral joint, the 
ACL is critical in maintaining knee stability during sporting activities. High-magnitude and high-
rate anterior translation and/or rotation of the tibia with respect to the femur cause ACL sprains 
or ruptures. Excessive inflammation due to damage to ligament, cartilage, meniscus, and 
synovium tissue in addition to adverse biomechanical loading of these tissues following 
destabilization of the knee are postulated factors contributing to the onset of PTOA (Anderson et 
al., 2011; Buckwalter and Brown, 2004; Mankin et al., 2007). Though the gold-standard 
treatment of ACL ruptures is ACL reconstruction in efforts to remove damaged tissues and 
restabilize tibiofemoral articulation, PTOA following ACL rupture is reported to be as high as 
90% . (Gillquist and Messner, 1999; Lohmander et al., 2004; Myklebust and Bahr, 2005; Roos et 
al., 1995; Von Porat et al., 2004) 
Stem and progenitor cells are critical components of tissue homeostasis, metabolism , 
turnover, repair, and immunomodulation.(Singer and Caplan, 2011) During neonatal 
development, mesenchymal stem cells (MSCs) are responsible for the formation of mesenchymal 
tissues, including articular cartilage, bone, tendons, ligaments, meniscus, and the connective 
tissue component of the synovium. Following severe bodily injury such as myocardial infarction, 
stroke, multi-trauma, or whole-body irradiation, MSCs and hematopoietic stem cells (HSCs) are 
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known to be mobilized out of the bone marrow or perivascular niche to be involved in tissue 
regeneration and immunomodulation. However, to date, little is known regarding the systemic 
and local response of stem or progenitor cells in the setting of ACL rupture. It is unknown 
whether ACL rupture causes bone marrow-derived MSCs to be mobilized into peripheral blood 
and homed to the knee joint to participate in repair or immunomodulation. It is, thus, postulated 
that the onset of PTOA following ACL rupture is, in part, due to the incomplete MSC response 
and, consequently, an incomplete regenerative capacity.  
Animal models of PTOA following ACL injury rely, to date, on surgical transection of 
the ACL to simulate the anterior instability of the knee present following rupture. However, 
surgical transection may fail to accurately represent the biological response due to high-
magnitude tibiofemoral loading and subsequent ACL injury.  In the rat, ACL transection to study 
PTOA is widespread (Guilak et al., 1994a; Hashimoto et al., 2002a; Jansen et al., 2011; Jansen et 
al., 2012; Martin and Buckwalter, 2006a; Ruan et al., 2013a), but very little research has 
investigated noninvasive ACL rupture and the associated biological phenomena related to MSC 
mobilization, migration, and homing in a setting more representative of human injury. The 
purpose of this proposal is to (1) mechanically characterize a noninvasive model of rat ACL 
rupture using an applied axial tibial force; (2) compare the onset of PTOA in this noninvasive 
model to the onset of PTOA after surgical transection; and (3) study the acute biological 
response following noninvasive ACL rupture as it relates to MSC mobilization and the 
expression of cartilage-related biomarkers. 
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CHAPTER 2: BACKGROUND 
2.1 - The Form and Function of Articular Cartilage: 
Articular cartilage (AC) covers the surfaces of interfacing bones in most diarthrodial 
joints in the mammalian body.(Mankin et al., 2007) It is viscoelastic and provides lubrication for 
efficient motion of a joint while absorbing various loading types to prevent injury to surrounding 
tissues. Although often described as inert, AC is a highly dynamic tissue with complex 
interactions between chondrocytes, the only cell type of this tissue, solid tissue matrix 
macromolecules, and interstitial fluid.  
Biochemical Composition of Articular Cartilage 
AC is most commonly described as a biphasic material: it consists solid matrix phase (ca. 
20% of total wet tissue mass by weight) and an interstitial fluid phase (ca. 80% of total wet tissue 
mass by weight). Biomechanically speaking, it is often described as triphasic – the third phase 
being fixed charge density (FCD) – and this will be covered in later sections. AC contains four 
main tissue layers or zones – the superficial or tangential zone (10%-20% of total thickness), the 
transitional or middle zone (40% - 60%), the radial or deep zone (30%-38%), and the calcified 
cartilage zone (<2%) (Figure 2.1.1). A “tidemark” delineates the interface between the calcified 
cartilage zone and subchondral bone, but this interface is not always distinct, and as such, the 
calcified cartilage zone is described as a hybrid between cartilage and bone.(Mankin et al., 2007)   
Collagens contribute nearly 60% of the dry weight of AC, proteoglycans contribute 25%-
35%, and noncollagenous proteins and glycoproteins contribute 15%-20%.(Mankin et al., 2007) 
The collagen network has a distinct orientation throughout the entire thickness of AC, often 
described as a series of arches. Collagen fibers are oriented nearly parallel to the joint surface in 
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the superficial layer, 30° - 60° to the joint surface in the middle layer, and perpendicular to the 
joint surface in the deep layer (Figure 2.1.1B), as first described by Benninghoff in 
1925.(Benninghoff, 1925) This configuration allows for the effective absorption and 
transmission of compressive, shear, and tensile loading. Like most collagenous tissues, AC 
contains a large variety of collagen types. The most common collagens are types II, VI, IX, X, 
and XI, and the relative proportions of these do not change drastically from layer to layer in adult 
cartilage. During skeletal development, a larger proportion of collagen IX (~10%) and collagen 
XI (~10%) exist relative to collagen II (~80%), and these proportions diminish during maturation 
(collagen IX: ~1%, collagen XI: ~3%, collagen II: >90%).(Eyre and Wu, 1987) These three 
collagen polymers are able to form a highly crosslinked collagen II:IX:XI heteropolymer, which 
is highly resistive to tensile loading and biochemical digestion, making it an important 
macromolecule of the cartilage matrix.(Hagg et al., 1998) 
 
 
Figure 2.1.1 – Schematic representation of the layers of articular cartilage, chondrocyte 
orientation, and collagen fiber orientation. Figure reproduced from Fox.(Fox et al., 2009) 
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Proteoglycans (PG), the second major macromolecules type in AC, are made up of a 
protein core and one or numerous glycosaminoglycan (GAG) chains, and they account for 10%-
15% of the wet weight of AC. The concentration of PGs increases with cartilage depth, with very 
little PGs in the superficial layer and a high concentration in the deep layer. GAGs are long 
unbranched polysaccharide chains made up of repeating disaccharides that contain an amino 
sugar.(Bayliss et al., 1983) GAG chains, often made up of up to 100 monosaccharides, extend 
from the protein core and repel one another due to their similar charge but attract cations, giving 
rise to the fixed charge density of AC (Figure 2.1.2). The most common GAGs found in AC are 
hyaluronic acid, chondroitin sulfate, keratan sulfate, and dermatan sulfate,(Mankin et al., 2007) 
and their relative proportion and size varies with both age, injury, and disease. Proteoglycans 
within AC can be split up into two major classes: large aggregating macromolecules termed 
“aggrecans”, making up nearly 90% of all PGs in AC, and the smaller proteoglycans, making up 
~10% of PGs in AC. Examples or smaller proteoglycans are decorin, biglycan, and 
fibromodulin. Aggrecans possess a large number of both chondroitin sulfate and keratan sulfate 
chains, whereas smaller PGs can have only one or two chains.  The majority of aggrecans 
noncovalently bind with hyaluronic acid (HA), and GAG chains interact with the central core via 
link proteins (Figure 2.1.2). The length of the central HA molecule can vary between 100-10,000 
nm, and aggregate size has been shown to diminish with both age and disease (Roughley and 
White, 1980), correlating with the age-related decrease in hydration and biomechanical integrity 
of AC.  Smaller PGs have much shorter protein cores and,  rather than contributing to hydration 
or biomechanical properties of AC like aggrecans do, have been attributed to modulating cell 
function, cell-cell, cell-matrix, and matrix-matrix behavior(Fox et al., 2009). For example, 
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fibromodulin and decorin both bind to type II collagen fibrils and have been attributed to 
stabilizing the collagen network(Bayliss et al., 1983). 
 
Figure 2.1.2 – Schematic Representation of an Aggrecan Proteoglycan. A central protein 
“backbone”, here hyaluronic acid, is bound to a large number (up to 100) 
glycosaminoglycan(GAG) side chains, most commonly chondroitin sulfate, keratan sulfate, or 
dermatan sulfate, via link proteins. GAGs repel each other due to similar charge and attract 
cations from the AC matrix. Aggregate size is directly proportional to the compressive properties 
of AC and has been shown to diminish with age and disease. Figure reproduced from 
Newman.(Newman, 1998) 
Noncollagenous proteins and glycoproteins make up the smallest proportion of the solid 
phase of AC. While they are the least studied and understood constituent of AC, they are mainly 
involved in cell-matrix interactions. For example, anchorin CII is a collagen-binding protein 
found to bind to the surface of chondrocytes to facilitate “anchoring” of cells to type II 
collagen.(Mollenhauer et al., 1984) Other common molecules are vitronectin, fibronectin, and 
cartilage oligomeric protein (COMP).  
The proportion of interstitial fluid within the AC matrix is a critical component of AC as 
it relates directly to the tissue’s ability to absorb and distribute loads without transferring adverse 
forces to chondrocytes. Water contributes ~80% of the wet weight of AC, and the interaction of 
water with macromolecules, namely aggrecans, is the primary source of the high compressive 
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properties of AC. Fluid movement in and out, and within, the AC matrix is dependent upon 
loading magnitude and speed in addition to aggrecan density. Aggrecans possess a large number 
of negative charges that attract cations and repel anions, which increases the concentrations of 
important cations such as sodium and decrease the concentration of anions such as chloride. This 
regulation of tissue osmolarity gives rise to the fixed charge density of AC, which is heavily 
dependent upon water content. Furthermore, due to the inherently low vascularity of AC, fluid 
movement due to cyclic loading during normal daily activity is thought to be the primary source 
of nutrient delivery within the AC.(Fox et al., 2009) Thus, decreased fluid content can be 
attributed to decreased nutrient transport and, ultimately, degeneration. As a highly viscoelastic 
tissue, cartilage mechanics are dependent upon the movement of fluid within the matrix, and the 
delicate balance between fluid content and macromolecule concentration is an important 
physiologic phenomenon. 
Chondrocytes 
Mature AC contains only a single cell type – the articular chondrocyte.(Dell’Accio et al., 
2003) In comparison to tissue such as skin, muscle, liver, or kidney, AC has a very low 
concentration of cells – chondrocytes make up less than 1% - 2% of the total tissue volume of 
AC. Although the AC chondrocyte is a highly specialized, terminally differentiated cell, it varies 
distinctly in shape, size, and phenotype from AC zone to zone. Chondrocytes in the superficial 
zone are flattened and oriented along the tangential collagen fibers. As the inherent biochemical 
composition of the superficial zone suggests, chondrocytes in the superficial zone exhibit high 
expression of collagen genes and low expression of proteoglycans.(Coates and Fisher, 2010)   
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2.2 - Pathophysiology of Post-Traumatic Osteoarthritis 
Although the exact pathophysiologic mechanism of PTOA remains to be fully defined, it 
is understood that numerous types of events can lead to PTOA. The sudden application of a 
mechanical force to the joint is generally defined as the initiating event of PTOA.(Anderson et 
al., 2011) Acute damage to AC is caused either directly during the force application or 
immediately following the destabilization of the joint, leading to nonanatomic articulation and/or 
subluxation. In the former, the magnitude and frequency of loading determines the degree of 
injury to AC. Low-energy loading can cause damage to cells and/or extracellular matrix (ECM) 
macromolecules without macrophysical damage to the AC tissue (i.e. a tear, rupture). High-
energy may cause complete disruption of the ECM, causing macroscopic tears or cracks in 
addition to damage to cells, and very high-energy force application is able to completely displace 
articular cartilage fragments.(Buckwalter, 2002; Buckwalter and Brown, 2004) Acute damage 
caused due to subluxation and nonanatomic articulation following immediately after the force 
application, oftentimes still within the same gait or loading cycle, is less common but potentially 
equally damaging. (Buckwalter and Brown, 2004)   
Chronic damage to AC leading to PTOA can also be caused by joint destabilization 
following ligamentous or tendinous injury. Tear or complete rupture of a supporting ligament, 
meniscus, or tendon responsible for facilitating anatomic articulation can lead to adverse, 
nonanatomic stress distributions within the joint, leading to focal regions of high-magnitude 
loading. For example, rupture of the medial collateral ligament (MCL) of the knee causes medial 
instability, which can result in increased lateral loading and medial subluxation due to the lack of 
the primary medial support the MCL provides.(Gardiner and Weiss, 2003)  
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Following joint trauma, a seemingly unstoppable cascade of biologic events take place. 
Anderson et al have created a schematic diagram illustrating the variety of events both acutely 
and chronically following joint injury(Anderson et al., 2011) (Figure 2.2.1).  The timeline 
demonstrates the catabolic processes such as cell and tissue necrosis, apoptosis, matrix 
degradation, and tissue inflammation present after injury. Anabolic processes become restored in 
the intermediate phase and begin to predominate in the late phase, where tissue remodeling 
occurs.  
 
Figure 2.2.1 – Schematic timeline of biologic events following joint trauma. Catabolic processes 
such as cell and tissue necrosis, apoptosis, matrix degradation, and tissue inflammation 
predominate in the early phase. In the intermediate phase, balance between catabolism and 
anabolism is slowly restored. In the late phase, matrix synthesis is upregulated to remodel 
injured tissue. Figure reproduced from Anderson(Anderson et al., 2011). 
Numerous biologic moieties are released into synovial fluid following joint injury. 
Proinflammatory cytokines such as members of the Interleukin family, namely IL-1β, IL-6, IL-8, 
tumor necrosis factor alpha (TNF-α), in addition to nitric oxide and matrix metalloproteinases 
(MMP-1, -2, -3, -8, -9, -13) are well-documented to be released after injury.(Green et al., 2006; 
Lohmander et al., 2003; Martin and Buckwalter, 2006a; Schaible et al., 2010; Tchetverikov et 
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al., 2005) Though the exact temporal and spatial relationships of these molecules and, 
importantly, their tissue of origin, has yet to be outlined, it has been shown that nearly every 
tissue in the joint is able to contribute to this molecular release. In addition to the aforementioned 
molecules, recent studies have demonstrated that reactive oxygen species (i.e. oxygen free 
radicals) are released from AC chondrocytes, a feed-forward loop of chondrocyte apoptosis and 
matrix degradation.(Goodwin et al., 2010; Martin et al., 2009) Tenascin-C, a glycoprotein found 
mainly in tendons and ligaments, has recently been shown to be released into synovial fluid 
following ACL rupture in humans.(Chockalingam et al., 2012)  
The chronic pathophysiology of PTOA are less well understood, mainly due to the lack 
of representative animal models and corresponding time scales able to mimic the chronic stages 
of PTOA. It is, however, known that progressive ECM loss, most notably PGs, as well as cellular 
apoptosis and phenotypic shifts are present in advanced PTOA.(Anderson et al., 2011; Mankin et 
al., 2007) Loss of water content, most likely due to changes in electrostatic interactions 
concurrent with sGAG loss, in addition to cartilage thinning are also commonly cited symptoms. 
It can, thus, be understood how PTOA, or any OA for that matter, is inherently self-accelerating: 
loss of water content and mechanical properties leads to adverse loading of chondrocytes and 
ECM molecules, which leads to further loss of mechanical properties.  
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2.3 - Anterior Cruciate Ligament Anatomy and its Injury as a Cause for Post-Traumatic 
Osteoarthritis  
As one of the most common sporting injuries worldwide(Jones and Rocha, 2012), 
anterior cruciate ligament (ACL) rupture or tear also represents a major mechanism by which 
PTOA can develop.(Feller, 2004)  The incidence of ACL rupture is not well described and varies 
as a function of age, but studies have reported 30-81 per 100,000 (Ferry et al., 2013; Frobell et 
al., 2007; Gianotti et al., 2009) , 4.8% among ambulatory patients aged 50 – 90 years(Englund et 
al., 2006), and 3.6% of patients aged ~25 years.(Shelbourne et al., 1998) 
Anterior Cruciate Ligament Anatomy  
The ACL is the major anterior stabilizer of the tibiofemoral joint, resisting anterior 
translation of the tibia with respect to the femur. It connects to the femur in the intercondylar 
notch/fossa at the medial surface of the lateral femoral condyle and to the tibia at the 
anterocentrally (Figure 2.3.1) 
 
 
Figure 2.3.1 – Anatomy of the Intact Anterior Cruciate Ligament (ACL). On sagittal proton 
density-weighted MRI (left image), the ACL appears as a dark band (red outline, red arrow) 
connecting the anterior tibia (white arrows) to the posterolateral femoral condyle within the 
intercondylar fossa (black arrows).Macroscopically, the ACL is visualized from the anterior 
knee (middle image) as a ~32 mm long, ~10mm wide ligament. A sagittal cross section (right 
image) shows that the ACL is thickest at the tibial insertion. P=patella; F=femur; T=tibia; 
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Ant=anterior; Post=posterior; lat=lateral; med=medial. Left image reproduced from Craig et 
al(Craig et al., 2005). Middle and right image reproduced from Duthon et al.(Duthon et al., 
2006) 
The cross-sectional shape of the ACL is irregular along its length and varies during 
flexion-extension, but its tibial insertion is generally described as larger and wider in the medial-
lateral direction.(Amis and Dawkins, 1991) The ACL is made up of two distinct bundles: the 
anteromedial bundle (AMB) and posterolateral bundle (PLB) (Figure 2.3.2). The AMB connects 
to the anterior – cranial aspect of the femoral ACL attachment and attaches to the anteromedial 
aspect of the tibial attachment. The PLB connects to the posterior – caudal aspect of the femoral 
attachment and to the posterolateral aspect of the tibial attachment.(Amis and Dawkins, 1991) 
Due to non-concentric articulation of the femoral condyles on the menisci, the two bundles are 
not isometric and are strained in varying magnitudes along the flexion-extension spectrum: the 
AMB lengthens and tightens in flexion whereas the PLB shortens and becomes lax. In extension,  
the PLB tightens slightly and the AMB relaxes but never becomes as lax as the PLB.(Hollis et 
al., 1991) As such, the two bundles provide complementary stabilization along the flexion-
extension spectrum, giving rise to the continuous anterior stability.   
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Figure 2.3.2 – The two bundles of the ACL. The posterolateral bundle (PLB) is taught in 
extension (left image, blue suture) but shortens and becomes slack in flexion (right image, blue 
suture). The anteromedial bundle (AMB) lengthens and tightens in flexion (right image, purple 
suture) and shortens slightly in extension (right image, purple suture). F = femur; T=tibia. 
Image reproduced from Duthon et al.(Duthon et al., 2006) 
Anterior Cruciate Ligament Rupture 
ACL rupture can occur in a variety of loading scenarios. Rupture mechanisms are 
generally divided into two categories: noncontact and contact injuries. One mechanism of 
contact injury is the application of a valgus force to the knee, causing the ACL to rupture due to 
extensive strain caused by valgus deformation.(Boden et al., 2000a). The valgus force is 
sometimes coupled with rotation and/or flexion, and injury mechanisms are therefore not purely 
valgus. Furthermore, contact ACL rupture can also occur due to an excessive posterior force on 
the distal femur with a static, or “planted” foot, causing rapid posterior motion of the femur with 
respect to the tibia and, ultimately, ACL rupture. It is important to note that a contact force may 
be combined with a noncontact initiating motion, thus compounding, for example, torsional and 
translational forces.  
A large variety of noncontact ACL injury mechanisms have been proposed in the 
literature,(Yu and Garrett, 2007) and large prospective clinical studies have sought to investigate 
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risk factors associated with noncontact ACL rupture.(Uhorchak et al., 2003) Amongst proposed 
noncontact injury mechanisms are sudden and high-magnitude quadriceps contraction at 20° of 
flexion analogous to sudden deceleration from sprinting(DeMorat et al., 2004), high-magnitude 
joint loading during valgus deformation and slight flexion, analogous to landing from a jump 
with a valgus knee(Krosshaug et al., 2007), high-speed direction change, causing extreme tibial 
rotation and translation such as during “cutting” while sprinting (Krosshaug et al., 2007; Meyer 
and Haut, 2008),  high-magnitude compressive loading at 30° of flexion(Meyer and Haut, 2008), 
and others.     
Numerous injuries concomitant to ACL rupture have been described, and it is generally 
understood that multiple injuries (i.e. multi trauma) leads to lower clinical outcomes.(Levy et al., 
2009)  Among the most common injuries present after ACL rupture are MCL injury, PCL injury, 
LCL injury, meniscus injury, posterolateral corner injury, and gross articular cartilage 
injury.(Bin and Nam, 2007; Lohmander et al., 2007; Strobel et al., 2006; Widuchowski et al., 
2007) Bone bruising is a common symptom following ACL rupture and has been shown to vary 
with the mechanism of injury.(Viskontas et al., 2008)  
Post-Traumatic Osteoarthritis following Anterior Cruciate Ligament Rupture 
The onset and progression of PTOA following ACL rupture is well-documented. The 
incidence of PTOA in the tibiofemoral compartment following ACL rupture with or without 
reconstruction vary from 10 % - 100% at 10 to 30 years following injury, depending on patient 
factors, injury severity, and reconstruction. (Ait Si Selmi et al., 2006; Gillquist and Messner, 
1999; Lohmander et al., 2004; Myklebust and Bahr, 2005; Nebelung and Wuschech, 2005; Roos 
et al., 1995; Von Porat et al., 2004) Less data exists regarding PTOA in the patellofemoral 
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compartment, with numbers ranging from 16 - 75%.(Cohen et al., 2007; Järvelä et al., 2001; 
Neuman et al., 2009)  
Clinical data pertaining to OA following ACL rupture is highly variable, and Lohmander 
et al used a systematic review to compile the incidence of radiographically-diagnosed OA and a 
knee-specific subjective outcomes score, the Knee Injury and Osteroarthritis score (KOOS), as a 
function of years after ACL injury and subsequent reconstruction (Figure 2.3.3).(Lohmander et 
al., 2007) 
 
 
Figure 2.3.3 – A scatterplot of radiographically-diagnosed OA as a function of years of follow-
up after ACL injury and/or reconstruction (Left). A knee-specific subjective clinical outcomes 
measure (KOOS) as a function of years of follow-up after ACL injury and subsequent 
reconstruction (right). Figures reproduced from Lohmander.(Lohmander et al., 2007) 
The plots demonstrate that there is extensive variability in the incidence of OA following 
ACL injury but that the high incidence of OA does not necessarily result in lower outcomes as a 
function of time after injury and/or reconstruction. Clinical outcomes do, however, seem to 
deteriorate slowly after 2-4 years of follow-up regardless of OA status. Interestingly, these 
graphs also do not directly support that ACL reconstruction provides long-term protection 
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against progressive PTOA. On the contrary, the literature seems to show that even if ACL 
reconstruction is performed quickly after injury, PTOA is nearly inevitable.  
There are a variety of direct and indirect risk factors associated with the development of 
PTOA following ACL rupture.(Louboutin et al., 2009) In addition to concomitant injuries at the 
time of the index injury, obesity, female gender, age, meniscectomy as part of surgical treatment, 
high native anterior tibial translation, genu recurvatum, genu varum, and intensity of physical 
exercise are among known risk factors for the development of PTOA. 
Molecular and Cellular Mechanisms following ACL Rupture 
It is unclear whether the onset of PTOA following ACL rupture is mainly due to the 
initial joint trauma at the time of injury or due to the alteration of native joint kinematics after 
rupture. Although ACL reconstruction does not fully restore tibiofemoral articulation to that of 
its healthy state, the literature clearly demonstrates that ACL reconstruction restores joint 
stability by reducing anterior tibial translation(Gao and Zheng, 2010). However, as previously 
stated, the incidence of PTOA does not seem to vary between surgically and nonsurgically 
treated patients.(Lohmander et al., 2007) It can, thus, be reasoned that the onset of PTOA is 
initiated at the time of injury and is largely due to the excessive biomechanical loads and 
catabolic moieties released within the joint after injury occurs.  
To date, most research has focused on catabolic and proinflammatory proteins and 
cytokines along with their inhibitors after ACL rupture, and it is widely documented that 
synovial fluid-borne levels of these factors are elevated after ACL rupture.(Higuchi et al., 2006; 
Lohmander et al., 2003; Lohmander et al., 1994; Tang et al., 2009c) A paucity of data exists 
regarding the cellular response, both locally and systemically, following ACL rupture. Though it 
18 
 
 
 
is known that injured tissues undergo necrosis and apoptosis, little research has been done to 
determine whether stem and/or progenitor cells are involved in events following ACL rupture in 
the context of PTOA. Mesenchymal stem cells (MSCs) are present in the synovium(Sakaguchi et 
al., 2005; Yoshimura et al., 2007), in the ACL itself(Nohmi et al., 2012; Steinert et al., 2011), 
and in very small quantities in the other tissues of the joint.(da Silva Meirelles et al., 2006) 
Furthermore, MSCs can be found in vascular structures as perivascular MSCs, sometimes termed 
pericytes,(Crisan et al., 2008) though it is not known in what concentration, if any, MSCs reside 
in the intraarticular vasculature. In addition to their potent regenerative capacity, MSCs serve as 
immunomodulatory cells and may, therefore, play an integral role in the modulation of post-
injury inflammation.(Chen and Tuan, 2008)  
Nohmi and coworkers have shown that MSCs isolated from ruptured ACLs have a 
diminishing capacity to form colonies and differentiate as time from rupture increases.(Nohmi et 
al., 2012) Morito et al have shown that synovial fluid-level MSC concentrations are increased 
after ACL rupture compared to healthy patients.(Morito et al., 2008) The study demonstrated 
that, in addition to increased MSC levels in injured patients, MSC levels continued to increase 
after reconstructive surgery and that these MSCs were more similar to synovium-derived MSCs 
than bone marrow-derived MSCs, as analyzed by GeneChip. Lastly, in a rabbit model, they 
showed that intraarticularly injected MSCs adhered preferentially to the injured ligament rather 
than other tissues, an indicator that the injured tissue was signaling for homing, migration, and 
adhesion. Sekiya et al have shown that MSC concentration in synovial fluid increases with 
increasing OA grade(Sekiya et al., 2012), and this group also demonstrated that these circulating 
MSCs were more similar to synovium-derived MSCs than bone marrow-derived MSCs. Jones 
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and coworkers showed increased synovial fluid levels of MSCs in early OA patients while 
confirming that these cells are distinct from bone marrow (BM) cells.(Jones et al., 2008)  
Homing of injected MSCs to injured tissues within the knee joint has been shown by only 
a few studies. Agung et al  created surgical injury to the ACL, medial meniscus, and the femoral 
condyles and subsequently injected green fluorescent protein (GFP)-positive bone marrow-
derived MSCs. (Agung et al., 2006) When 106 MSCs were injected, GFP-positive cells were 
observed only in the ACL at 8 weeks. When 107 cells were injected, GFP-positive cells were 
observed in the ACL, the meniscus, and the cartilage. These cells were surrounded by positive 
collagen staining, indicating their roles in tissue repair. This study highlights the homing 
capacity of injured tissues but also the need for high MSC concentrations.  In a similar 
experiment, Horie et al showed that synovium-derived MSCs injected into the joint homed to 
massive meniscal defects and participated in regeneration.(Horie et al., 2009) 
Some circulating, serum-level and synovial-level biomarkers for PTOA have been 
identified following ACL rupture. Catterall et al collected serum and synovial fluid from patients 
immediately following ACL rupture (~15 days after injury) and at the follow-up visit prior to 
reconstructive surgery (~48 days after injury).(Catterall et al., 2010) They analyzed 21 
biomarkers by ELISA and assessed sGAG content in synovial fluid by Alcian Blue staining. The 
study did not have data from healthy patients to establish baseline biomarker concentrations. 
Their results show that in synovial fluid, C-Reactive protein (CRP), lubricin, and proteoglycan 
markers had significant decreases between the time of injury and the time of surgery. 
Interestingly, collagen biomarkers increased after time of injury. Pruksakorn et al showed that 
chondroitin sulfate epitope (WF6) and hyaluronic acid are present in increased concentrations in 
patients after ACL rupture, but had limited patient numbers.(Pruksakorn et al., 2009) Svoboda et 
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al used ELISA to measure levels of 4 biomarkers of cartilage turnover before and after ACL 
injury in 45 patients and used 45 healthy patients as matched controls.(Svoboda et al., 2013) 
They analyzed the two markers for cartilage synthesis: procollagen II carboxy propeptide (CPII) 
and aggrecan chondroitin sulfate 846 epitope (CS846); and two markers for cartilage 
degradation, type I and II degradation Col2 3/4 short assay (C1,2C) and collagen type II cleavage 
(C2C). They found significant differences in the change in concentration in 3 of the 4 biomarkers 
between injury and control patients and showed no pre-injury differences. Future work is 
necessary to determine the exact temporal patterns of these cartilage turnover markers. Tourville 
and coworkers measured biomarkers of collagen turnover and correlated those to clinical 
outcomes and joint space width in healthy patients and patients following ACL injury.(Tourville 
et al., 2013) They found increased ratios of collagen cleavage-to-synthesis ratios (type I and II 
cleavage product (uC1,2C) to procollagen II C-propeptide (sCPII)) in the serum of injured 
patients compared to controls both at 1 and 4 year follow-up. Also, the study found that 
increased type II cleavage-to-synthesis ratios (i.e. uCTX-II/sCPII ratio) were found in patients 
with abnormal joint space width at 4 year follow-up.  Recently, Zhang et al showed that serum-
level small non-coding RNA (snoRNA) U38 and U48 were significantly higher in the serum of 
patients with progression PTOA following ACL injury.(Zhang et al., 2012) No study has 
performed a high throughput proteome-wide investigation of serum-level or synovial fluid-level 
biomarkers following ACL rupture, and future work is warranted in this area to potentially 
identify more biomarkers indicative of PTOA after ACL injury.   
To date, no study has shown whether ACL rupture induces systemic mobilization of stem 
cells and how the concentration of serum-level biomarkers of cartilage turnover and homing 
factors change in conjunction to MSC mobilization. While serious bodily injury such as 
21 
 
 
 
myocardial infarction(Zohlnhöfer et al., 2006) or stroke(Sprigg et al., 2006) induces systemic 
mobilization of BM-derived MSCs due to high secretion of the potent MSC-homing factor 
Stromal Cell Derived Factor -1 (SDF-1), no group has elucidated whether orthopaedic soft tissue 
injuries induce mobilization of BM-derived MSCs into the peripheral vascular system. As the 
BM represents the largest depot of MSCs, a possible explanation for incomplete healing of 
intraarticular injuries is the lack of MSC mobilization. Although synovium-derived MSCs are 
known to be increased in synovial fluid following injury, it is not known whether these cells 
alone are sufficient in providing an immunomodulatory and regenerative response. To this end, 
the onset of PTOA following intraarticular injury, namely ACL rupture, may therefore be, in 
part, due to the insufficient MSC response immediately after injury. Future research is necessary 
to elucidate the systemic mobilization of MSCs following ACL rupture to determine their 
potential role as mediators of PTOA. Additionally, proteome-wide analyses of cartilage 
biomarkers and stem cell homing factors in peripheral blood after ACL rupture can provide 
treatment targets for inhibition of cartilage degradation and/or increased stem cell mobilization 
acutely after rupture.  
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2.4 - Animal Models of Post-Traumatic Osteoarthritis 
To accurately study PTOA, a variety of animal models have been developed and 
subsequently employed. Aside from PTOA due to ligamentous injury, other models have used 
intra-articular fracture(Furman et al., 2007), high impact- joint loading(Borrelli et al., 2009), or 
meniscectomy(Ashraf et al., 2011; Lindhorst et al., 2000). Animals most commonly utilized are 
the mouse(Furman et al., 2007; Ruan et al., 2013a), rat(Ashraf et al., 2011; Guilak et al., 1994a; 
Hashimoto et al., 2002a; Jansen et al., 2011; Jansen et al., 2012; Martin and Buckwalter, 2006a; 
Ruan et al., 2013a), rabbit(Borrelli et al., 2009; Guilak et al., 1994a), and dog(Lindhorst et al., 
2000). A variety of ligamentous injury-induced PTOA models, sometimes termed joint 
instability-induced PTOA models, have been published, and these include ACL 
transection(Guilak et al., 1994a; Hashimoto et al., 2002a; Jansen et al., 2011; Jansen et al., 2012; 
Martin and Buckwalter, 2006a; Ruan et al., 2013a), combined meniscectomy and ACL 
transection(Appleton et al., 2007; Hayami et al., 2006), noninvasive injury via biomechanical 
loading (Christiansen et al., 2012b; Onur et al., 2013; Tang et al., 2009b; Tang et al., 2009c), or 
knee triad injury (MCL transection, medial meniscus, ACL transection) (Jones et al., 2010).  
The most widely published model of PTOA following ligamentous injury is ACL 
transection.(Guilak et al., 1994a; Hashimoto et al., 2002a; Jansen et al., 2011; Jansen et al., 2012; 
Martin and Buckwalter, 2006a; Ruan et al., 2013a) ACL transection causes joint instability, 
leading to adverse compressive and shear forces on articular cartilage during tibiofemoral 
articulation. This model of PTOA has been well characterized, and numerous studies have shown 
that long-term findings are representative of OA: loss of proteoglycan content(Altman et al., 
1984b; Guilak et al., 1994b), osteophyte formation(Hashimoto et al., 2002b), altered 
biomechanical properties of articular cartilage(Altman et al., 1984b), loss/thinning of articular 
23 
 
 
 
cartilage(Guilak et al., 1994b), and chondrocyte death(Martin and Buckwalter, 2006b). Ruan et 
al used an ACL transection model in mice and demonstrated increased Col10a1 and MMP13 
gene expression, decreased cartilage volume, along with decreased motor and sensory reactions 
two months following transection. (Ruan et al., 2013b)  Altman et al studied ACL transection in 
a canine model and showed decreased water content, increased joint swelling, decreased 
proteoglycan content, and increased cartilage stiffness. (Altman et al., 1984b) Hayami et al 
examined multiple time points post-ACL transection in a rat (1,2,4,6,10 weeks) and found 
detectable cartilage surface damage and proteoglycan loss as early as one week. (Hayami et al., 
2006)   
Only a few groups have used noninvasive, traumatic ACL rupture by mechanical loading 
in efforts to induce PTOA. Onur et al applied a 12 N compressive load at 5 mm/s for 230 cycles 
or until ACL rupture in a 90° flexed knee joint in mice. (Onur et al., 2013)  After 1 and 8 weeks 
they saw a significant increase in OA score and osteophyte formation in the group that received 
cyclic cartilage compression with ACL rupture. Christiansen and coworkers also used a mouse 
model in which they applied tibal compression via the paw, keeping the ankle flexed at 30° . 
Each leg was subjected to a compressive load of 12 N, causing transient anterior subluxation of 
the tibia relative to the femur and ultimate rupture of the ACL. (Christiansen et al., 2012b) 
PTOA was characterized with micro-computed tomography (µCT) and Safranin-O histology. 
They demonstrated loss of trabecular bone volume, proteoglycan loss, chondrocyte atrophy, loss 
of the superficial zone of cartilage by 56 days. Interestingly, this study also demonstrated 
extensive heterotopic ossification, likely a byproduct of the high displacement induced during 
loading. A later paper published by the same group examined loading rate-dependent injury 
modes in the same mechanical loading protocol in mice and found that low loading rates caused 
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bony avulsion at the ACL insertion whereas high loading rates caused midsubstance rupture of 
the ACL (Lockwood et al., 2013). Tang et al used a rotational mechanical load in a rat to show 
increased levels of IL-1β, IL-6, TNF-α, and MMP-2 levels in explanted ACL, PCL, synovium, 
cartilage, and meniscal tissue. (Tang et al., 2009b) A follow-up study by the same group showed 
temporal shifts in MMP and tissue inhibitor of matrix metalloproteinase (TIMP) levels following 
noninvasive, rotational ACL rupture.(Xue et al., 2009) A lack of data exists regarding the 
molecular and cellular events following noninvasive ACL rupture of the rat in the context of 
PTOA. Future studies utilizing biomechanical loading to induce an isolated, noninvasive ACL 
rupture are necessary.  
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CHAPTER 3: STATEMENT OF PROBLEM 
While the animal model of surgical ACL transection is widely utilized in rats, it fails to 
properly represent a clinically-relevant ACL injury as it occurs in humans. In addition to the 
absence of high-magnitude biomechanical loading of knee tissues, surgical transection induces 
confounding biological phenomena within the joint due to surgical cutting of the skin, synovium, 
and ACL, and, thus, does not provide an appropriate research platform with which to study the 
acute biologic mechanisms associated with ACL injury that may be initiators of the post-
traumatic osteoarthritis (PTOA) cascade. Anterior cruciate ligament (ACL) rupture has been 
shown to be a major initiator of PTOA, and even ACL reconstruction fails to thwart the 
progression of PTOA. While it is known that the concentration of synovium-derived 
mesenchymal stem cells (MSCs) within the synovial fluid increases after ACL rupture, no study 
has elucidated whether ACL rupture induces systemic mobilization of bone marrow-derived 
MSCs into the peripheral vascular system to allow for homing and migration of these cells to the 
injured tissue. Furthermore, analyses of cartilage biomarkers and stem cell mobilization factors 
in peripheral blood following ACL rupture are, to date, lacking. A need exists for a repeatable, 
noninvasive ACL rupture model representative of human ACL injury with which to study the 
aforementioned mechanisms following injury in order to elucidate the etiology of PTOA.  
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CHAPTER 4: RESEARCH HYPOTHESIS 
It is hypothesized that the rapid application of an axial tibial force in a flexed rat knee 
causes noninvasive, isolated rupture of the anterior cruciate ligament. Furthermore, it is 
hypothesized that this rupture leads to the onset and progression of PTOA, and that this will 
occur in a manner more representative of the process in humans. Lastly, it is hypothesized that 
mesenchymal stem cells are not mobilized into peripheral blood following ACL rupture but 
several serum-level biomarkers indicative of joint injury can be identified as potential targets for 
PTOA regulation.    
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CHAPTER 5: SPECIFIC AIMS 
 
1). Develop and Biomechanically Characterize a Model of Noninvasive Rupture of the 
Anterior Cruciate Ligament of the Rat 
- Methods: Axial tibial force in 100° of flexion; varying endpoint displacement and 
displacement rate; quantitative motion capture; quantitative joint laxity assessment; 
injury assessment using µCT, and dissection. 
2). Compare and Contrast the Onset and Progression of Post-Traumatic Osteoarthritis 
Following Noninvasive Rupture of the ACL to Surgical Transection of the ACL 
- Methods: Noninvasive ACL rupture using developed protocol, surgical transection 
using established protocol, 4 and 10-week endpoint, quantitative µCT, histology, 
cartilage biomarker assays. 
3). Analyze and Compare the Acute Biological Response Following both Noninvasive ACL 
Rupture and Surgical ACL Transection 
- Methods: Noninvasive ACL rupture, acute stem cell mobilization using flow cytometry, 
serum-level biomarkers, synovial fluid-level SDF-1.  
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CHAPTER 6: AIM # 1 - DEVELOP AND BIOMECHANICALLY CHARACTERIZE A 
MODEL OF NONINVASIVE RUPTURE OF THE ANTERIOR CRUCIATE LIGAMENT 
OF THE RAT 
6.1 - Introduction 
The pathomechanisms, kinetics, and potential treatment strategies of PTOA are 
commonly investigated using small-animal models. The most common model of PTOA 
following ACL injury is surgical ACL transection(Guilak et al., 1994a; Hashimoto et al., 2002a; 
Jansen et al., 2011; Jansen et al., 2012; Martin and Buckwalter, 2006a; Ruan et al., 2013a), 
which causes acute joint destabilization and, consequently, adverse joint kinematics and 
inflammation, leading to the onset of OA-like symptoms such as the loss of proteoglycan 
content(Altman et al., 1984a; Guilak et al., 1994a), osteophyte formation(Hashimoto et al., 
2002a), altered biomechanical properties of articular cartilage(Altman et al., 1984a), 
loss/thinning of articular cartilage(Guilak et al., 1994a), and chondrocyte death(Martin and 
Buckwalter, 2006a). Due to the invasive nature of surgically-induced ACL injury, the ACL 
transection model may not accurately mimic the native biological response present in humans 
following ACL injury. The lack of high-magnitude tibiofemoral loading and tensile failure of the 
ACL represents a short-coming of the ACL transection model, and, furthermore, surgical cutting 
and suturing of the skin and joint capsule may induce confounding biological phenomena not 
present in human tissues after ACL injury.  
Noninvasive loading protocols to induce ACL injury in small animals have been 
employed by only a few studies. Onur et al applied a cyclic compressive load to the distal femur 
of the flexed knee joint in mice until ACL rupture occurred, which induced OA-like degenerative 
changes at 8 weeks.(Onur et al., 2014) Tang et al used a rotational mechanical load in a rat to 
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characterize pro-inflammatory cytokine and proteinase expression following noninvasive ACL 
rupture.(Tang et al., 2009a; Wu et al., 2009) Christiansen and coworkers used a mouse model in 
which they applied tibial compression via the paw with the knee flexed at ~90°. Each leg was 
subjected to a compressive load of 12 N, causing transient anterior subluxation of the tibia 
relative to the femur and ultimate failure of the ACL.(Christiansen et al., 2012a) They 
demonstrated a loss of trabecular bone volume, proteoglycan loss, chondrocyte atrophy, and loss 
of the superficial zone of cartilage by 56 days. Another study by the same group examined 
loading rate-dependent injury modes in the same mechanical loading protocol in mice and found 
that low loading rates caused bony avulsion at the ACL insertion whereas high loading rates 
caused midsubstance rupture of the ACL.(Lockwood et al., 2014) 
To date, the tibial compression ACL injury model has not been employed in the rat, and 
no group has characterized joint biomechanics and/or laxity during and after injury. As the rat is 
a common model for PTOA as well as ACL reconstruction(Brophy et al., 2011; Kadonishi et al., 
2012; Mifune et al., 2013), a clinically-relevant model of ACL injury in the rat can be of 
significant use for future studies.  To this end, the purpose of this study was to biomechanically 
characterize a noninvasive ACL injury in the rat using a tibial compression protocol. 
Specifically, we sought to investigate the repeatability of four loading protocols at varying speed 
and endpoint displacement, perform motion capture to quantity joint motion during loading, and 
quantify post-loading laxity. We hypothesized that both high displacement and high speed are 
necessary to induce complete ACL injury and that complete ACL injury results in increases in 
anterior-posterior laxity but not varus or valgus laxity. 
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6.2 – Methods 
This work has been recently accepted for publication(Maerz et al., 2015) and has been 
closely replicated in the following sections.                   
Specimen Preparation 
Adult, female Lewis rats (200-250 grams) (n=9 per group) were euthanized by CO2 
asphyxiation under an Institutional Animal Care and Use Committee (IACUC)-approved 
protocol. Immediately after euthanasia, both hind limbs were dissected to remove the skin, and 
small incisions were made over the lateral aspect of the femoral metaphysis and the lateral aspect 
of the tibial tuberosity using a No. 15 scalpel. A 1.00 mm Kirschner wire (K-Wire) was used to 
drill a hole into the femoral metaphysis and tibial tuberosity, and a 1.00 mm pin attached to a 
4.00 mm hemispherical retroreflective motion-tracking marker was rigidly inserted into each 
hole. One additional reference marker was drilled into the greater trochanter of the femur, and 
another reference marker was attached to the testing fixture holding the animal’s paw.  
Mechanical Loading Protocol 
The fixture and testing protocol utilized in this study are modified from a previously-
published tibial compression knee injury model in mice.(Christiansen et al., 2012a) A custom 
fixture was rigidly mounted onto the stage of an electromechanical materials testing system 
(MTS Insight 5, Eden Prairie, MN, USA). The bottom fixture supports the animal in a prone 
position, and a knee stage with an 8.5 mm wide, 25 mm long, and 3.5 mm deep trough is 
positioned at the center of the actuator. The knee stage limits medial-lateral motion while 
providing room for anterior subluxation of the tibia relative to the femur. The top fixture was 
mounted at the center of the actuator, and it rigidly supports the rat’s hind paw in 30° of 
dorsiflexion without allowing medial or lateral motion. Resultant knee flexion after positioning 
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of the animal is ~100° (Figure 6.2.1A).  
Four displacement-controlled loading protocols were employed to induce tibial-compression 
knee injury and/or anterior cruciate ligament injury. A 3 N preload was held for 10 seconds, 
followed by 10 preconditioning cycles of 1 – 5 N at 0.5 Hz. A 15 N preload ramp at 0.1 mm/s 
was then applied, and immediately after reaching a 15 N load, a displacement-controlled ramp 
using one of four testing conditions is applied: high and low speed (8 mm/s and 1 mm/s, 
respectively), and high and low endpoint displacement (3 mm and 2 mm, respectively). The four 
resultant testing groups were: high-speed, high-displacement (HSHD); high-speed, low-
displacement (HSLD); low-speed, low-displacement (LSLD), and low-speed, high-displacement 
(LSHD). These loading parameters were chosen based on preliminary tests performed at varying 
speeds and endpoint displacement. These preliminary experiments demonstrated that 
displacements higher than 3 mm increased the incidence of fracture while 2 mm was found to be 
the minimum displacement necessary to induce ACL injury. Load, displacement, and time data 
was sampled at 200 Hz during each test. 
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Figure 6.2.1 – Mechanical Loading and Laxity testing fixtures. (A) To induce ACL injury, a 
compressive displacement is applied to the tibia with the knee flexed to ~100°. Medial-lateral 
motion of the knee is constrained with a trough in the knee stage, and the paw is fully 
constrained and flexed to 30° of dorsiflexion. (B) Following injury loading, Anterior-Posterior 
(AP) laxity was quantified with a subluxation test by the application of a constant tibial 
compressive load. (C) Varus and valgus laxity are assessed by the application of a constant load 
applied at the distal tibia to induce either varus or valgus joint stress.  
 
Motion Tracking and Analysis 
During the duration of each mechanical test, motion of each reflective marker was 
tracked using a four-camera, 5 megapixel motion capture system (Oqus 5, Qualisys, Göteborg, 
Sweden). Data was collected continuously at a 179 Hz and analysis was performed using both 
the Qualisys Track Manager software and Matlab (v2013a, Mathworks, Natick, MA). 
Experiments performed to determine the resolution of this system using the same reflective 
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markers, the same camera-to-object distance, and displacement speeds of both 1 mm/s and 8 
mm/s found that the system has a resolution of 279 µm with a 98.07% accuracy at 8 mm/s, and a 
49.02 µm resolution with 99.31% accuracy at 1 mm/s. The motion-capture system was 
synchronized to the materials testing system using an external circuit to capture time-
synchronized data between the two systems. Following acquisition, data was converted into a 
calibrated coordinate system where the z direction constitutes the vertical axis of the actuator 
(i.e. the direction of the applied load along the tibia), the x axis constitutes the medial-lateral 
direction with respect to the animal, and the y axis constitutes the cranial-caudal direction with 
respect to the animal. To analyze the motion of the tibia relative to the femur, the position of the 
proximal tibial marker was normalized to the position of the distal femoral marker at each data 
point. Relative tibiofemoral motion was analyzed in all three 2D anatomical planes (transverse, 
coronal, and sagittal) as well as in 3D. Motion was analyzed at the point of peak load, which 
constituted either ACL injury or the highest load when injury was not successfully induced, as 
well as motion between the point of peak load and maximum 3D joint displacement, which 
represented joint motion after ACL injury when injury was successful. Motion was also analyzed 
as total motion (i.e. total distance traveled by the tibia relative to the femur) as well as net 
motion. 
Quantitative Joint Laxity Testing 
Following mechanical loading, limbs were disarticulated at the hip joint, and 
approximately 1 cm of the proximal femur was exposed to facilitate clamping. Anterior-Posterior 
(AP) laxity was assessed using a subluxation test in which the femur was rigidly clamped, the 
knee was flexed to 90°, and the paw was fixed in a clamp in 30° of dorsiflexion.(Figure 6.2.1B) 
AP Laxity testing was performed with a 10 second 0.3 N preload, 10 preconditioning cycles 
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between 0.1 and 0.5 N at a rate of 0.25 Hz, another 10 second 0.3N preload, and a ramp to 2 N at 
0.25 mm/s, which was held for 10 seconds. AP laxity was expressed as net displacement due to 
the applied 2N load as well as compliance during the applied load, expressed in mm/N. After AP 
laxity testing, the paw was disarticulated at the ankle joint, and a 1mm pinhole was drilled 
anterior-to-posterior in the distal tibia. The femur was rigidly mounted in the clamp, and the 
distal tibia was attached to a linear bearing with a 0.8 mm stainless steel pin via the drilled pin 
hole. The linear bearing was attached to the actuator, which applied a downward load to assess 
varus laxity and an upward load to assess valgus laxity (Figure 6.2.1C). The linear bearing 
ensured that linear actuator motion resulted in arc motion of the tibia in order to eliminate joint 
distraction, which would skew load-controlled testing. Varus and valgus laxity testing was 
performed with a 10 second 0.3 N preload, 10 preconditioning cycles between 0.1 and 0.5 N at a 
rate of 0.25 Hz, another 10 second 0.3N preload, and a ramp to 1 N at 0.25 mm/s, which was 
held for 10 seconds. Varus and valgus laxity were expressed as net displacement due to the 
applied 2N load in the respective directions as well as compliance during the applied load. 
Healthy, non-loaded specimens were used as laxity controls. 
Micro Computed Tomography and Gross Dissection 
Following mechanical loading and assessment of joint laxity, limbs were imaged using 
micro computed tomography (µCT) at 70 kVp, 114 µA at an isotropic voxel size of 36 µm 
(µCT40, Scanco Medical, Brüttisellen, Switzerland). A blinded investigator assessed each image 
set for gross fractures of the tibia or femur, and bony avulsions of the ACL were identified by 
small bone pieces in the center of the joint near the femoral notch.  
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Following imaging, each sample was dissected to confirm ACL injury, to identify and 
confirm potential fractures, ruptures, or avulsions, and to characterize the location and/or type of 
injury. 
Data Analysis and Statistical Comparison 
Statistical analysis was performed in SPSS (v22, IBM, Armonk, NY). The normality and 
equal variance assumptions were assessed using the Shapiro-Wilk test and Levene’s test, 
respectively. Differences in independent normally distributed and non-normally distributed 
variables were compared between groups using one-way analysis of variance (ANOVA) and 
Kruskal-Wallis tests, respectively. Multiple comparisons were performed with a Sidak P-value 
correction at α = 95%. Differences in independent, normally distributed and non-normally 
distributed variables between two groups (e.g. injured vs non-injured specimens) were compared 
using t-tests and Mann Whitney U tests, respectively. The association between complete ACL 
injury and testing speed and displacement was assessed using χ2 tests. P values lower than 0.05 
were considered significant.  
6.3 - Results 
Complete Injury and Fracture Incidence 
Complete ACL injury occurred in 100% of rats in HSHD, 33.33% (3/9) in HSLD, 
55.56% (5/9) in LSHD, and 0% in LSLD.  Injury was significantly associated with higher testing 
speed (χ2  = 5.46, P = 0.019) and higher endpoint displacement (χ2  = 13.48, P < 0.001). No bony 
metaphyseal fractures occurred during loading, and no fractures involving the pin hole were 
identified on µCT images. However, a distal femoral physeal fracture/slip occurred in one 
specimen in each of HSLD, LSHD, and LSLD during mechanical loading. These fractures were 
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confirmed on µCT images, indicating separation of the distal femoral physis with a concomitant 
coronally-oriented bony fracture of the distal femoral epiphysis (Figure 6.3.1A). All three of 
these fractures were several millimeters away from the pinholes drilled for retroreflective marker 
placement, and µCT images did not indicate fracture propagation to the pinholes.  
 
Figure 6.3.1 – µCT imaging following loading. Three specimens exhibited physeal displacement 
(A, white arrow) with a concomitant distal femoral epiphyseal fracture (A, red arrow). Avulsions 
were noted by small pieces of bone in the joint space, apparent near the femoral footprint on 
both sagittal (B, red arrow) and coronal slices (C, red arrow).  
 
Loading-dependent Injury Types 
ACL injury was confirmed with gross observation of the dissected joint (Figure 6.3.2). Of 
the 17 specimens that experienced complete ACL injury, three major injury types were observed: 
a true midsubstance rupture with ligamentous tissue fully attached to both the femoral and tibial 
footprints, where the rupture was found to be closer to the femoral footprint in all specimens. 
The second injury type was a combination avulsion and midsubstance rupture where one bundle 
of the ACL avulsed from the femoral footprint and the other bundle exhibited a midsubstance 
rupture . The third injury type was a full avulsion of the femoral attachment where both bundles 
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remained attached to bone, and the avulsion footprint could be visualized on the femur.  Of the 9 
injured specimens in HSHD, 2 specimens exhibited midsubstance rupture of the ACL, 4 
specimens in HSHD exhibited the combination rupture-avulsion injury, and 3 specimens 
exhibited full avulsions. In two of the combination injury specimens, we were able to confirm 
that the anteromedial bundle was the avulsed bundle, and the posterolateral bundle was ruptured.  
Of the 3 injured specimens in HSLD, 2 exhibited the combination avulsion-rupture injury and 1 
exhibited a midsubstance rupture. All 5 of the 5 injured specimens in LSHD were full avulsions. 
µCT data confirmed avulsion injuries by the appearance of a small bony piece in the femoral 
notch (Figure 6.3.1B,C), whereas no bone pieces were visualized in the joint in specimens that 
experienced midsubstance rupture.   
 
Figure 6.3.2 – Complete ACL injury was confirmed in dissected joints. The intact ACL spans the 
joint from the anterior tibia to the medial wall of the lateral femoral condyle (A). Complete 
injury of the ACL (B) occurred by either midsubstance rupture, bony avulsion from the femoral 
footprint, or a combination injury where one bundle of the ACL was avulsed and the other 
bundle exhibited a midsubstance rupture. F = femur; T = tibia; P = patellar tendon. Med = 
medial; Lat = lateral. 
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Joint Motion During Tibial Compression Loading 
Relative tibiofemoral joint motion of all tested specimens is summarized in Table 6.3.1. 
In general, the motion in the transverse plane was most pronounced. HSHD exhibited 
significantly higher total coronal motion and transverse motion after peak load compared to 
HSLD. LSHD had significantly higher total sagittal motion compared to HSLD. HSHD had the 
highest 3D motion compared to other groups, but these differences were not significant due to 
the relatively large standard deviations when grouping both complete-injury and uninjured 
specimens. When comparing only specimens that exhibited complete ACL injury, more 
pronounced differences in relative tibiofemoral joint motion are observed between groups (Table 
6.3.2). HSHD exhibited significantly higher total coronal motion, higher total 3D motion, and 
higher transverse motion after peak load compared to HSLD. LSHD had significantly higher 
total sagittal motion compared to HSLD. 
Table 6.3.1 – Relative Tibiofemoral Joint Motion during Injury Loading (All Specimens) 
 
Table 6.3.2 – Relative Tibiofemoral Joint Motion during Rupture Loading 
(Complete-Injury Specimens Only) 
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Complete-injury specimens had significantly higher total motion after peak load in the 
transverse plane (2.58 mm ± 1.65) compared to specimens that did exhibit complete injury(1.25 
mm ± 0.97, P = 0.031). There was significantly higher net displacement in the coronal plane in 
injured specimens (2.15 mm ± 0.87) compared to non-injured specimens (1.45 mm ± 0.69, P = 
0.034). Joint motion plots indicate that complete-injury specimens exhibited tibial internal 
rotation up to the point of ACL failure, and after failure, the tibia displaced caudally, anteriorly 
and exhibited external rotation (Figure 6.3.3A, 4B), indicating tibial subluxation over the femoral 
condyles with a rotational component. Specimens that did not exhibit complete injury, however, 
exhibited only tibial internal rotation with less pronounced tibial subluxation (Figure 6.3.3C, D). 
Motion after the point of peak loading is markedly lower in specimens that did not exhibit ACL 
failure, most notably in the medial-lateral direction, and no external rotation past the point of the 
start of loading is noted.  
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Figure 6.3.3 - Joint motion in the coronal plane (A,C) and transverse plane (B,D) in specimens 
that exhibited complete ACL injury (A,B) and specimens that did not exhibit complete injury (C, 
D). The tibia internally rotates up to the point of peak load or ACL failure, but tibial external 
rotation with pronounced anterior and caudal subluxation is noted only in specimens that 
exhibited ACL failure and complete injury. 
 
The most profound differences in relative tibiofemoral joint motion were observed when 
grouping high displacement groups (HSHD, LSHD) and low displacement groups (HSLD, 
LSLD). There was a significant difference in total 3D motion (high-displacement: 7.17 mm ± 
1.29; low-displacement: 5.19 mm ± 2.38, P = 0.008), 3D motion after peak load (high-
displacement: 2.84 mm ± 1.57; low-displacement: 1.70 mm ± 1.19, P = 0.036), motion after peak 
load in the transverse plane (high-displacement: 2.69 mm ± 1.66; low-displacement: 1.22 mm ± 
0.88, P = 0.014), total motion in the transverse plane (high-displacement: 6.58 mm ± 1.37; low-
displacement: 4.41 mm ± 2.27, P = 0.004 ), motion after peak load in the coronal plane (high-
displacement: 2.74 mm ± 1.49; low-displacement: 1.43 mm ± 1.04, P = 0.016), total motion in 
the coronal plane (high-displacement: 4.70 mm ± 1.07; low-displacement: 3.20 mm ± 1.76, P = 
0.013),  total motion in the sagittal plane (high-displacement: 5.46 mm ± 0.92; low-
displacement: 3.72 mm ± 1.76, P = 0.002), and motion after peak load in the sagittal plane 
(High-displacement: 1.75 mm ± 1.11; Low-displacement: 0.95 mm ± 0.85; P  = 0.037). 
Differences between grouped high and low speed groups were less pronounced, and the only 
difference was observed in transverse motion after peak load (high speed: 2.59 mm ± 1.64; low 
speed: 1.35 mm ± 1.13, P = 0.043).  
Joint Laxity  
Quantitative joint laxity testing results of all specimens are summarized in Table 6.3.3. 
When all specimens are analyzed, only HSHD exhibited a significant increase in AP and varus 
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displacements compared to uninjured limbs, with corresponding decreases in respective 
compliance. There were no significant differences in valgus laxity between any groups. When 
comparing only specimens that exhibited complete ACL injury, HSHD, HSLD, and LSHD all 
had significant increases in AP net displacement, AP compliance, varus displacement, and varus 
compliance compared to unloaded controls. (Table 6.3.4) No group exhibited significant 
increases in valgus displacement or valgus compliance. There were no differences in any laxity 
variable between groups when comparing only specimens that exhibited complete injury.   
Table 6.3.3 – Laxity Testing Results 
 
Table 6.3.4 – Laxity Testing Results (Complete-Injury Specimens Only) 
 
Specimens that exhibited complete injury had significantly higher AP displacement 
(Injured: 1.16 mm ± 0.4; Non-injured: 0.257 mm ± 0.11, P < 0.001) and AP compliance (Injured: 
0.541 mm/N ± 0.12; Non-injured: 0.128 mm/N ± 0.06, P < 0.001) compared to non-injured 
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specimens.  Specimens that had complete injury had significantly higher varus displacement 
(Injury: 3.64 mm ± 0.78; Non-injury: 2.18 mm ± 0.69, P < 0.001) and varus compliance (Injury: 
5.61 mm/N ± 1.30; Non-injury: 3.86 mm/N ± 1.51, P < 0.001) compared to non-injured 
specimens. There was no difference in valgus displacement or valgus compliance between 
injured and non-injured specimens.  
There were marked differences in AP and varus laxity when comparing high and low 
displacement groups. High-displacement had significantly larger AP displacement (High-
displacement: 0.991 mm ± 0.53; Low-displacement: 0.444 mm ± 4.3, P = 0.003), AP compliance 
(High-displacement: 0.457 mm/N ± 0.20; Low-displacement: 0.217 mm/N ± 0.19, P = 0.006), 
varus displacement (high-displacement: 3.29 mm ± 0.93; low-displacement: 2.55 mm ± 1.03, P = 
0.031), and varus compliance (high-displacement: 4.96 mm/N ± 1.39; low-displacement: 3.83 
mm/N ± 1.75, P = 0.021). Valgus displacement or compliance did not vary as a function of 
displacement. When comparing high and low speed groups, there were significant differences in 
AP displacement (high-speed: 0.873 mm ± 0.45; low-speed: 0.569 mm ± 0.61, P = 0.026) and 
AP compliance (high-speed: 0.447 mm/N ± 0.22; low-speed: 0.228 mm/N ± 0.18, P = 0.004), 
but no difference was found in varus displacement, varus compliance, valgus displacement, or 
valgus displacement. 
6.4 - Discussion 
Animal models accurately reproducing the biologic cascades after joint injury are 
important research tools, but the most prevalent model for PTOA in the rat is surgical ACL 
transection, which could introduce confounding biological variables due to its surgical nature.  
To date, models of noninvasive ACL injury in the rat are sparse, and, to this end, the purpose of 
this study was to biomechanically characterize the tibial compression model in the rat. We 
43 
 
 
 
hypothesized that both high speed and high displacement are necessary to induce complete ACL 
injury. This hypothesis was confirmed, but high displacement was more highly associated with 
complete injury than high speed. We found that complete ACL injury can be repeatedly induced 
with a 3 mm compressive displacement of the tibia at 8 mm/s when the knee is flexed to 100°. 
We also hypothesized that complete ACL injury would induce A-P laxity but not varus or valgus 
laxity. This hypothesis was only partially confirmed: ACL injury causes marked increases in 
anterior-posterior and varus laxity, and joint displacement in the transverse and coronal planes 
was the most contributory to ACL injury in our model. 
Only a few studies have utilized noninvasive joint loading to induce ACL rupture in the 
rat, and no study has utilized the tibial compression model in the rat. Tang et al utilized a 
rotational model to study post-injury protein expression. (Tang et al., 2009a) In this model, ACL 
injury was induced by rotating the tibia and femur in opposite directions in 120° of joint 
extension. No characterization of the injury or post-injury joint mechanics was performed, and it 
is difficult to determine how injury induced by their loading protocol compares to injuries 
observed in the present study. The tibial compression model has been previously employed in the 
mouse. Christiansen et al applied a 12 N tibial compressive load to induce a noninvasive ACL 
injury(Christiansen et al., 2012a), which induced OA-like changes such as cartilage degeneration 
and subchondral bone changes. The load was applied at 1 mm/s and the authors stated that bony 
avulsion of the ACL occurred in all specimens. A follow-up study by that group indicated that 
true ACL rupture was achieved at higher speed (500 mm/s) whereas lower speed injury (1 mm/s) 
caused a “disruption of the ACL with an avulsion fracture from the posterior femur.”(Lockwood 
et al., 2014) Interestingly, histologic evidence of articular cartilage degeneration did not vary 
between injury mode (i.e. avulsion vs. mid-substance rupture, and only acute trabecular bone 
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changes were impacted by injury mode). Our data corroborates that loading rate determines 
injury type. We also observed ACL avulsion at 1 mm/s, but since the 8 mm/s loading rate in our 
“high speed” group was markedly lower than the 500 mm/s “high speed” group used by 
Christiansen et al , we observed avulsion, midsubstance rupture, and a combination avulsion-
rupture injury in our high speed group. Although differences in joint biomechanics between the 
mouse and rat may cause some discrepancies in injury type, this finding likely indicates that 8 
mm/s represents the lower end of the loading rate range necessary to induce true ACL rupture, 
and future studies are necessary to determine which loading rate repeatedly induces ACL rupture 
in the rat.  
ACL rupture in humans occurs most prevalently in non-contact scenarios during rapid 
deceleration or change of direction(Boden et al., 2000b; Boden et al., 2010), and several 
biomechanical motions have been shown to induce ACL rupture, including anterior tibial 
translation due to high-magnitude tibiofemoral compression (Meyer and Haut, 2005), internal 
tibial rotation(Meyer and Haut, 2008), and combined tibial rotation and valgus joint 
stress.(Boden et al., 2010; Meyer and Haut, 2008) Meyer et al have shown that tibial 
compression causes transient anterior subluxation of the tibia relative to the femur.(Meyer and 
Haut, 2008) In their study, internal tibial rotation was noted to occur during pre-failure 
compressive loading, and following ACL rupture, the tibia rotated externally. In our study, we 
observed that joint motion in the transverse and coronal planes was markedly higher in 
specimens that exhibited complete ACL injury compared to specimens that did not exhibit 
injury. The medial-lateral motion component of these planes was most pronounced, and motion 
plots indicate that this is tibial rotation and/or translation. Due to anatomic size restrictions, it 
was only possible to place one marker in each bone, and we, therefore, cannot definitively 
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conclude whether rotation or translation predominated. However, our results of motion in the 
medial-lateral direction after rupture are consistent with Meyer’s biomechanics study of human 
ACL rupture, indicating that not only vertical and anterior tibial displacement occurs during and 
after ACL rupture. We observed that only specimens that experienced ACL injury exhibited 
increased LCL laxity, a concomitant joint injury also observed in humans following ACL 
rupture, although rarer than MCL injury.(Lee et al., 1988; Levine et al., 2013) Since total motion 
after peak load in the transverse plane as well as net displacement in the coronal plane was 
significantly higher in injured specimens, we conclude that these motions cause LCL injury, and 
tibial external rotation immediately after ACL failure is the most likely cause. Meyer et al did 
not investigate LCL injury following ACL rupture, nor were joint laxity tests performed, and we 
cannot conclude whether our proposed mechanism of LCL injury is fully representative of 
concomitant LCL injury in humans. Future studies assessing the exact pathomechanism of LCL 
injury in both our models and human injury are necessary.  
We did not measure any increases in valgus laxity due to ACL injury. Medial collateral 
ligament (MCL) injury is a common concomitant injury during ACL rupture in humans(Sankar 
et al., 2006; Yoon et al., 2011), notably during the common “valgus collapse” mechanism of 
ACL injury.(Boden et al., 2010; Koga et al., 2010; Quatman and Hewett, 2009) In a 
biomechanics study assessing relative ACL and MCL strain during simulated landing-induced 
ACL rupture in human cadaveric specimens, Quatman et al found that MCL strain is most 
pronounced in multiplanar tibiofemoral loading, which includes anterior shear, abduction, and 
internal tibial rotation.(Quatman et al., 2013) They stated that the MCL strain observed in their 
study is not sufficient to induce MCL injury, but a valgus and internal rotation moment are 
necessary to strain the MCL. Their simulated landing model allowed unconstrained tibial 
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rotation and varus-valgus joint deformation at 25° of flexion. Our loading protocol rigidly fixed 
the paw at 100° of knee flexion, which inherently constrains tibial internal rotation and valgus 
deformation (i.e. tibial abduction).  Other studies have indicated that concomitant MCL injury 
during ACL rupture is induced by valgus loading (Mazzocca et al., 2003; Shin et al., 2009), and 
we, therefore, conclude that valgus injury was not induced in our model due to the lack of valgus 
loading and fully unconstrained tibial internal rotation. 
This study has several limitations. Our motion capture data is inherently limited by the 
system’s resolution at a given speed. At a capture rate of 179 Hz and with 4 mm retroreflective 
markers, our resolution was 279 µm with a 98.07% accuracy at 8 mm/s, and a 49.02 µm 
resolution with 99.31% accuracy at 1 mm/s. Inherently higher error at the higher loading rate 
could not be avoided, and high-speed groups may therefore have higher error. Secondly, we 
utilized µCT imaging at a resolution of 36 µm to assess specimens for fractures and bony 
avulsions, but we cannot exclude the possibility of missing microfractures or very small 
avulsions given the µCT imaging parameters. Due to size restrictions and the risk of fracture, we 
were only able to place one retroreflective marker in the tibia and femur, which limited the 
information able to be ascertained from motion capture data. Lastly, as this is a biomechanics 
study of cadaveric rats, the biomechanical behavior of live tissue may not be fully represented in 
our data set, and no information about the actual impact of this ACL injury on PTOA can be 
gathered. Further studies are underway to assess cartilage degeneration following ACL injury 
due to tibial compression in the rat.  
 This study biomechanically characterized the tibial compression model of ACL injury in 
the rat. A reproducible ACL injury can be induced by the application of a tibial axial 
displacement of 3 mm at 8 mm/s when the knee is flexed at ~100°, and this injury causes 
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concomitant LCL injury due to post-failure tibiofemoral motion in the transverse and coronal 
planes. Motion-capture data indicates that this injury is consistent with human models of ACL 
injury, and this injury model may be applied in future rat studies of PTOA and/or ACL 
reconstruction.   
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CHAPTER 7: AIM # 2 - COMPARE AND CONTRAST THE ONSET AND 
PROGRESSION OF POST-TRAUMATIC OSTEOARTHRITIS FOLLOWING 
NONINVASIVE RUPTURE OF THE ACL TO SURGICAL TRANSECTION OF THE 
ACL 
7.1 - Introduction 
The biological events leading to PTOA after joint injury have yet to be fully outlined. 
Animal models of PTOA are widespread, and the most common ACL injury-induced PTOA 
model is surgical ACL transection. It has been shown to induce the onset of OA-like symptoms 
such as the loss of proteoglycan content(Altman et al., 1984a; Guilak et al., 1994a), osteophyte 
formation(Hashimoto et al., 2002a), altered biomechanical properties of articular 
cartilage(Altman et al., 1984a), loss/thinning of articular cartilage(Guilak et al., 1994a), and 
chondrocyte death(Martin and Buckwalter, 2006a). However, given the invasive surgical nature 
of the model, it is unclear whether these changes are representative of human PTOA after 
traumatic ACL rupture.   
Clinical studies have shown that ACL rupture induces acute and chronic changes to 
articular cartilage morphology(Argentieri et al., 2014; Roemer et al., 2014; Su et al., 2013), the 
menisci(Roemer et al., 2014; Williams et al., 2012), subchondral bone(Nakamae et al., 2006; 
Peterfy et al., 2004; Roemer et al., 2014), epiphyseal bone(Nakamae et al., 2006), 
synovium(Roemer et al., 2014), and ligaments(Roemer et al., 2014) in the knee. It is still 
unknown whether the acute trauma and inflammation, the joint destabilization, or the chronic 
change in joint kinematics has the largest impact on the degenerative changes observed in knee 
tissues after ACL injury, but it is generally understood that the PTOA cascade is self-
perpetuating.  
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   As outlined in Section 2.2, the kinetics of PTOA following joint injury can be divided 
into three main phases: early, intermediate, and late(Anderson et al., 2011). During the early 
phase, constituting the first several days after injury, catabolic events such as inflammation and 
cell death predominate. In the following intermediate phase, inflammation begins to subside and 
anabolic remodeling processes are initiated, though these do not yet outweigh ongoing catabolic 
cascades. In the late phase, anabolic matrix synthesis predominates to compensate previous 
events, and tissue remodeling proceeds chronically. All aforementioned knee tissues are 
influenced by these three phases, and understanding the kinetics of degenerative changes in the 
context of the anabolic-catabolic balance is critical when investigating interventional or 
regenerative therapies. 
 To date, no study has compared the degenerative, PTOA-like changes observed in the rat 
following surgical ACL transection to a noninvasive, traumatic model of ACL injury. 
Specifically, it is unknown whether the ACL transection model underestimates the degenerative 
cascades due to the lack of a traumatic injury or whether the surgical nature of the ACL 
transection model (i.e. surgical cutting and suturing of the skin and synovium, surgical cutting of 
the ACL) introduces confounding inflammatory effects that potentially exacerbate and 
overestimate degenerative changes in the knee. As demonstrated in Section 6 – Aim #1, a 
noninvasive ACL injury model able to repeatably induce ACL rupture using axial tibial 
compression has been developed and characterized. The mode of injury and tibiofemoral joint 
motion during loading are representative of human ACL injury, and it is hypothesized that this 
injury model will lead to PTOA-like degenerative changes in the rat knee. As such, the purpose 
of the following aim was to compare and contrast the onset and progression of PTOA following 
noninvasive ACL rupture to the surgical ACL transection model. We hypothesize that 
50 
 
 
 
noninvasive ACL rupture induces more extensive degenerative changes in articular cartilage 
compared to ACL transection and that these will coincide with increased serum and synovial 
fluid concentrations of cartilage biomarkers. Furthermore, we hypothesize that bony remodeling 
will be observed in both groups but the ACL rupture group will exhibit increases in bone mineral 
density and trabecular thickness due to the traumatic nature of the injury.  
7.2 - Methods 
Treatment Groups and Procedures 
Under an institutional animal care and use committee (IACUC)-approved protocol, 
thirty-six female Lewis Rats (14 weeks of age) were randomized to one of three treatment 
groups: Control, Rupture, or Transection (n=12 per group). Animals within each group were then 
randomized to one of two time-points: 4 weeks or 10 weeks.  On the morning of all procedures, 
animals were administered 5 mg/kg subcutaneous Carprofen, a non-steroidal anti-inflammatory 
drug. Anesthesia was induced by intraperitoneal 75-100 mg/kg ketamine with 3-5 mg/kg 
xylazine and maintained using 0.5% - 1.5% isofluorane during the duration of the procedure. 
Subcutaneous atropine (0.05 mg/kg) was administered immediately after anesthetic induction. 
Post-operative analgesia was administered with an initial dose of subcutaneous buprenorphine 
(0.03 mg/kg) following immediately after anesthesia recovery and an additional dose (0.01 
mg/kg) 8-12 hours after the initial dose. No animals required additional doses after the second 
dose. 
Animals in the Rupture group were administered a noninvasive anterior cruciate ligament 
(ACL) rupture using a biomechanical loading protocol with a custom fixture on a materials 
testing system (Insight, MTS, Eden Prarie, MN, USA), as previously described and characterized 
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in Section 6 - Aim #1.(Maerz et al., 2015) In brief, the protocol is a variation of the tibial 
compression model first demonstrated in mice by Christiansen et al(Christiansen et al., 2012a). 
In the present study, the animal is placed prone on a bed, and the right knee is flexed to 100⁰ on a 
stage with a 3 mm deep trough restricting medial/lateral translation. The paw is rigidly mounted 
in 30⁰ of dorsiflexion in a fixture constraining all motions except flexion/extension (Figure 
6.2.1A). Following preload, 10 cycles of preconditioning, and a secondary preload to 15N, a 
rapid vertical displacement of 3 mm at 8 mm/s was applied to the paw fixture. The rapid axial 
tibial displacement causes anterior tibial subluxation, tibial internal rotation, failure of the ACL, 
followed by tibial external rotation, as previously characterized in Section 6 - Aim #1 and by 
Maerz et al(Maerz et al., 2015). ACL failure occurs at ca. 60 – 70 N of axial force, and in 
addition to anterior laxity, varus laxity is observed following this injury protocol, as 
characterized in Section 6 – Aim #1. Complete ACL rupture was confirmed following 
biomechanical loading using an anterior drawer test, whereby anterior joint laxity is confirmed 
by the application of an anterior tibial force  (Figure 7.2.1). 
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Figure 7.2.1 – Confirmation of ACL rupture using an anterior drawer test. The reduced knee 
joint (A) is anteriorly dislocated by the application of an anterior tibial force, causing 
subluxation of the tibia with respect to the femur (B) due to the loss of anterior stability afforded 
by the ACL. 
In the Transection group, complete surgical transection of the ACL was performed as 
previously described(Jansen et al., 2012; Martin and Buckwalter, 2006a; Ruan et al., 2013b). In 
brief, following anesthetic administration as described above, the right knee was shaved and 
prepared with betadine and alcohol. The animals were positioned supine on a warm water 
recirculator to aid in thermoregulation. A midline knee incision was made using a No. 15 scalpel 
blade. Medial and lateral skin flaps were then developed. A medial parapatellar arthrotomy was 
made, and the patella was subluxated laterally. The knee was then hyperflexed to aid in 
visualization of the ACL and to maintain patellar subluxation. The ACL was transected mid-
substance using a Size 0 micro scalpel (Biomedical Research Instruments, Silver Spring, 
Maryland, USA), taking care to avoid contact with any cartilaginous surfaces. Anterior and 
posterior drawer testing was subsequently performed to confirm complete ACL rupture and PCL 
integrity, respectively. The knee was lavaged with sterile saline. The arthrotomy was then closed 
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using 6-0 Prolene (Ethicon 8697G) interrupted sutures and the skin was closed using 5-0 undyed 
Vicryl (Ethicon J493G) buried interrupted sutures.  
Animals in the Control group were administered identical analgesia and anesthesia but 
received no injury or surgical treatment. All animals were allowed normal diet and ad libitum 
cage activity until sacrifice at either 4 or 10 weeks. Sacrifices were performed by CO2 asphyxia, 
and a 5 ml blood draw was immediately performed via cardiac puncture. Blood was allowed to 
coagulate for 30 mins and centrifuged for 10 mins at 2000 rpm in order to collect serum. All 
serum was aliquoted into 150 µL volumes and immediately stored at -80⁰C for future analysis.  
Following blood collection, synovial fluid was aspirated from the right knee using a 
lavage procedure. The posterior joint capsule was carefully exposed but not violated, and a 23-
gauge needle was carefully inserted into the center of the knee via the femoral notch in a 
posterior-to-anterior fashion. A 27-gauge needle was then used to inject 400 µL of PBS using an 
anteromedial approach immediately lateral to the patellar tendon. Slow injection of the PBS 
facilitated the collection of ca. 150-200 µL of joint lavage fluid, which was immediately stored at 
-80⁰C for future analysis. 
Micro computed Tomography (µCT) 
Following sacrifice, the right limb was carefully dissected to expose articular cartilage of 
the femur and tibia. Periarticular soft tissues such as the synovium, meniscus, and ligaments 
were removed, and the tibia and femur were cut distally and proximally, respectively, to expose 
the medullary cavity. All specimens were fixed using 10% neutral buffered formalin (NBF) for 
48 hours. Specimens were then rinsed five times using distilled water and rehydrated in 
phosphate-buffered saline (PBS) for 24 hrs. To facilitate contrast-enhanced imaging of articular 
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cartilage, equilibrium partitioning of an ionic contrast agent (EPIC) - µCT was employed. This 
previously-described technique contrast enhances articular cartilage by the preferential exclusion 
of a negatively-charged molecule from sulfated glycosaminoglycan (sGAG)-rich tissues(Kotwal 
et al., 2012; Palmer et al., 2006; Xie et al., 2010). In addition to enabling accurate segmentation 
and visualization, this technique also facilitates quantification of differential sGAG distribution 
within a tissue. Specimens were incubated in 20% ioxaglate (Hexabrix, Guerbet Group, France) 
pH = 7.2, for 24 hrs. Specimens were then carefully dabbed with a moist towel and mounted 
rigidly in a humidified µCT specimen holder containing humidifying beads able to maintain an 
80% humid atmosphere within the holder. µCT imaging of the distal femur and proximal tibia 
was performed at 70 kVp, 114 mA with an isotropic voxel resolution of 12 µm and a 250 ms 
integration time (µCT40, Scanco Medical, Brütissellen, Switzerland).  Following imaging, 
specimens were rinsed in PBS to remove the contrast agent and dehydrated using an ethanol 
series up to 70% v/v ethanol, in which all specimens were stored until histologic processing. 
µCT Segmentation of Articular Cartilage, Subchondral Bone, and Epiphyseal Bone 
µCT images were converted to DICOM, filtered using a noise-reducing Gaussian filter (σ 
= 0.2) , and a custom MATLAB (r2014a, The Mathworks, Nattick, MA, USA) program was 
employed to segment articular cartilage. In brief, blinded manual outlining of the articular 
surface of both the tibia and femur was performed on sagittal images. Due to the drastic 
differences in the attenuation between air (-1000 HU), contrast-enhanced articular cartilage (800 
– 2500 HU), and bone (3500 – 6500 HU), outlining around articular cartilage to include both air 
and subchondral bone allows for accurate segmentation (Figure 7.2.2). A three-dimensional (3D) 
region-growing algorithm (Christian Wuerslin, University of Tuebingen and University of 
Stuttgart, Germany. http://www.mathworks.com/matlabcentral/fileexchange/41666-fast-3d-2d-
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region-growing--mex-) was employed to segment cartilage voxels. This algorithm requires only 
a seed point within the 3D structure and a single intensity difference threshold describing the 
acceptable difference in intensity between the seed point and any other voxel. A difference 
threshold of 1500 was found to reproducibly segment cartilage without including any bone 
voxels. Small, malsegmented objects representing subchondral bone marrow were removed 
using size-exclusion and connectivity algorithms, which dictate that only one large volume (i.e. 
articular cartilage) can remain following processing. 
 
Figure 7.2.2 – Outlining of Articular Cartilage on Contrast-Enhanced µCT images. Regions-of-
interest (ROIs) were manually drawn on sagittal µCT images around articular cartilage, 
encompassing subchondral bone and air (A). A 3D region-growing algorithm was used to 
accurately segment only articular cartilage, which could be confirmed and edited on axial (B) 
and coronal images (C).Tibial cartilage was outlined in an identical manner. 
Subchondral bone was segmented automatically using a custom MATLAB program 
which employs the already-segmented articular cartilage volume. The program segmented 
subchondral bone 252 µm (i.e. 21 voxels) deep to any articular cartilage voxel using a binary 
dilation with a disk-shaped structuring element. Following dilation, a high-pass intensity 
threshold of 3500 HU removed air, articular cartilage, bone marrow, and other soft tissue to yield 
only subchondral bone. 
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Epiphyseal bone was segmented from metaphyseal bone using manual outlining on 
coronal images along the distal femoral epiphysis and proximal tibial epiphysis. A high-pass 
intensity threshold of 3500 HU removed air, articular cartilage, bone marrow, and other soft 
tissue to yield only epiphyseal bone (Figure 7.2.3). 
 
Figure 7.2.3 – Segmented epiphyseal bone. Manual outlining and a high-pass threshold was 
used to segment femoral (A,B) and tibial (C,D) epiphyseal bone for densitometric and 
morphologic analysis.  
µCT Analysis of Articular Cartilage, Subchondral Bone, and Epiphyseal Bone 
Segmented 3D articular cartilage volumes were converted to consistent 2D height maps 
using conformal parameterization, as outlined in detail in Appendix 1. Following segmentation 
of compartments, parameterization, generation of height maps, and subsequent 
subcompartmental segmentation, articular cartilage morphology was analyzed by mean height, 
peak-to-valley distance (P-V), and arithmetic surface roughness Sa.  
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Subchondral and epiphyseal bone were analyzed using a custom MATLAB algorithm in 
conjunction with Miji, a Matlab-ImageJ interface(Sage et al., 2012; Schindelin et al., 2012), and 
the BoneJ plug-in for ImageJ(Doube et al., 2010). Bone volumes were exported to ImageJ, and 
mean trabecular thickness (Tb.Th. Mean), trabecular thickness standard deviation (Tb. Th. Std), 
and maximum trabecular thickness (Tb.Th. Max) were quantified using the trabecular thickness 
script in the BoneJ plugin. Bone volume fraction (BV/TV) was calculated using a bone threshold 
of 3500 HU. Bone mineral density (BMD) and tissue mineral density (TMD) were calculated 
using calibration data of a series of hydroxyapatite concentrations. All analyses were performed 
separately in the medial, lateral, and trochlear compartments of both the femur and tibia as well 
as the entire tibial and femoral volumes.  
Histologic Processing and Analysis 
Following fixation in 10% NBF, all samples were decalcified to completion in 10% 
formic acid and dehydrated in an increasing ethanol series. Both the tibia and femur were 
bisected sagittally to facilitate separate sectioning of the medial and lateral compartments. Due to 
the natural taper of the trochlear cartilage with respect to the condylar cartilage, sectioning of the 
femoral compartments was performed with a 10⁰ oblique angle to capture both trochlear and 
condylar cartilage on all sections. Tibial compartments were sectioned in true sagittal fashion 
without an oblique angle. Four sections spaced 200 µm from the medial and lateral compartment 
of the femur and tibia were then stained with both Hematoxylin & Eosin (H&E) as well as 
Safranin-O/Fast Green (Saf-O). Microscopic imaging was performed at 20x using an automatic 
slide imaging system (Aperio, Leica Biosystems, Buffalo Grove, IL, USA ). Qualitative 
evaluation of articular cartilage was performed by three blinded investigators using the OARSI 
Modified Mankin score (Table 7.2.1)(Kraus et al., 2010). Results of all three raters were 
58 
 
 
 
averaged to calculate a composite score for each animal, and composite scores of each animal 
within a group were averaged to obtain a group average at each time point.  
Biomarker Quantification in Serum and Synovial Lavage Fluid 
Collected serum was thawed at room temperature prior to quantification. Following a 5 
min centrifugation at 2,000 rpm to settle particulate, concentrations of six biomarkers of cartilage 
metabolism and breakdown (Table 7.2.2) were quantified using enzyme-linked immunosorbent 
assays (ELISAs). Synovial fluid was thawed, centrifuged, and analyzed for cartilage oligomeric 
matrix protein (COMP) concentration using ELISA.  
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Table 7.2.1 – OARSI Modified Mankin Score using for Qualitative Histological Assessment 
Parameter Grade Description 
Articular Cartilage Structure 0 Normal, smooth, uninterrupted surface 
 1 Mild surface irregularities (undulations) 
 2 Irregular surface, 1-3 superficial clefts (fissures) 
 3 >3 fissures and/or loss of cartilage in the superficial zone 
 4 1-3 fissures extending into the middle zone 
 5 >3 fissures and/or loss of cartilage extending into the middle zone 
 6 1-3 fissures extending into the deep zone 
 7 >3 fissures extending into the deep zone and/or loss of cartilage to 
deep zone 
 8 Fissures or loss of cartilage extending to the zone of calcified 
cartilage 
Proteoglycan Content (staining by 
Safranin-O) 
0 Uniform throughout articular cartilage 
1 Decreased in superficial zone only and for < half the length of the 
condyle or plateau 
2 Decreased in superficial zone for half the length or greater of the 
condyle or plateau 
3 Decreased in superficial and middle zones for <half the length of 
the condyle or plateau 
4 Decreased in superficial and middle zones for half the length or 
greater of the condyle or plateau 
5 Decreased in all 3 zones for <half the length of the condyle or 
plateau 
6 Decreased in all 3 zones for half the length or greater of the 
condyle or plateau 
Cellularity 0 Normal (1/2 cells/lacuna) 
 1 Diffuse/slight hypercellularity 
 2 Regions of hypercellularity and clustering 
 3 Diffuse hypocellularity 
Tidemark Integrity 0 Intact/single tidemark 
 1 Crossed by vessels/duplication of tidemark 
Osteophytes 0 No osteophyte present 
 1 Small osteophyte 
 2 Medium-sized osteophyte 
 3 Large osteophyte 
 
Table 7.2.2 – Biomarkers of cartilage metabolism and breakdown analyzed in serum 
Analyte Analyte Details Supplier 
CS846 Aggrecan Epitope Ibex, Montreal, Quebec Canada 
C2C Collagenase neoepitope of Collagen II Ibex, Montreal, Quebec Canada 
CTxII Collagen II turnover Nordic Bioscience, Herlev, Denmark 
CPII Collagen II synthesis Ibex, Montreal, Quebec Canada 
C1,2C Type I/II collagen turnover Ibex, Montreal, Quebec Canada 
COMP Cartilage Oligomeric Matrix Protein MD Bioproducts, St. Paul, MN, USA 
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Data Analysis and Statistical Comparison 
All statistical analyses were performed in SPSS (v22, IBM, Armonk, NY). The normality 
and equal variance assumptions were assessed using the Shapiro-Wilk test and Levene’s test, 
respectively. Differences in independent, normally distributed and non-normally distributed 
variables were compared between groups at each time point using one-way analysis of variance 
(ANOVA) and Kruskal-Wallis tests, respectively. Differences in independent, normally 
distributed and non-normally distributed variables between the 4 and 10-week time points were 
assessed using t-tests and Mann Whitney U tests, respectively. Multiple comparisons were 
performed with a Sidak P-value correction at α = 95%. Inter-rater agreement in qualitative 
assessment of histologic grade was calculated using the intraclass correlation coefficient (ICC). 
Correlations of continuous, normally-distributed variables were calculated using the Pearson 
product-moment correlation coefficient. Correlations of ordinal, nonparametric variables were 
calculated using the Spearman rank-order correlation coefficient. P values lower than 0.05 were 
considered significant. 
7.3 - Results 
Subchondral Bone Remodeling 
Subchondral bone remodeling was observed as a function of both age and injury A 
comprehensive numerical summary of subchondral bone remodeling data can be found in 
Appendix 2, Femur: Tables A2.1 and A2.2; Tibia: Tables A2.3 and A2.4. Due to aging, Control 
animals exhibited significant increases in femoral and tibal bone volume fraction (BV/TV), bone 
mineral density (BMD), and tissue mineral density (TMD) in all compartments between 4 and 10 
weeks. Trabecular thickness mean and trabecular thickness max increased significantly between 
4 and 10 weeks in both the femur and in the tibia as a result of aging in the Control group. 
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Transection induced a loss of femoral subchondral BV/TV at both 4 and 10 weeks (Figure 7.3.1, 
Figure 7.3.2), whereas Rupture exhibited only slight, non-significant decreases at 4 weeks and 
significant decreases in the trochlear compartment and whole femur at 10 weeks. Transection 
had a significantly lower femoral subchondral BV/TV compared to Rupture in all compartments 
at 4 weeks and in the lateral compartment at 10 weeks (Figure 7.3.2).  
 
 
Figure 7.3.1  – Representative sagittal sections of the medial femoral condyle of Control (left), 
Rupture (middle), and Transection (right) at 4 weeks. Significant subchondral bone loss was 
observed in the Transection group (red arrows), with only subtle changes in the Rupture group. 
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Figure 7.3.2 – Femoral and Tibial Subchondral Bone Volume Fraction (BV/TV) at 4 weeks and 
10 weeks. * denotes significant difference to Control. ◊ denotes significant difference between 
Rupture and Transection. 
 
Slight decreases in femoral subchondral BMD and TMD (Figure 7.3.3) were observed in 
both Rupture and Transection at 4 weeks, and Transection had significantly lower femoral 
subchondral BMD in the trochlear compartment and significantly lower femoral subchondral 
TMD in the lateral compartment compared to Rupture at 4 weeks. At 10 weeks, Rupture 
exhibited globally higher femoral subchondral TMD compared to Control, whereas Transection 
exhibited globally lower femoral subchondral TMD and BMD. Rupture had significantly higher 
femoral subchondral BMD in the lateral compartment and whole femur and significantly higher 
femoral subchondral TMD in the medial and lateral compartments as well as the whole femur 
compared to Transection (Figure 7.3.3). Only slight changes in femoral subchondral trabecular 
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morphology were observed. Rupture exhibited significantly higher Tb.Th. Mean in the lateral 
compartment compared to Transection at 10 weeks, and both Rupture and Transection exhibited 
significantly lower femoral subchondral Tb. Th. Mean compared to Control at 10 weeks (Figure 
7.3.4; Appendix 2, Table A2.2). 
Figure 7.3.3 – Femoral and Tibial Subchondral Bone Tissue Mineral Density (TMD) at 4 weeks  
and 10 weeks. * denotes significant difference to Control. ◊ denotes significant difference 
between Rupture and Transection. 
Less profound changes were observed in the subchondral bone of the tibia. Both Rupture 
and Transection exhibited significant decreases in tibial subchondral BV/TV in the medial 
compartment compared to Control at both 4 and 10 weeks, and Transection had significantly 
lower tibial subchondral BV/TV in the medial compartment compared to Rupture at 4 and 10 
weeks (Figure 7.3.2). Rupture had significantly higher tibial subchondral BMD and TMD 
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compared to Transection at 10 weeks (Figure 7.3.3). No extensive changes in tibial subchondral 
trabecular morphology were noted (Figure 7.3.4; Appendix 2, Table A2.3, A2.4).   
Figure 7.3.4 – Femoral and Tibial Subchondral Trabecular Thickness (Tb.Th.) Mean  at 4 weeks 
and 10 weeks. * denotes significant difference to Control. ◊ denotes significant difference 
between Rupture and Transection. 
Subchondral BV/TV correlated strongly with subchondral BMD in both the femur (r = 
0.991, P < 0.001, Figure 7.3.5A) and tibia (r = 0.965, P < 0.001, Figure 7.3.5B), demonstrating 
the relationship between bone loss and subchondral bone mineral density. Furthermore, 
subchondral BV/TV correlated highly with subchondral TMD in both the femur (r = 0.804, P < 
0.001) and the tibia (r = 0.816, P < 0.001) and with Tb .Th. Mean in both the femur (r = 0.969, P 
< 0.001) and the tibia (r = 0.813, P < 0.001), indicating a relationship between inherent bone 
tissue mineral density, trabecular morphology, and bone loss.  
65 
 
 
 
 
Figure 7.3.5 – Correlation between subchondral BV/TV and subchondral BMD in the femur (A) 
and tibia (B). The solid line indicates the linear regression, and dashed lines indicate the 95% 
confidence interval of the regression. 
 
Epiphyseal Bone Remodeling 
Bony remodeling of the femoral and tibial epiphysis was observed as a function of both 
age and injury.  A comprehensive numerical summary of epiphyeal bone remodeling data can be 
found in Appendix 2, Femur: Tables A2.5, A2.6; Tibia: Tables A2.7, A2.8. Aging induced 
increases in epiphyseal BV/TV, BMD and TMD, and Tb.Th. mean increased in only the tibia. 
Compared to Control, femoral epiphyseal BV/TV was significantly lower in Rupture and 
Transection in the trochlear compartment and whole femur at 4 weeks and only in the trochlear 
compartment at 10 weeks. There were no direct differences in femoral epiphyseal BV/TV 
between Rupture and Transection. (Figure 7.3.6)  
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Figure 7.3.6 – Femoral and Tibial Epiphyseal Bone Volume Fraction (BV/TV) Mean at 4 weeks 
and 10 weeks. * denotes significant difference to Control. ◊ denotes significant difference 
between Rupture and Transection. 
Femoral epiphyseal BMD was significantly lower in the trochlear compartment in both 
Rupture and Transection at 4 weeks. In general, compared to Control, Rupture exhibited 
increases in femoral epiphyseal bone mineral density whereas Transection exhibited slight 
decreases or no change. At 10 weeks, Rupture exhibited significant increases in femoral 
epiphyseal BMD in the lateral compartment and TMD in the medial compared to both Control 
and Transection. Rupture had significantly higher femoral epiphyseal TMD compared to 
Transection in all compartments at 10 weeks (Figure 7.3.7). Compared to Control, Rupture 
exhibited significantly higher femoral epiphyseal Tb.Th. Mean at both 4 and 10 weeks, whereas 
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Transection had increased Tb.Th. Mean at only 10 weeks (Figure 7.3.8). The same trend was 
observed for Tb.Th.Std.  
 
Figure 7.3.7 – Femoral and Tibial Epiphyseal Bone Tissue Mineral Density (TMD) at 4 weeks 
and 10 weeks.* denotes significant difference to Control. ◊ denotes significant difference 
between Rupture and Transection. 
Injury-induced bony remodeling of epiphyseal bone of the tibia was less extensive than 
the femur (Appendix 2, Table A2.7, A2.8) . Transection induced a significant decrease in tibial 
epiphyseal BV/TV in all compartments at 4 weeks and only in the medial compartment at 10 
weeks (Figure 7.3.6). BV/TV was not altered in the Rupture group at either time point, and there 
were no direct differences between Rupture and Transection. Rupture had significantly higher 
tibial epiphyseal BMD in the lateral compartment and whole tibia at 4 weeks compared to 
Transection, but no significant differences in bone mineral density were observed between the 
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two groups at 10 weeks. Transection exhibited significantly lower tibial epiphyseal TMD in the 
whole tibia compared to Control at 4 weeks, but no other changes in TMD were seen in either 
injury group at either time point (Figure 7.3.7) Tb.Th.Mean was significantly higher in the 
Rupture group compared to Control in the medial compartment at 10 weeks, but no other 
changes in Tb. Th. Mean were observed in either injury group (Figure 7.3.8).  
 
Figure 7.3.8 – Femoral and Tibial Epiphyseal Trabecular Thickness (Tb.Th.) Mean  at 4 weeks 
and 10 weeks. * denotes significant difference to Control. ◊ denotes significant difference 
between Rupture and Transection. 
Epiphyseal BV/TV correlated strongly with epiphyseal BMD in both the femur (r = 
0.850, P < 0.001, Figure 7.3.9A) and the tibia (r = 0.885, P < 0.001, Figure 7.3.9). Furthermore, 
there were significant correlations between epiphyseal BV/TV and epiphyseal TMD in both the 
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femur (r = 0.564,  P < 0.001) and the tibia (r = 0.403, P < 0.015). Epiphyseal BV/TV correlated 
with epiphyseal Tb.Th. Mean only in the tibia (r = 0.770, P < 0.001).  
 
Figure 7.3.9 –Correlation between epiphyseal BV/TV and epiphyseal BMD in the femur (A) and 
tibia (B). The solid line indicates the linear regression, and dashed lines indicate the 95% 
confidence interval of the regression. 
Articular Cartilage Morphology 
Extensive changes in articular cartilage (AC) morphology were observed due to both 
Rupture and Transection. A comprehensive numerical summary of femoral and tibial articular 
cartilage thickness, peak-to-valley distance (P-V), and surface roughness between Control, 
Rupture, and Transection is shown in Appendix 3, Tables A3.1 – A3.4. Parameterized femoral 
cartilage thickness maps indicate profound compartmental and sub-compartmental changes in 
articular cartilage height due to injury, most notably on the medial condyle (Figure 7.3.11). 
Control animals exhibited smooth, congruent femoral articular cartilage with zones of slightly 
increased cartilage thickness at the weight-bearing regions of both condyles and the trochlear 
groove. A global decrease in AC thickness was observed in Control animals between 4 and 10 
weeks due to aging, and this decrease was consistent throughout each compartment (Figure 
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7.3.10). At 4 weeks, both Rupture and Transection exhibited significant increases in whole femur 
AC thickness, with extensive sub-compartmental thickening in the medial zone of the medial 
condyle and thinning in the lateral zone of the medial condyle, evident numerically (Figure 
7.3.10) and graphically on both parameterized height maps (Figure 7.3.11) and raw axial 
microCT slices (Figure 7.3.12). Thinning was observed to be with respect to the group’s mean 
AC thickness rather than the Control’s AC thickness, implying that although thinning was 
observed, these zones were still not significantly thinner than AC in Control animals. As such, 
cartilage thickness in the lateral zone of the medial condyle was significantly thinner than the 
medial zone of the medial condyle within both treatment groups. Both Rupture and Transection 
exhibited significant increases in AC thickness in the medial zone of the medial condyle, but 
only Rupture had a significant AC thickness increase in the whole medial condyle at 4 weeks. 
(Figure 7.3.10)   
 
Figure 7.3.10 – Femoral Articular Cartilage Thickness following Rupture and Transection at 4 
weeks (left) and 10 weeks (right). * denotes significant difference to Control. ◊ denotes 
significant difference between Rupture and Transection. 
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Figure 7.3.11 – Representative Femoral Articular Cartilage Thickness Maps of Control (left 
column), Rupture (middle column) and Transection (right column) at 4 weeks (top row) and 10 
weeks (bottom row). M = medial; L = lateral.  
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At 10 weeks, AC remained globally thicker each in compartment of Rupture and 
Transection compared to Control. Whereas the lateral zone of the medial condyle was not 
significantly thicker in either group at 4 weeks, significantly thicker AC was observed at 10 
weeks, and this same trend was observed in the trochlea. Differences between Transection and 
Rupture were observed in the medial condyle at 10 weeks: Transection exhibited significantly 
thicker AC compared to Rupture in the whole medial condyle and the lateral zone of the medial 
condyle (Figure 7.3.10). The Rupture group had a larger overall decrease in AC thickness 
between 4 and 10 weeks whereas the Transection group maintained AC thickening in most 
compartments and sub-compartments at 10 weeks (Appendix, Table A3.2). Specifically, whole-
femur, lateral condylar, and trochlear AC thickness significantly decreased in the Rupture group 
between 4 and 10 weeks, whereas this was not observed in the Transection group.  
 
Figure 7.3.12 – Representative axial contrast-enhanced µCT slices demonstrating sub-
compartmental articular cartilage thickening (white arrows) and thinning (red arrows) on the 
medial femoral condyle in both Rupture (middle) and Transection (right). 
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Surface roughness of AC was quantified using arithmetic surface roughness (Sa) and 
peak-to-valley distance (P-V). Both metrics of surface roughness were significantly increased in 
the whole femur, the medial condyle, and the lateral condyle at 4 and 10 weeks, but no drastic 
changes in surface roughness were observed in the trochlea (Appendix, Tables A3.1 and A3.2). 
Sa was highest in the medial condyle of both Rupture and Transection at 4 weeks, further 
elucidating the subcompartmental thickening and thinning observed on the medial femoral 
condyle. Compared to Control, Sa and P-V remained elevated at 10 weeks, with significant 
decreases between 4 and 10 weeks in only the lateral aspect of the lateral condyle in both the 
Rupture and Transection groups.  Rupture exhibited significantly higher Sa in the whole trochlea 
compared to Control whereas Transection did not exhibit this finding. Furthermore, there was a 
significant increase in Sa of the medial trochlea between 4 and 10 weeks only in the Rupture 
group. However, no direct differences in Sa or P-V were observed between Rupture and 
Transection at either time point.  
 
Figure 7.3.13 - Femoral Articular Cartilage Surface Roughness (Sa) following Rupture and 
Transection at 4 weeks (left) and 10 weeks (right). * denotes significant difference to Control. ◊ 
denotes significant difference between Rupture and Transection. 
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Changes in tibial articular cartilage were also observed in both injury groups at both time 
points. In contrast to the subcompartmental thickening and thinning observed in femoral articular 
cartilage of Rupture and Transection animals, tibial articular cartilage exhibited only global 
thickening, with the most extensive changes observed in the medial tibial compartment (Figure 
7.3.14, Figure 7.3.15). At 4 weeks, both Rupture and Transection exhibited significantly higher 
AC thickness in the whole tibia, whole medial tibia, and whole lateral tibia (Figure 7.3.14). 
Compared to Control, all tibial subcompartments had increased thickness in the Transection 
group, whereas the Rupture group did not exhibit thicker AC in the medial zone of the medial 
compartment and the lateral zone of the lateral compartment. There were no direct differences in 
tibial AC thickness between Rupture and Transection in any compartment or subcompartment. 
At 10 weeks, tibial AC remained globally thicker in both groups compared to Control except for 
the medial zone of the medial compartment and lateral zone of the lateral compartment (Figure 
7.3.14). As with femoral AC, only the Rupture group exhibited a significant decrease in whole-
tibia AC thickness between 4 and 10 weeks, whereas the Transection group did not demonstrate 
this finding. There were no direct differences in tibial AC thickness between Rupture and 
Transection in any compartment or subcompartment at 10 weeks.  
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Figure 7.3.14 - Tibial Articular Cartilage Thickness (Sa) following Rupture and Transection at 4 
weeks (left) and 10 weeks (right). * denotes significant difference to Control. ◊ denotes 
significant difference between Rupture and Transection. 
 
 
Figure 7.3.15 - Representative Tibial Articular Cartilage Thickness Maps of Control (left 
column), Rupture (middle column) and Transection (right column) at 4 weeks (top row) and 10 
weeks (bottom row). M = medial; L = lateral; A = anterior. 
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Both P-V and Sa were significantly higher at 4 weeks compared to Control in all 
compartments and subcompartments of the tibia in the Transection group and in all 
compartments and subcompartments except for the lateral zone of the lateral tibia in the Rupture 
group. Transection exhibited significantly higher P-V in the lateral tibia compared to Rupture at 
4 weeks, but no difference in P-V was observed between the groups at 10 weeks (Appendix, 
Table A3.3). Transection also exhibited significantly higher Sa in the medial and lateral zones of 
the medial tibia as well as the lateral zone of the lateral tibia and the whole lateral tibia (Figure 
7.3.16). At 10 weeks, P-V remained significantly higher compared to Control in each 
subcompartment and compartment of the tibia in both Rupture and Transection, but only the 
whole lateral compartment in the Rupture group demonstrated a significant increase between 4 
and 10 weeks. No significant increases in P-V were observed between 4 and 10 weeks in the 
Transection group (Appendix, Tables A3.3, A3.4). Sa remained significantly higher compared to 
Control in each compartment and subcompartment in the Transection group, and Rupture 
exhibited significantly higher Sa in all compartments and subcompartments except the lateral 
zones of the medial and lateral tibia. Transection had significantly higher Sa compared to 
Rupture in the whole tibia, the whole lateral tibia, and the medial zone of the lateral tibia. (Figure 
7.3.16) 
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Figure 7.3.16 - Tibial Articular Cartilage Surface Roughness (Sa) following Rupture and 
Transection at 4 weeks (left) and 10 weeks (right). * denotes significant difference to Control. ◊ 
denotes significant difference between Rupture and Transection. 
Metrics of articular cartilage morphology correlated with several epiphyseal and 
subchondral bone morphometric parameters. Femoral cartilage thickness correlated with 
epiphyseal BV/TV (r = -0.719, P < 0.001), epiphyseal TMD (r = -0.522, P = 0.001), epiphyseal 
BMD (r = -0.609, P < 0.001), subchondral BV/TV (r = -0.774, P < 0.001, Figure 7.3.17), 
subchondral TMD (r = -0.515, P = 0.001), subchondral BMD (r = -0.744, P < 0.001), and 
subchondral Tb.Th. Mean (r = -0.777, P < 0.001). Femoral cartilage P-V correlated only weakly 
with epiphyseal BV/TV (r = -0.334, P = 0.046) and epiphyseal Tb.Th. Mean (r = 0.429, P  = 
0.009). Femoral cartilage Sa correlated with epiphyseal BV/TV (r = -0.426, P = 0.010), 
epiphyseal TMD (r = -0.387, P = 0.020), epiphyseal BMD (r = -0.379, P = 0.023), epiphyseal 
Tb.Th. Mean (r = 0.377, P = 0.024) subchondral BV/TV (r = -0.522, P = 0.001), subchondral 
BMD (r = -0.466, P = 0.004), and subchondral Tb.Th. Mean (r = -0.485, P = 0.003).  
Correlations between cartilage morphology and bone morphometry were also observed in 
the tibia. Tibial cartilage thickness correlated with epiphyseal BV/TV (r = -0.535, P = 0.001), 
epiphyseal TMD (r = -0.488, P = 0.003), epiphyseal BMD (r = -0.641, P < 0.001), subchondral 
BV/TV (r = -0.737, P < 0.001, Figure 7.3.17), subchondral TMD (r = -0.487, P = 0.003), 
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subchondral BMD (r = -0.651, P < 0.001), and subchondral Tb.Th. Mean (r = -0.513, P = 0.001). 
Tibial cartilage P-V correlated with epiphyseal BMD (r = -0.357, P = 0.033), subchondral 
BV/TV (r = -0.541, P = 0.001), subchondral TMD (r = -0.404, P = 0.015), and subchondral 
BMD (r = -0.500, P = 0.002). Tibial cartilage Sa correlated with epiphyseal BV/TV (r = -0.455, 
P = 0.005), epiphyseal TMD (r = -0.466, P = 0.004), epiphyseal BMD (r = -0.568, P < 0.001), 
subchondral BV/TV (r = -0.717, P < 0.001), subchondral TMD (r = -0.521, P = 0.001), 
subchondral BMD (r = -0.653, P < 0.001), and subchondral Tb.Th. Mean (r = -0.385, P = 0.020).  
 
Figure 7.3.17  - Correlation between subchondral BV/TV and articular cartilage thickness in the 
femur (A) and tibia (B). The solid line indicates the linear regression, and dashed lines indicate 
the 95% confidence interval of the regression. 
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Histological Evaluation  
Qualitative histologic assessment of H&E- and Saf-O-stained sections indicated 
extensive changes in AC structure, cellularity, and extracellular matrix (ECM) content as a 
function of treatment, and varying degrees of degenerative changes were observed in the 
compartments and subcompartments of both the femur and tibia. Healthy AC in the Control 
group exhibited a smooth, congruent surface with homogenous cellularity and Saf-O staining 
throughout the matrix. Aside from normal differences in thickness, trochlear and condylar 
cartilage appeared histologically identical. Chondrocytes in the Control group were observed as 
singlets or doublets within a chondron, and cellular size and orientation varied natively as a 
function of AC depth. A distinct, single, uninterrupted tidemark was observed between the deep 
zone and calcified zone in the Control group, and no capillaries penetrated into through the 
tidemark.  
 
 
Figure 7.3.18 – Articular cartilage morphology on µCT (A) and histology (B). Histologic 
evaluation confirmed µCT-based findings indicating zones of articular cartilage thickening (red 
arrow) immediately next to articular cartilage thinning (blue arrow) on the medial femoral 
condyle of both Rupture and Transection. 
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Femoral AC exhibited histologic evidence of osteoarthritis-like changes in both Rupture 
and Transection, and these changes varied between compartments. Histologic assessment 
confirms µCT-based findings of AC morphology, namely subcompartmental thickening and 
thinning on the medial femoral condyle (MFC) (Figure 7.3.18). Magnified sections indicate that 
the zones of thickening are hypertrophic, hypercellular, and exhibit intense Saf-O staining 
(Figure 7.3.19B, D, black arrows). Chondrocytes exhibited abnormal clonality and clustering, 
and chondrons contained numerous chondrocytes in zones of hypercelluarity. Whereas the 
superficial layer of AC in healthy samples of the Control group exhibits flattened cells oriented 
parallel to the surface (Figure 7.3.19A, C), AC of the MFC in both Rupture and Transection 
exhibit nearly complete loss of the superficial layer with numerous fissures extending into the 
middle and deep zone (Figure 7.3.19B, D, red arrows). The zone of thinning was devoid of Saf-
O staining and severely hypocellular with complete loss of the superficial, middle, and in some 
instances, deep zones of AC (Figure 7.3.19B, D, blue arrows). The tidemark was discontinuous 
and, at times, duplicated in zones of severe AC degeneration.  
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Figure 7.3.19 – Histological Appearance of Subcompartmental Thickening and Thinning 
observed on the medial femoral condyle in both Rupture and Transection groups. Control 
cartilage (A,C) appears as a congruent tissue with even thickness, homogenous cell distribution 
and consistent Saf-O staining (C). Both treatment groups (B,D) exhibit a zone of severe cartilage 
thickening (black arrows) next to a zone of severe thinning (blue arrows). The cartilage tissue is 
hypocellular in the thin zone and hypercellular in the thick zone, with numerous fissures 
extending into the superficial zone (red arrows).  
The lateral femoral condyle and trochlea of both Rupture and Transection exhibited 
whole-compartment AC thickening with interspersed fissures and surface irregularities, but no 
zones of thinning were observed. These findings are also in accordance with µCT-based AC 
morphology results, demonstrating thickening in the medial and lateral subcompartments of the 
lateral and trochlear femoral compartment. Fissures generally extended into the superficial and 
middle zones, but whole-thickness lesions/fissures were rarely observed. Slight hypercellularity 
and cellular clustering were also observed in the lateral and trochlear compartments of both 
Rupture and Transection, and increased Saf-O staining was evident throughout the ECM. 
Numerous instances of bone marrow and vascular infiltration through the tidemark and into the 
deep zone of AC were noted in trochlear cartilage of both Rupture and Transection (Figure 
7.3.20), consistent with decreases in BV/TV noted on µCT measurements. 
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Figure 7.3.20 – Infiltration of vasculature into the deep zone of trochlear articular cartilage. 
Healthy articular cartilage from Control animals exhibits a continuous tidemark (A, red arrows). 
Infiltration of subchondral vasculature (B, black arrows) into the deep zone of articular 
cartilage and a disrupted tidemark (B, red arrows) was observed in both Rupture and 
Transection animals.  
The OARSI Modified Mankin score was used to grade sagittal histologic sections. Inter-
rater agreement between the three raters was calculated using the intraclass correlation 
coefficient (ICC). There was a high level of agreement in each subsection of the OARSI grade in 
the femur (Articular Cartilage Structure: ICC = 0.957; Proteoglycan Content: ICC = 0.881; 
Cellularity: ICC = 0.903; Tidemark Integrity: ICC = 0.739) as well as the averaged whole-femur 
grade (ICC = 0.966). A comprehensive numerical summary of histologic grading of the femur 
stratified by score subsection, treatment group, and time point can be found in Appendix 4, 
Tables A4.1 – A4.2. Both Rupture and Transection exhibited significantly higher whole femur, 
medial femur, and lateral femur histologic grade at both 4 and 10 weeks compared to Control 
(Figure 7.3.21). Each subsection of the score was significantly higher in both Rupture and 
Transection compared to Control, with the largest differences measured in the “Articular 
Cartilage Structure” subsection. The medial femur exhibited significantly higher histologic grade 
in both Rupture and Transection at both time points.  
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Figure 7.3.21 – OARSI Modified Mankin Histologic Grading of the Femur in Control, Rupture, 
and Transection at 4 weeks (left) and 10 weeks (right).* denotes significant difference to 
Control. 
 
Rupture had a significantly higher Cellularity subsection grade compared to Transection 
in the whole femur and lateral femur at 4 weeks and in the lateral femur at 10 weeks (Figure 
7.3.22). No other subsection grade differed significantly between Rupture and Control, and 
neither group exhibited significant changes in histologic grade or subsection grade between 4 
and 10 weeks. Control animals exhibited a significant increase in Proteoglycan Content 
subsection grade in the medial femur between 4 and 10 weeks, but no other subsection grade 
varied between the two time points (Appendix 4, Tables A4.1 – A4.2).  
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Figure 7.3.22 – Histologic Cellularity Subsection Grade the Femur in Control, Rupture, and 
Transection at 4 weeks (left) and 10 weeks (right). Cellularity grade: 0 = normal cellularity; 1 = 
diffuse/slight hypercellularity; 2 = hypercellularity and clustering; 3 = Diffuse hypocellularity.  
* denotes significant difference to Control. ◊ denotes significant difference between Rupture and 
Transection.  
 
Degenerative changes were also noted on tibial cartilage of both Rupture and 
Transection. Though the overall extent of degeneration was milder on tibial cartilage compared 
to femoral cartilage, extensive evidence of structural, compositional, and cellular degeneration 
was evident in both the medial and lateral tibial compartments at 4 and 10 weeks. Structural 
damage was largely contained to the superficial zone, and no subcompartmental pattern of 
thickening and thinning was observed. Superficial structural degeneration coincided with 
hypocellularity and loss of Saf-O staining, and the middle and deep zones exhibited 
hypercellularity and cell clustering (Figure 7.3.23). The posterior aspect of tibial cartilage 
exhibited more extensive structural damage and erosion, likely due to anterior subluxation of the 
tibia with respect to the femur due to loss of anterior stability in both Rupture and Transection. 
Loss of Saf-O staining was largely localized to the superficial and middle zones, and the deep 
zone exhibit little to no loss of staining intensity.  
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Figure 7.3.23 – Histological appearance of superficial structural degeneration and 
hypocellularity on the posterior tibia in both Rupture and Transection. Control tibial cartilage 
(A, C) exhibits a smooth surface with homogenous cellularity and Saf-O staining intensity. 
Structural erosion of the superficial zone of cartilage was noted in both treatment groups (B, D). 
A thickened, hypocellular superficial zone with no Saf-O staining (red arrows), hypercellularity 
in the middle and deep zones (black arrow), and tidemark disruption with vascular infiltration 
(white arrow) were observed. 
 
Tibial histology was also graded using the OARSI Modified Mankin scale. There was a 
high level of agreement between the three raters in each subsection of the OARSI score 
(Articular Cartilage Structure: ICC = 0.847; Proteoglycan Content: ICC = 0.765; Cellularity: 
ICC = 0.935; Tidemark Integrity: ICC = 0.765) and in the averaged whole-tibia grade (ICC = 
0.892). A comprehensive numerical summary of histologic grading of the tibia stratified by score 
subsection, treatment group, and time point can be found in Appendix 4, Tables A4.3 – A4.4.   
Both Rupture and Transection exhibited significantly higher whole tibia, medial tibia, and lateral 
tibia histologic grade at both 4 and 10 weeks compared to Control (Figure 7.3.24). Transection 
exhibited slightly lower whole tibia histologic grade compared to Rupture at 4 weeks, but this 
finding was not found to be statistically significant (P = 0.105). At 10 weeks, Transection 
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exhibited slightly higher histologic grade than Rupture, but this comparison was also not 
significant. There was no difference in histologic grade between the medial and lateral tibia in 
any of the groups. While the Control and Rupture group exhibited no differences in whole tibia, 
medial tibia, or lateral tibia histologic grade between the 4 and 10 week time points, there was a 
significant increase in whole tibia and lateral tibia histologic grade between the two time points 
in the Transection group. Furthermore, the Transection group had significant increases in the 
whole tibia Articular Cartilage and Proteoglycan Content subsection scores between the two time 
points (Appendix 4, Table A4.4).  
 
Figure 7.3.24 – OARSI Modified Mankin Histologic Grading of the Tibia in Control, Rupture, 
and Transection at 4 weeks (left) and 10 weeks (right).* denotes significant difference to 
Control. 
 
Serum-Level Biomarkers of Cartilage Metabolism and Breakdown 
The concentrations of six articular cartilage biomarkers were measured in the serum of Control, 
Rupture, and Transection animals at both 4 and 10 weeks using commercially-available ELISA 
kits. Assay results of the six biomarkers are summarized in Figure 7.3.25. Compared to Rupture, 
Transection had significantly higher C2C concentration at both 4 and 10 weeks (Figure 7.3.25A), 
significantly higher COMP concentration at 4 weeks (Figure 7.3.25C), and significantly higher 
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CTxII concentration at 4 weeks (Figure 7.3.25F). Furthermore, Transection had significantly 
higher COMP and CTxII concentration at 4 weeks compared to Control. There was no difference 
in the concentration of any analyte between Control and Rupture at either time point.  
 
Figure 7.3.25 – Quantification of C2C (A), C1,2C (B), COMP (C), CPII (D), CS846 (E), and 
CTxII (F) in serum of Control, Rupture, and Transection at 4 and 10 weeks. * denotes significant 
difference to Control. ◊ denotes significant difference between Rupture and Transection. 
Collagen cleavage-to-synthesis ratios were calculated using the four markers of Type I 
and/or Type II collagen cleavage C2C, C1,2C, CTxII, and COMP and the marker of collagen 
synthesis, CPII (Figure 7.3.26). Transection had a significantly higher C2C/CPII ratio compared 
to Rupture at 4 weeks and compared to both Control and Rupture at 10 weeks. There were no 
differences in C1,2C/CPII ratios between any of the groups at either time points. Transection had 
a significantly higher CTxII/CPII ratio compared to Control at 4 weeks, but there was no 
difference in CTxII/CPII ratio compared to Rupture at either time point. Lastly, Transection had 
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a significantly higher COMP/CPII ratio compared to Rupture at 4 weeks, and both treatment 
groups had a significantly higher COMP/CPII ratio compared to Control at 10 weeks.  
 
Figure 7.3.26 – Collagen Cleavage-to-Synthesis Ratios of Serum-level biomarkers. Collagen 
cleavage-to-synthesis ratios were calculated using a marker of collagen synthesis, CPII, and 
four biomarkers of collagen cleavage C2C (A), C1,2C (B), CTxII (C), and COMP (D). * denotes 
significant difference to Control. ◊ denotes significant difference between Rupture and 
Transection. 
COMP Concentration in Synovial Lavage Fluid 
Synovial lavage fluid was assayed for COMP concentration using a commercially-
available ELISA kit. Although the assay was not expired and the manufacturer’s protocol was 
followed precisely, the assay did not return usable results. No color development was noted in 
any assay well, and the standard curve samples all indicated optical density values below 
baseline. We conclude that one or more assay reagent(s) were impure, falsely packaged, or 
expired without indication, and given that all synovial fluid lavage samples were used up, no 
second quantification was able to be done. 
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7.4 – Discussion 
Animal models are used to simulate a disease process in order to gain an understanding 
of its etiology and to screen potential therapeutic strategies. In the setting of PTOA, numerous 
animal models have been developed, and the most common ACL injury model is surgical ACL 
transection. While several studies have demonstrated that ACL transection induces degenerative 
changes, the extent to which this model mimics the biologic phenomena of human ACL rupture 
is unknown. The surgical nature of the ACL transection model may introduce several biological 
and biomechanical confounding factors, and models employing noninvasive injury could provide 
a more accurate representation of human injury. The purpose of this study was to characterize the 
onset and progression of PTOA in a new model of noninvasive ACL rupture in the rat, as 
characterized in Section 6 - Aim #1, and to compare the findings to the surgical ACL transection 
model. We hypothesized that the noninvasive rupture model would induce more extensive 
degenerative changes in articular cartilage and that a differential bony remodeling response 
would be observed. Our hypothesis regarding articular cartilage degeneration was proven false as 
both the Rupture and Transection groups exhibited extensive degeneration at both time points, 
and the Transection group exhibited more profound degeneration in femoral and tibial articular 
cartilage. Our hypothesis regarding differential bony remodeling was confirmed, and several 
differences in bone mineral density and morphometry were observed between the two groups. 
A change in AC morphology is a hallmark sign of PTOA. While chronic OA is generally 
associated with global AC thinning (Lohmander et al., 2007), the acute and intermediate phases 
of PTOA have been shown to be associated with both AC thinning and thickening. In a clinical 
study of patients 2 years after ACL rupture and reconstruction, Su et al demonstrated AC 
thickening on the medial femoral condyle of patients with ACL injury and reconstruction 
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compared to healthy controls,(Su et al., 2013) a finding very similar to AC morphology results in 
the present study. However, Su et al also found AC thinning of the lateral tibia, an opposite 
finding to our results indicating AC thickening of the lateral tibia. In another clinical study, Buck 
et al used MRI to image 75 women with signs of mild to moderate OA and compared articular 
thickness of femoral and tibial compartments and subcompartments to 77 asymptomatic, healthy 
controls.(Buck et al., 2010) The study found that medial femoral thickening was as frequently 
detected as thinning in patient with moderate OA. The most extensive thickening was observed 
on the medial aspect of the medial femoral condyle, the same location where thickening was 
observed in our study. In a recent paper, Eckstein et al performed longitudinal quantification of 
AC thickness in the weight-bearing region of the tibiofemoral compartments following ACL 
rupture and reconstruction.(Eckstein et al., 2015) The study demonstrated thickening of the 
medial femoral condyle and medial tibial between baseline and 2-year follow-up and between 2-
year and 5-year follow-up. The lateral tibia exhibited thinning between baseline and 2 years 
followed by thickening between 2 and 5 years. The overall cartilage thickness increase was 31 
µm/year over the entire 5-year study duration, and more drastic overall, compartment-dependent 
changes were observed in the baseline-to-2 year interval.   
Our results demonstrate that both noninvasive ACL rupture and surgical ACL transection 
cause subcompartmental cartilage thickening and thinning. We observed drastic thickening of the 
medial aspect of the medial femoral condyle in both treatment groups compared to Control 
animals, and a region of cartilage thinning on the lateral aspect of the medial femoral condyle 
was observed immediately next to the zone of thickening. The region of thinning was not 
significantly thinner than cartilage in Control animals, but since an overall, whole-joint increase 
in cartilage thickness was observed in treatment animals, the region of thinning was significantly 
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thinner than both groups’ mean. Histologic analysis confirmed that this zone was in immediate 
proximity to the region of thickening and exhibited extensive loss of structure, cellularity, and 
proteoglycan content. AC surface roughness was globally elevated but highest in the medial 
femoral condyle in both groups, reiterating that cartilage degeneration is most profound in the 
medial compartment. This finding was subsequently supported by histologic analysis 
demonstrating higher histologic grades in the medial femoral compartment. Our data indicates 
several differences in AC morphology between the Rupture and Transection models.  At 4 
weeks, only the Rupture group exhibited a significant increase in whole femoral medial condyle 
AC thickness. Since both groups had significant increases in AC thickness in the medial zone of 
the medial condyle, this finding likely indicates that the Transection group had more profound 
thinning on the medial femoral condyle, thereby lowering the whole-condyle average. At 10 
weeks, the Transection group had significantly thicker AC in the whole medial femoral condyle 
and the lateral zone of the medial femoral condyle compared to Rupture. While AC surface 
roughness was globally increased in the medial and lateral condyles of the femur, only the 
Rupture group exhibited significantly highly surface roughness in the trochlea at 10 weeks. 
Differences in AC morphology between the two groups were also observed on the tibia. Only the 
Transection group exhibited a significant increase in AC thickness of the medial zone of the 
medial tibia and the lateral zone of the lateral tibia at 4 weeks, and the Transection group 
exhibited significantly higher AC surface roughness on the medial and lateral tibia at 4 weeks in 
addition to the whole tibia and lateral tibia at 10 weeks. This data indicates that surgical ACL 
transection induces more profound degenerative response on the tibia compared to noninvasive 
ACL rupture. 
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Bony remodeling is a major part of the OA cascade.(Burr and Gallant, 2012; Karsdal et 
al., 2008) In the setting of PTOA, acute and chronic changes in joint kinematics alter the loading 
patterns of subchondral and epiphyseal bone, and the release of pro-inflammatory cytokines 
trigger cascades of bone resorption, causing remodeling to occur as a compensatory mechanism 
due to both mechanical loading and biologic signaling. The formation of osteophytes, sclerosis 
of subchondral bone, bone loss, change in bone mineral density, trabecular thinning and loss of 
trabecular elasticity are all known clinical symptoms of bony remodeling during OA(Karsdal et 
al., 2008), and these symptoms have been demonstrated thoroughly by several animal models of 
PTOA.(Boyd et al., 2000; Christiansen et al., 2012b; Florea et al., 2014; Hayami et al., 2006; 
Intema et al., 2010) In a model of noninvasive ACL injury using tibial compression in the 
mouse, Christiansen et al demonstrated that injured animals exhibit a drastic loss of femoral and 
tibial epiphyseal bone volume and apparent mineral density acutely.(Christiansen et al., 2012b) 
Both bone volume and density partially recovered but remained lower than uninjured controls at 
8 weeks. A similar pattern was observed in femoral and tibial trabecular thickness, and the study 
demonstrates a drastic increase in heterotopic bone formation around the knee joint. Our study 
results also indicate bone loss following injury, and this was more pronounced in the Transection 
group than the Rupture group.  Extensive differences in subchondral bone remodeling were 
observed between the Rupture and Transection group at 4 weeks, with the Transection group 
exhibiting significantly lower femoral and tibial subchondral BV/TV whereas the Rupture group 
showed no significant loss of either femoral or tibial subchondral BV/TV at 4 weeks.  These 
differences largely disappeared in the femur at 10 weeks but remained in the tibia. Changes in 
epiphyseal BV/TV were less extensive, with both treatment groups exhibiting a whole-femur 
decrease at 4 weeks but not at 10 weeks. Only the Transection group had significant decreases in 
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tibial epiphyseal BV/TV whereas the Rupture group showed no change in tibial epiphyseal 
BV/TV at all. While the exact mechanism of bone loss following ACL injury is not yet known, 
the role of the injury-induced release of inflammatory factors in perpetuating bone resorption has 
been partially described. Pro-inflammatory cytokines such as interleukin (IL)-1β, tumor necrosis 
factor (TNF)-α, and IL-6 known to be released in the joint following ACL injury(Tang et al., 
2009b; Tang et al., 2009c; Xue et al., 2009) perpetuate bone resorption directly or indirectly by 
promoting osteoclastogenesis.(Schett, 2011; Walsh et al., 2005; Wei et al., 2005) The surgical 
nature of the ACL transection model may cause a greater degree of pro-inflammatory cytokine 
expression in the knee joint compared to a noninvasive injury model due to the introduction of 
foreign bodies such as surgical tools and sutures, consequently causing increased bone loss, but 
future research is necessary to determine this. 
Our data also indicates extensive differences in bone mineral density and trabecular 
morphology between the Rupture and Transection models. Whereas the Transection model 
exhibited a general decrease in both femoral BMD and femoral TMD, the Rupture model 
exhibited either no change or increases in BMD and TMD, and these differences were most 
pronounced at 10 weeks. Significant differences in BMD and TMD were noted between the 
Rupture and Transection groups in both epiphyseal and subchondral bone, and these findings 
indicate a differential bone remodeling response between the two models. We also found a 
difference in trabecular morphology between the two injury models in our study. Transection 
exhibited a decrease in femoral subchondral trabecular thickness at both 4 and 10 weeks whereas 
Rupture had no decrease at 4 weeks and slighter decreases at 10 weeks. In the femoral epiphysis, 
Rupture exhibited a drastic increase in trabecular thickness at both 4 and 10 weeks, whereas 
Transection did not exhibit an increase until 10 weeks. Significant differences were noted 
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between the two groups at 4 weeks, but these differences disappeared at 10 weeks. Interestingly, 
in their model of noninvasive ACL injury using the tibial compression model, Christiansen et al 
demonstrate an acute and chronic loss of femoral epiphyseal BMD and trabecular thickness in 
injured animals.(Christiansen et al., 2012b) This study represents the closest comparison to the 
noninvasive rupture model employed in the present study, and the causes leading to these 
differences in results between their study and the present study remain unknown.  
Histologic evidence of OA was observed in both injury models. We found that extensive 
degenerative changes to femoral articular cartilage structure and proteoglycan content were 
equivalent between the two groups and that these changes are present at 4 weeks with minimal 
change between the 4 and 10 week time point. The Rupture group exhibited a higher Cellularity 
subsection histologic grade in the femur at both 4 and 10 weeks compared to Transection. As a 
higher cellularity grade indicates diffuse regions of hypocellularity within otherwise 
hypercellular AC, this data indicates that Rupture induces a greater loss of cellularity. End-stage 
OA can be characterized by extensive hypocellularity(Anderson et al., 2011), and this data may 
suggest that the Rupture model induces an earlier onset of the progressive loss of cellularity. 
Future studies involving immunohistochemical analysis of cell necrosis and/or apoptosis could 
clarify this differential cellular response. Tibial histology also indicated signs of OA-like 
degeneration with erosion of the superficial layer of AC, loss of superficial proteoglycan, whole-
AC hypercellularity, and cellular clustering. Overall degeneration of tibial cartilage was, 
however, much milder than that observed on the femur, and our data does not indicate a 
differential degenerative state between the medial and lateral tibial compartment in either 
Rupture or Transection.  
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Biomarkers of cartilage degeneration have been used extensively to study the onset and 
progression of OA.(Catterall et al., 2010; Pruksakorn et al., 2009; Svoboda et al., 2013; Tourville 
et al., 2013) A biomarker can be any biochemical moiety indicating a disease state, and in the 
setting of OA, biomarkers of cartilage turnover and cleavage are most commonly employed due 
to the relative ease of detecting them in serum, synovial fluid, and urine. We quantified the 
concentrations of six cartilage biomarkers in the serum of injured and control rats, and our results 
indicate that Transection had higher absolute concentrations of C2C, COMP, and CTxII 
compared to Rupture. C2C and CTxII are byproducts of type II collagen cleavage, and COMP is 
a non-collagenous ECM protein expressed in increased amounts during OA-related cartilage 
turnover.  We did not detect significant group-to-group differences in the absolute concentration 
of CPII, a marker of type II collagen synthesis, C1,2C, a byproduct of type I and type II collagen 
cleavage, or  CS846, an epitope of chondroitin sulfate released during proteoglycan cleavage. 
The Rupture group did not have any elevated levels of biomarkers, and we partially attribute this 
finding to extensive animal-to-animal variability in our data. Due to the use of a cardiac puncture 
blood draw, we were unable to obtain baseline, pre-injury concentrations of the assayed 
biomarkers, thereby eliminating the possibility of an internal normalization. Furthermore, we did 
not normalize the absolute biomarker concentration to total serum protein, which represents a 
limitation of our study. However, we also compared the collagen cleavage-to-synthesis ratios 
C2C/CPII, C1,2C/CPII, CTxII/CPII, and COMP/CPII, as previously shown(Tourville et al., 
2013), which inherently provided an internal normalization. This lowered overall animal-to-
animal variability, and our data indicates that Transection had a significantly higher C2C/CPII 
ratio compared to Rupture at both 4 and 10 weeks, elevated CTxII/CPII ratio compared to 
Control at 4 weeks, higher COMP/CPII ratio compared to Rupture at 4 weeks, and higher 
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COMP/CPII ratio compared to Control at 10 weeks. Rupture animals had a higher COMP/CPII 
ratio compared to Control at 10 weeks, but no other ratios were elevated in the Rupture group. 
Given the drastic degenerative changes observed in our study, we expected highly elevated 
biomarker concentrations given their previous uses as indicators of OA in both human and 
animal studies, but our biomarker results do not fully corroborate our morphologic and histologic 
data. We attribute this to a lack of baseline normalization, the use of cardiac puncture, and 
inherent animal-to-animal variability. Future studies should employ a non-lethal venipuncture 
blood draw both pre- and postoperatively, which limits the total volume of serum able to be 
obtained but provides an important level of protein normalization.   
This study is not without limitations. We did not perform imaging and histology on 
uninjured, contralateral limbs. The use of a healthy contralateral joint allows for internal 
normalization of results to limit the effect of animal-to-animal variability, but given the number 
of specimens used for analysis in this study, contralateral limbs were not analyzed. The imaging-
based analysis of morphology of any tissue is limited by imaging resolution. To limit imaging 
time and time-dependent effects on tissue morphology during imaging, we employed a µCT 
protocol yielding an isotropic voxel size of 12 µm. While we believe this resolution to be more 
than sufficient for our analyses, the detection of small AC surface irregularities and the 
segmentation of the bone-cartilage interface was inherently limited. The contrast-enhanced 
imaging technique utilized in our studies necessitates the full dissection of the joint, incubation 
of the cartilage tissue in the contrast agent, and imaging in a humidified air chamber rather than 
in solution. As such, limiting acquisition time is of utmost importance to avoid tissue degradation 
and desiccation, which cause imaging and histologic artifacts. Histologic analyses are inherently 
limited by their 2D representation of a 3D tissue, and we made attempts to address this limitation 
97 
 
 
 
by obtaining 4 sagittal, 200 µm-spaced sections per compartment on both the tibia and femur. As 
mentioned above, our biomarker analysis was limited by the lack of a baseline, preoperative 
concentration with which to normalize post-operative concentrations, and future studies should 
obtain a baseline blood draw using non-lethal techniques. Lastly, our characterization of the 
noninvasive injury model in Section 6 – Aim #1 indicated that the injury protocol employed in 
the present study causes midsubstance ACL rupture, ACL avulsion of the femoral footprint, and 
a combination injury where one bundle avulses and one bundle ruptures. Since we did not 
confirm the exact injury type in each animal in the present study, we cannot rule out that animals 
in the Rupture group exhibited variable injury types, and this could have introduced variability in 
our dataset. 
 In conclusion, this study assessed differences in the onset and progression of PTOA in a 
model of noninvasive ACL injury compared to the frequently used model of surgical ACL 
transection. While both models cause the onset of PTOA with several similar results indicative 
of joint degeneration, numerous differences were found between the two models. Our study 
demonstrates that the two models exhibit a differential bony remodeling response, similar 
histologic findings with slight differences in cellularity, and that the surgical ACL transection 
model results in more extensive changes in articular cartilage morphology with correspondingly 
higher concentrations of serum-level cartilage biomarkers indicative of cartilage breakdown. We 
conclude that the surgical nature of the ACL transection model introduces several confounding 
biologic factors that perpetuate the OA cascade, and it may be overestimating the overall 
biological response of the joint following ligamentous injury. While some studies may benefit 
from a more rapid onset of OA-like joint degeneration, a more accurate representation of joint 
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biology following human ACL injury is, undoubtedly, obtained with a noninvasive injury model, 
and future studies assessing interventional treatment strategies can benefit its use. 
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CHAPTER 8: AIM #3 - ANALYZE AND COMPARE THE ACUTE BIOLOGICAL 
RESPONSE FOLLOWING BOTH NONINVASIVE ACL RUPTURE AND SURGICAL 
ACL TRANSECTION 
8.1 - Introduction 
Post-traumatic osteoarthritis (PTOA) is the consequence of a traumatic injury, acute 
inflammation, and chronic changes in joint kinematics and biology. Following ACL injury, 
surgical reconstruction has been shown to alleviate pain and restore joint stability by reducing 
anterior tibial translation, but the incidence of PTOA does not vary between surgically and 
nonsurgically-treated patients(Lohmander et al., 2007). While chronically unstable tibiofemoral 
articulation is known to increase the incidence of PTOA(Lohmander et al., 2007), current ACL 
reconstruction techniques do not appear to eliminate the risk for PTOA, and previous studies 
have indicated that the long-term risk for PTOA after ACL injury is as high as 100% . (Ait Si 
Selmi et al., 2006; Gillquist and Messner, 1999; Lohmander et al., 2004; Myklebust and Bahr, 
2005; Nebelung and Wuschech, 2005; Roos et al., 1995; Von Porat et al., 2004)  
Due to the lack of difference in PTOA incidence between surgically and nonsurgically 
treated patients, the PTOA cascade may be initiated at the time of injury and in the immediate, 
acute period following injury. However, the acute biological phenomena following ACL injury 
have yet to be fully elucidated (Section 2.3), and very little data exists regarding systemic 
cellular signaling, namely the mobilization and migration of mesenchymal stem cells.  Morito et 
al have shown that synovial fluid-level MSC concentrations are increased after ACL rupture 
compared to healthy patients, (Morito et al., 2008) and these MSCs are more similar to 
synovium-derived MSCs than bone marrow-derived MSCs. No study has shown whether MSCs 
mobilize into circulation following ACL injury, and it is also unknown whether any mobilized 
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MSCs have the capacity to home to injured tissues in order to participate in immunomodulatory 
and/or regenerative processes. 
The purpose of this aim was to assess the acute biological response following 
noninvasive ACL rupture and surgical transection. Specifically, we aimed to quantify MSC 
concentration in circulation, the concentration of cartilage metabolism biomarkers, and the 
concentration of stromal-derived factor-1 alpha (SDF-1α) in synovial fluid 72 hours after injury. 
We hypothesize that SDF-1 concentration will be elevated intraarticularly but neither 
noninvasive ACL rupture nor ACL transection induce systemic MSC mobilization. Furthermore, 
we hypothesize that serum-level increases in cartilage biomarker concentrations are only 
observed in the noninvasive ACL rupture group. 
8.2 - Methods 
Treatment Groups and Procedures 
Eighteen adult, female Lewis rats 14 weeks of age were randomized to one of three 
groups: Control, Rupture, or Transection (n=6 per group). Noninvasive ACL rupture and surgical 
ACL transection were carried out exactly as described in Section 7. All animals were allowed ad 
libitum cage activity until sacrifice by CO2 asphyxia at 72 hours. Five ml of whole blood were 
collected via cardiac puncture, and 4 ml were allowed to coagulate for 30 mins and processed for 
serum collection. One ml of blood was collected in EDTA-coated tubes at 4°C for flow 
cytometric analysis of MSCs. Synovial fluid aspirate was collected from the affected joint as 
outlined in Section 7 and frozen at -80°C until analysis. 
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Flow Cytometric Analysis of Circulating Mesenchymal Stem Cells 
Whole blood was transferred to red blood cell lysis buffer (5 Prime Inc, Gaithersburg, 
Maryland, USA) and incubated for 10 mins at room temperature. Following centrifugation and 
washing, two samples of 106 cells from each animal were stained for cell-surface expression of 
CD29, CD34, CD45, and CD90. In brief, cells were incubated with 5 µg/ml sheep anti-rat CD34 
primary antibody (R&D systems, Minneapolis, Minnesota, USA) for 30 mins at 4⁰C. Following 
a wash, cells were incubated with 0.2 µg/ml donkey anti-sheep APC-conjugated secondary 
antibody (R&D systems). After another wash, cells were incubated with 2 µg/ml hamster anti-rat 
CD29-PE antibody (BD Biosciences, San Jose, California, USA), 2 µg/ml mouse anti-rat CD45-
APC-Cy7 antibody (BD Biosciences), and 1 µg/ml mouse-anti rat CD90-PerCp antibody (BD 
Biosciences) for 30 mins at 4⁰C. Another sample from each animal was also stained with isotype 
controls corresponding to each antibody. Cells were washed and transferred to flow cytometry 
tubes (BD Biosciences) and analyzed using a flow cytometer (FACSCanto II, BD Biosciences). 
Concentrations and flow cytometer voltages were optimized according to established 
protocols(Hulspas, 2010), and fluorescence compensation was performed using built-in 
compensation calculation following analysis of single-stained cells and an unstained control. 
Mesenchymal stem cells were identified by CD29+ CD90+ CD34- CD45- expression, and these 
cell surface markers have been previously used to identify MSCs in blood(Hong et al., 2009; 
Motawi et al., 2014; Nagaya et al., 2005; Yoshimura et al., 2007). The results of the two stained 
samples from each animal were averaged and analyzed as both absolute concentration and 
concentration normalized to control.  
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Figure 8.2.1 – Panel of cell surface receptors analyzed using flow cytometry. The fraction of 
circulating MSCs was quantified using a CD29+ (A), CD90+ (B), CD34- (C), and CD45- (D) 
expression profile. Red = MSC expression profile. Blue = positive control. Grey = Isotype 
control. 
Serum Biomarker Quantification and Synovial Lavage Fluid SDF-1α Quantification 
Collected serum was analyzed for cartilage biomarker concentrations of CS846, C2C, 
CTxII, CPII, C1,2C, and COMP as described in Section 7.2. Synovial lavage fluid was analyzed 
for SDF-1α concentration using ELISA (R&D Systems, Minneapolis, MN, USA).  
Data Analysis and Statistical Comparison 
All statistical analyses were performed in SPSS (v22, IBM, Armonk, NY). The normality 
and equal variance assumptions were assessed using the Shapiro-Wilk test and Levene’s test, 
respectively. Differences in independent, normally distributed and non-normally distributed 
variables were compared between groups using one-way analysis of variance (ANOVA) and 
Kruskal-Wallis tests, respectively. Multiple comparisons were performed with a Sidak P-value 
correction at α = 95%. P values lower than 0.05 were considered significant. 
8.3 - Results 
Mesenchymal Stem Cell Mobilization Following ACL Rupture and Transection 
The concentration of MSCs in blood of Control animals was 1.08% ± 0.75. MSC 
concentration was significantly higher in the Rupture group (6.81% ± 3.68, P = 0.028) and 
elevated in the Transection group, though not significantly (6.08% ± 4.49, P = 0.059) (Figure 
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8.3.1A). The fraction of CD34+ cells was decreased in both Rupture and Transection, though 
neither comparisons were statistically significant (P = 0.367 and P = 0.815, respectively) (Figure 
8.3.1B). The same trend was observed for the cell fraction of CD45+ cells (P = 0.153 and P  = 
0.290, respectively) (Figure 8.3.1C). 
 
Figure 8.3.1 – Flow Cytometric Analysis of cell fraction of MSCs (A), CD34+ cells (B), CD45+ 
cells (C) in whole blood 72 hours following injury. * denotes significant difference to Control. 
Serum-Level Biomarkers of Cartilage Metabolism and Breakdown 
 Biomarkers of cartilage breakdown and metabolism were quantified in the serum of 
Control, Rupture, and Transection animals. Results indicate that although small shifts in 
biomarker concentrations were observed between groups, neither Rupture nor Transection 
caused a significant increase in serum-level C2C, C1,2C, CPII, CS846, or CTxII concentration 
72 hours after injury (Figure 8.3.2). Transection had a significantly higher COMP concentration 
compared to Rupture (P = 0.029), but no difference in COMP concentration was measured 
between Control and Transection or between Rupture and Transection (Figure 8.3.2C).  
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Figure 8.3.2 - Serum C2C (A), C1,2C (B), COMP (C), CPII (D), CS846 (E), and CTxII (F) in 
Control, Rupture, and Transection at 72 hours. ◊ denotes significant difference between Rupture 
and Transection. ◊ denotes significant difference between Rupture and Transection. 
 
 Collagen cleavage-to-synthesis ratios were calculated using the four markers of Type I 
and/or Type II collagen cleavage C2C, C1,2C, CTxII, and COMP and the marker of collagen 
synthesis, CPII (Figure 8.3.3). No group-to-group differences were found in C2C/CPII ratio, 
C1,2C/CPII ratio, or CTxII/CPII ratio. Transection had a significantly higher COMP/CPII ratio 
compared to Rupture, but neither group had a higher COMP/CPII ratio compared to Control.  
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Figure 8.3.3 - Collagen Cleavage-to-Synthesis Ratios of Serum-level Biomarkers 72 hrs after 
injury. Collagen cleavage-to-synthesis ratios were calculated using a marker of collagen 
synthesis, CPII, and four biomarkers of collagen cleavage C2C (A), C1,2C (B), CTxII (C), and 
COMP (D). ◊ denotes significant difference between Rupture and Transection. 
 
Synovial Fluid Lavage SDF-1α Concentration 
Synovial lavage was assayed for SDF-1α, but several animals had undeterminable 
concentrations due to sub-threshold spectrophotometric optical densities. Two of six animals in 
the Control group, two of six animals in the Rupture group, and four of six animals in the 
Transection group had undeterminable SDF-1α concentrations, and final analysis and 
comparisons were performed with the remaining, usable data points. The concentration of SDF-
1α in synovial fluid lavage was significantly higher in Rupture compared to Control (P = 0.032), 
but there was no difference between Transection and Control or between Rupture and 
Transection (Figure 8.3.4). 
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Figure 8.3.4 – Synovial Fluid SDF-1α in Control, Rupture, and Transection at 72 hours. * 
denotes significant difference to Control. 
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8.4 - Discussion 
The biological phenomena leading to post-traumatic osteoarthritis (PTOA) following 
joint injury remain largely unknown. While chronic inflammation and altered joint kinematics 
are known perpetuators of the OA cascade, addressing these factors with surgical and 
pharmacological management has not been proven to lower the long-term incidence of PTOA. In 
the case of ACL rupture, clinical data does not indicate that the incidence of PTOA varies as a 
function of treatment(Lohmander et al., 2007), suggesting that while ACL reconstruction restores 
anterior knee stability, relieves pain, and allows patients to return to sporting activity, the risk for 
development of PTOA is equivalent between surgical and nonsurgical treatment. Due to the lack 
of evidence indicating that addressing chronic destabilization and inflammation lowers the 
overall risk for PTOA, it stands to reason that the acute biological events during and immediately 
after injury are major contributors to the onset and progression of PTOA. However, little data 
describing these acute events exists, and it is unclear whether existing animal models accurately 
reproduce the biological events present in humans. To this end, the purpose of this study was to 
employ the noninvasive ACL rupture model to study acute MSC mobilization, serum-level 
biomarkers of cartilage breakdown and metabolism, and synovial fluid SDF-1α concentrations 
and to compare these factors to the ACL transection model. Study results indicate that MSCs are 
mobilized into systemic circulation and that synovial fluid SDF-1α concentration is increased 
following ACL rupture. Biomarkers of cartilage breakdown were not significantly elevated in 
either injury group, but the Transection group exhibited a higher COMP concentration and 
COMP/CPII ratio compared to Rupture. 
Stem cell mobilization has been shown to occur natively following myocardial 
infarction(Sprigg et al., 2006), stroke(Zohlnhöfer et al., 2006), fracture(Kitaori et al., 2009), lung 
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injury, (Yamada et al., 2004) and other trauma. Tissue trauma induces MSC and/or HSC 
mobilization, and mobilized stem or progenitor cells are able to migrate to injured tissue to 
participate in regenerative and immunomodulatory pathways.(Lapidot et al., 2005; Yagi et al., 
2010) While the recruitment of synovium- and/or synovial fluid-derived MSCs has been shown 
following intraarticular ligament injury(Morito et al., 2008), no group has shown whether 
traumatic ligament injury induces systemic mobilization of MSCs into circulation. Our data 
indicates that both noninvasive ACL rupture and surgical ACL transection induce a ~6-fold 
increase in circulating CD29+ CD90+ CD34- CD45- MSCs. This data demonstrates that our 
hypothesis was incorrect and that ACL injury is indeed severe enough to mount a systemic 
response involving MSC mobilization. Since we did not measure any significant differences in 
circulating MSC concentration between the Rupture and Transection groups, we conclude that 
surgical trauma to the skin, joint capsule, and ACL is equivalent to noninvasive ACL rupture 
induced by biomechanical loading in its capacity to mount a systemic mobilization response. 
While flow cytometric analysis was performed using a panel of cell-surface receptors commonly 
used to identify bone marrow-derived MSCs, we cannot definitely conclude the source of the 
mobilized cells in our study. Although the bone marrow niche is the most likely source of 
mobilized cells, future studies are necessary in this regard. 
The SDF-1 / CXCR-4 signaling axis is known to play an integral role in stem cell 
mobilization, migration, and homing. (Lau and Wang, 2011) SDF-1 is expressed by injured 
tissues and acts as a potent stem cell homing factor. In the setting of myocardial infarction,  
Abbott et al showed that SDF-1α is integral in the recruitment of bone marrow-derived stem 
cells following induced heart infarction.(Abbott et al., 2004) The study also showed that while 
exogenously-induced overexpression of SDF-1 is able to augment cellular recruitment, it is not 
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able to cause recruitment in the absence of tissue injury. Kitaori et al demonstrated that SDF-1 
signaling dictates MSC migration to a healing long bone fracture site in a murine model.(Kitaori 
et al., 2009) The study demonstrated that intravenously-injected bone marrow-derived MSCs 
were present in the fracture site 7 days following injection, and an in vitro migration assay 
indicated that MSC migration is induced by SDF-1 in a dose-dependent manner. We measured 
SDF-1α concentration in synovial lavage fluid aspirated from knee joints 72 hours after injury 
and, although highly variable concentrations were measured in several rats, our data indicates 
SDF-1α concentration is elevated in the joint following noninvasive ACL rupture, confirming 
our hypothesis. Since SDF-1α expression following injury is known to contribute to stem cell 
mobilization, we conclude that the elevation in intraarticular SDF-1α is a driving factor in MSC 
mobilization observed after injury in the present study.  However, it is unknown whether MSC 
migration into the joint occurred following systemic mobilization, and additional studies are 
underway to assess whether circulating MSCs are capable of migrating into the tissues of the 
knee joint.  
 We measured the concentration of six biomarkers of cartilage metabolism and turnover. 
Our results showed that animals treated with surgical ACL transection had a significantly higher 
COMP serum concentration and a significantly higher COMP/CPII ratio compared to the 
Rupture group. Our hypothesis that the Rupture group would exhibit higher cartilage biomarker 
levels was, therefore, disproven. Since neither treatment group exhibited significant increases in 
any biomarker concentration compared to Control, we conclude that the release of biomarkers 
indicative of cartilage turnover is minimal 72 hours following injury. Furthermore, we cannot 
conclude that the traumatic nature of the noninvasive rupture protocol causes acute structural 
damage to articular cartilage extensive enough to cause a release of the cartilage biomarkers 
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assayed in our study. Since rats in the Transection group were not subjected to any injury joint 
loading, our data indicates that surgical trauma and the inflammatory environment following 
surgery may be sufficient to initiate catabolic processes in cartilage to release COMP into serum, 
but this is not the case with other biomarkers. Furthermore, since cartilage degeneration and the 
onset of OA are known to be associated with increases in the serum concentration of all six 
biomarkers assayed in this study, we conclude that chronic inflammation and joint 
destabilization are necessary to cause measurable increases in serum biomarker concentration. 
Future research elucidating the temporal pattern of cartilage breakdown and biomarker release 
between surgical ACL transection and noninvasive ACL rupture using nonlethal blood draws are 
necessary.  
The baseline concentration of MSCs in Control rats in our study was ~1%, which is 
higher than previously-reported values of the homeostatic concentration of circulating 
MSCs(Lapidot et al., 2005). We attribute this increased baseline MSC concentration to the use of 
cardiac puncture as a blood collection technique in addition to the anesthesia and CO2 asphyxia-
induced euthanasia procedures to which Control rats were subjected. We chose to subject 
Control rats to these procedures in order to avoid these as confounding factors, and our data 
should therefore be interpreted in the context of an increase over baseline concentration. 
Asphyxia/hypoxia have been shown to induce MSC mobilization (Rochefort et al., 2006), and 
cardiac puncture may have caused the release of myocardium-derived MSCs with a similar cell 
surface receptor expression profile as the one used in the present study. Future studies could 
benefit from blood collection via live venipuncture to avoid increased MSC mobilization due to 
cardiac puncture and CO2 asphyxia. 
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This study is not without limitations. We employed cardiac puncture following CO2 
asphyxia to collect whole blood. This method was chosen to maximize the amount of blood 
available for analyses performed in our study, but we cannot rule out that this method of blood 
collection introduced confounding factors such as the release of myocardium-derived MSCs. 
Furthermore, as stated above, the use of CO2 asphyxia may have caused a baseline increase in 
MSC concentration. We used ELISA to measure the concentration of six biomarkers, and our 
results indicate extensive variability between animals. While the technique is highly specific and 
yields an absolute concentration via the use of a known standard, it does not allow for 
normalization to total serum protein concentration, and animal-to-animal variability cannot be 
accounted for.  Future studies should employ a non-lethal blood draw to obtain each animal’s 
preoperative baseline biomarker concentration. However, by using CPII as a known biomarker of 
collagen II synthesis, we were able to compare cleavage-to-synthesis ratios, which were 
inherently normalized for each animal. Lastly, our method of synovial fluid lavage collection 
yielded highly variable amounts of product, and we attribute our high result variability to the 
collection method. Future work is required to optimize synovial fluid collection from the rat 
joint. Lastly, our characterization of the noninvasive injury model in Section 6 – Aim #1 
indicated that the injury protocol employed in the present study causes midsubstance ACL 
rupture, ACL avulsion of the femoral footprint, and a combination injury where one bundle 
avulses and one bundle ruptures. Since we did not confirm the exact injury type in each animal in 
the present study, we cannot rule out that animals in the Rupture group exhibited variable injury 
types, and this could have introduced variability in our dataset. 
In conclusion, this study demonstrated that both noninvasive ACL rupture and surgical 
ACL transection cause mobilization of MSCs into circulation to increase MSC concentration in 
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blood by ~6-fold over baseline. The two models of ACL injury causes varying levels of cartilage 
biomarker concentrations within serum, and the potent stem cell homing cytokine SDF-1α is 
released into the joint following injury. This data indicates that an acute, systemic response is 
triggered following ACL injury, and future studies can address acute biological events to develop 
interventional strategies to thwart the onset of PTOA.  
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CHAPTER 9: FUTURE WORK 
The findings outlined in the present work open numerous avenues of future research. 
Three major categories of future research are, therefore, proposed: 1). Further characterization of 
the chronic changes following noninvasive ACL rupture; 2). further characterization of the acute 
biological phenomena following noninvasive ACL rupture; and 3). alterations to the noninvasive 
injury protocol to induce concomitant injuries or sub-rupture injuries.  
To begin, as PTOA is a complex pathology with numerous interconnected pathways, 
further characterization of the chronic degenerative changes occurring in the knee joint following 
noninvasive ACL rupture is necessary. The µCT-based characterization of articular cartilage 
necessitated the full dissection of the knee joint, removing the meniscus, all ligaments, and the 
synovium. As these tissues are known to be intimately involved in degenerative mechanisms, 
characterization of biological changes in these tissues is an important topic for future work. 
Specifically, the assessment of synovial hyperplasia and meniscal degeneration could lend 
important information about the findings in the present study. Furthermore, the synovial fluid 
aspiration technique employed in the present study was proven to be imperfect. Future 
optimization of this technique is required as the consistent aspiration of uncontaminated synovial 
fluid is an important tool for future characterization of chronic joint biology. It can then be used 
to perform high throughput, proteome-wide analyses of synovial fluid to assess chronically-
upregulated factors. These types of investigations can provide extremely useful information 
about the pathways responsible for chronic degeneration. As performed in the present study, all 
the proposed analyses can compare the noninvasive rupture model to the surgical ACL 
transection model in order to elucidate the source of their varying degenerative responses.  
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Secondly, in order to identify biological mechanisms triggering the onset of PTOA, 
extensive characterization of the acute phenomena following ACL injury are required. While 
current knowledge regarding the acute events after injury is limited, the noninvasive ACL 
rupture model can be employed to assess acute events leading to cartilage degeneration. As 
outlined above, following optimization of the synovial fluid aspiration technique, high 
throughput screening of the synovial fluid can identify specific moieties differentially expressed 
following injury. These can then be targeted using inhibitory strategies, which, in turn, may lead 
to the development of pharmacological therapies to lessen the degenerative effects of ACL 
rupture. Furthermore, one of the most significant findings of the present work is that ACL injury 
induces systemic MSC mobilization. Future experiments should isolate the mobilized cells by 
fluorescence-assisted cell sorting (FACS), magnetic-assisted cell sorting (MACS), or using 
conventional cell-culture based techniques such as density-gradient centrifugation followed by 
tissue culture plastic adherence. Isolated cells should be assessed for colony-forming unit 
capacity and tri-lineage differentiation capacity to confirm their MSC identity. Following this 
characterization, it will also be important to assess whether mobilized cells are able to migrate 
and home to the injured joint and to identify tissues into which MSCs have migrated. 
Subsequently, using tagged cells, one would be able to determine whether MSCs are 
differentiating into any of the joint tissues and/or whether they are participating in 
immunomodulatory mechanisms.  
Lastly, the noninvasive ACL rupture model characterized in the present work can be 
modified in order to induce sub-rupture injury (i.e. ligament sprain) and/or concomitant injuries. 
Clinically, ACL sprains occur frequently during sporting activities, and while this injury is 
considered less severe than a complete rupture, joint injury undoubtedly occurs. Very little is 
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known about the relationship between an ACL sprain and the onset of PTOA, and the loading 
mechanism outlined in the present study can be utilized to induce a sub-rupture injury. Results 
outlined in Chapter 6: Aim #1 demonstrate that specimens that did not exhibit a complete injury 
still exhibited joint strain (assessed by tibiofemoral joint motion) and increased laxity. Small 
modifications in endpoint displacement could be made to the loading protocol in order to 
simulate rapid joint loading without complete ACL injury. This model can then be employed to 
assess how ACL sprains lead to PTOA. Furthermore, modification of the loading protocol to 
induce MCL injury via tibiofemoral rotation can provide a model for the commonly observed 
clinical injury of ACL-MCL rupture.  
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CHAPTER 10: FINISHING CONCLUSIONS 
This work presented the biomechanical and biological development and characterization 
of a model of noninvasive ACL rupture in the rat. A complete, noninvasive ACL rupture can be 
repeatably induced with the application of a rapid 3 mm displacement of the tibia when the knee 
is flexed to 100°. This injury causes AP and varus laxity, indicating injury to the ACL as well as 
the LCL. Biological characterization of joint degeneration due to noninvasive ACL rupture and 
surgical ACL transection demonstrated that both injury models induce bony remodeling and 
changes in articular cartilage morphology indicative of PTOA-based degeneration. Histological 
evidence of articular cartilage degeneration was confirmed, and elevated serum-level 
concentrations were only observed in the surgical ACL transection group. Results from the 
present study lead us to conclude that the model of surgical ACL transection may be 
overestimating the degenerative response after injury, implying that confounding biological 
factors due to the surgical nature of the model introduce exacerbating degenerative effects. The 
investigation of acute phenomena following injury indicate that ACL injury triggers a systemic 
response, and to the authors’ knowledge, this is the first study demonstrating that mobilization of 
MSCs occurs after ACL injury. We did not observe acute cartilage breakdown at 72 hrs after 
injury, measured by serum-level concentrations of established biomarkers, and we conclude that 
prolonged inflammation is necessary to release measurable levels of cartilage biomarkers within 
the serum. In conclusion, while the etiology of PTOA remains largely unknown, the noninvasive 
ACL injury model developed in this work can be employed in future investigations assessing 
pathologic mechanisms and therapeutic interventions.   
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APPENDIX 
A1. Comprehensive Cartilage Parameterization Methods 
Principle of the technique 
Mesh parameterization refers to the bijective mapping of mesh vertices from a 3D (x,y,z) 
space onto a 2D (u,v) domain. Inherently, 3D surfaces are not able to be parameterized 
isometrically, and any parameterization algorithm needs to, therefore, be given criteria by which 
certain deformations are allowed to be introduced into the parameterization. As such, 
parameterizations can be either conformal (the angles between mesh vertices are preserved), 
equiareal (the areas of mesh triangles are preserved), or a combination of the two. The extent of 
deformation in either instance is directly correlated to the complexity of the 3D shape. In the 
application of analyzing cartilage morphology, accurate segmentation of compartments and 
subcompartments is crucial, and the delineation of compartmental borders is inherently 
challenging in 3D. Parameterization allows the mapping of the complex shape of an articular 
cartilage surface onto a relatively simple 2D surface, thereby allowing accurate segmentation and 
analysis. 
Dodin et al(Dodin et al., 2010) proposed that by resampling the intensity information 
normal to the femoral bone-cartilage interface (BCI) at distance h, the parameterized BCI surface 
in the (u,v) domain can be extended into the 3D domain (u,v,h), producing a resampled image 
stack describing the local image intensity information normal to the BCI. The algorithm 
employed in the present study is based upon this principle.  
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Mesh generation 
Cartilage volumes were segmented from µCT data sets as outlined in the Methods of 
Section 7 – Aim #2 (Figure A.1A). Each cartilage volume was triangulated into a mesh using 
MATLAB. Vertex normals were computed for each vertex (Figure A.1B), and the local image 
intensity was sampled normal to each vertex to determine adjacent tissues. Using intensity 
thresholding, vertices adjacent to bone (highly attenuating voxels) were defined part of the bone-
cartilage interface (BCI) surface, while vertices adjacent to air or low attenuating soft tissue were 
excluded. The resultant BCI surface was cleaned, smoothed and resampled for even vertex 
spacing using open-source Meshlab software (http://meshlab.sourceforge.net) (Figure 
A.1C)(Cignoni et al., 2008). 
 
Figure A.1 – Cartilage Parameterization Flow Chart. The bone-cartilage interface (BCI) is 
isolated using manual outling (A), and normal vectors are calculated following mesh generation 
(B). Individual compartments are isolated (C) and parameterized using conformal mesh 
parameterization (D). Meshes are discretized and height maps are generated (E). 
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Parameterization 
The cleaned mesh was reimported into MATLAB and mapped into the parameterized 
(u,v) space using an open-source Spectral Conformal Parameterization algorithm (Ryan Schmidt, 
http://dgp.toronto.edu/~rms/software/matlabmesh) based on the work of Mullen et al(Mullen et 
al., 2008) (Figure A.1D). The local attenuation around each vertex was then sampled along the 
normal line and discretized at a resolution of 12 µm/pixel to produce the (u,v,h) image stack. 
Parameterized image stacks were generated for the entire cartilage surface and for the individual 
sections (medial condyle, lateral condyle, trochlea) (Figure A.1E). 
Thickness map generation 
The cartilage layer of each parameterized image stack was segmented using fixed 
thresholds to eliminate air and bone, and a cartilage thickness map was generated from the 
resulting ROI (Figure A.1E). Because the h dimension describes the distance normal to the 
cartilage surface, the height of the cartilage at each position (u,v) corresponds to the normal 
cartilage thickness.  
Surface roughness analysis 
In addition to mean thickness, thickness maps were analyzed using metrics of areal 
surface roughness as defined by ISO 25178-6 (“Classification of methods for measuring surface 
texture,” International Organization for Standardization, 2014). The following areal surface 
roughness metrics were used: arithmetic surface roughness Sa and peak-to-valley distance (P-V). 
P-V is defined as the difference between the maximum and minimum thickness of the surface. 
The mathematical description of Sa is as follows: 
  =


∑ ∑ 	
 − μ	



  (1) 
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A2. Comprehensive Femoral and Tibial Bone Morphology and Densitometry Data 
Table A2.1 – Femoral Subchondral Bone Morphology and Densitometry (4 weeks) 
 Control Rupture Transection 
BV/TV  
(Fraction ± Std. Dev.) 
Medial 0.8411 ± 0.017 0.8203 ± 0.017 ◊ 0.736 ± 0.075 *,◊ 
Lateral 0.8391 ± 0.024 0.8696 ± 0.015 ◊ 0.8101 ± 0.032 ◊ 
Trochlear 0.7463 ± 0.039 0.6849 ± 0.027 ◊ 0.6044 ± 0.055 *,◊ 
Whole 0.7944 ± 0.02 0.7611 ± 0.016 ◊ 0.6879 ± 0.054 *,◊ 
BMD 
(mg HA/cm3 ± Std. Dev.) 
Medial 883.2 ± 6.396 880.6 ± 11.37 837 ± 48.15 * 
Lateral ? 93.8 ± 18.47 927.6 ± 12.94 882 ± 25.31 
Trochlear 820.9 ± 16.92 783.3 ± 19.03 *,◊ 743.5 ± 27.07 *,◊ 
Whole 855.8 ± 15.44 840.8 ± 10.22 801 ± 31.66 * 
TMD 
(mg HA/cm3 ± Std. Dev.) 
Medial 936.6 ± 8.957 945.5 ± 9.012 933.2 ± 20.14 
Lateral 944.6 ± 9.856 967.3 ± 7.315 *,◊ 947.3 ± 15.66 ◊ 
Trochlear 912.7 ± 5.955 905.3 ± 7.756 893.9 ± 13.74 * 
Whole 928.1 ± 7.859 932.5 ± 3.713 920 ± 14.73 
Tb.Th. Mean 
(µm± Std. Dev.) 
Medial 147.3 ± 11.47 145.2 ± 6.72 123.3 ± 22.09 * 
Lateral 154.6 ± 16.79 159.5 ± 4.621 132.2 ± 14.81 * 
Trochlear 107.8 ± 11.91 100.9 ± 5.505 ◊ 86.59 ± 12.21 * 
Whole 131.6 ± 13.41 128.4 ± 2.769 109.8 ± 15.08 * 
Tb.Th. Std 
(µm± Std. Dev.) 
Medial 50.51 ± 4.014 49.16 ± 3.936 42.33 ± 8.248 
Lateral 51.06 ± 4.686 46.37 ± 2.397 40.97 ± 4.421* 
Trochlear 31.85 ± 3.711 30.1 ± 3.429 24.34 ± 5.392 
Whole 48.49 ± 4.037 48.43 ± 2.817 41.1 ± 5.891 *,◊ 
Tb.Th. Max 
(µm± Std. Dev.) 
Medial 240.4 ± 10.23 245.7 ± 11.55 233.1 ± 21.93 
Lateral 250.1 ± 13.05 254.5 ± 5.284 ◊ 230.6 ± 9.991  *,◊ 
Trochlear 193.1 ± 17.36 191.7 ± 22.24 173.2 ± 31.34 
Whole 250.1 ± 13.05 256.9 ± 6.337 239.1 ± 13 ◊ 
 
* denotes significant difference to Control. ◊ denotes significant difference between Rupture and Transection.  
‡ denotes significant difference between 4 and 10 weeks. 
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Table A2.2 - Femoral Subchondral Bone Morphology and Densitometry (10 weeks) 
 Control Rupture Transection 
BV/TV  
(Fraction ± Std. Dev.) 
Medial 0.8867 ± 0.017  ‡ 0.8640 ± 0.019 ‡ 0.8334 ± 0.029 *, ‡ 
Lateral 0.9063 ± 0.010 ‡ 0.9135 ± 0.008 ◊, ‡ 0.883 ± 0.022 ◊, ‡ 
Trochlear 0.8703 ± 0.010 ‡ 0.8241 ± 0.020 *, ‡  0.8131 ± 0.028 *, ‡ 
Whole 0.8832 ± 0.011 ‡ 0.8549 ± 0.015 *, ‡ 0.8337 ± 0.023 *, ‡ 
BMD 
(mg HA/cm3 ± Std. Dev.) 
Medial 923.3 ± 10.42 ‡ 924.3 ± 19.11 ‡ 901.1 ± 25 ‡ 
Lateral 939.1 ± 7.048 ‡ 961.3 ± 11.72 *, ◊, ‡ 920.4 ± 9.559 *, ◊, ‡ 
Trochlear 886 ± 7.048 ‡ 862.3 ± 11.88 *, ‡ 859.7 ± 11.2 *, ‡ 
Whole 908.9 ± 5.13 ‡ 901.2 ± 10.44 ◊, ‡ 884.2 ± 13.6 *, ◊, ‡ 
TMD 
(mg HA/cm3 ± Std. Dev.) 
Medial 956.3 ± 6.817 ‡ 970.6 ± 17.23 ◊, ‡ 948.5 ± 14.37 ◊ 
Lateral 963.1 ± 6.036 ‡ 982.7 ± 12.86 *, ◊, ‡ 953.3 ± 10.32 ◊ 
Trochlear 935.7 ± 5.657 ‡ 938.7 ± 12.23 ‡ 929.8 ± 2.593 ‡ 
Whole 948.1 ± 4.91 ‡ 957.9 ± 11.56 ◊, ‡ 940.4 ± 6.484 ◊, ‡ 
Tb.Th. Mean 
(µm± Std. Dev.) 
Medial 170.3 ± 3.137 ‡ 157.5 ± 6.977 ‡ 153.1 ± 13.13 *, ‡ 
Lateral 184.7 ± 4.908 ‡ 178.3 ± 4.539 ◊, ‡ 168.2 ± 6.2 *, ◊, ‡ 
Trochlear 153.7 ± 6.068 ‡ 143.2 ± 4.761 *, ‡ 135.8 ± 7.378 *, ‡ 
Whole 165.9 ± 3.432 ‡ 155.7 ± 4.552 *, ‡ 148.1 ± 8.817 *, ‡ 
Tb.Th. Std 
(µm± Std. Dev.) 
Medial 52.16 ± 1.897  46.84 ± 4.397 45.31 ± 4.377 * 
Lateral 54.36 ± 1.376 44.13 ± 1.729 * 46.34 ± 4.783 * 
Trochlear 44.15 ± 2.541 ‡ 40.41 ± 2.147 ◊, ‡ 43.79 ± 2.38 ◊, ‡  
Whole 50.78 ± 0.6049 45.45 ± 1.703 * 47.04 ± 1.459 *, ‡ 
Tb.Th. Max 
(µm± Std. Dev.) 
Medial 255.8 ± 5.324 ‡ 253.3 ± 12.68 246.6 ± 16.65 
Lateral 268.1 ± 1.587 ‡ 260.7 ± 3.277 257.3 ± 11.71 ‡ 
Trochlear 239.3 ± 8.211 ‡ 239.4 ± 11.53 ‡ 251.2 ± 20.46 ‡ 
Whole 268.1 ± 1.587 ‡ 262 ± 3.155 265.5 ± 8.065 ‡ 
 
* denotes significant difference to Control. ◊ denotes significant difference between Rupture and Transection.  
‡ denotes significant difference between 4 and 10 weeks. 
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Table A2.3 - Tibial Subchondral Bone Morphology and Densitometry (4 weeks) 
 Control Rupture Transection 
BV/TV  
(Fraction ± Std. Dev.) 
Medial 0.899 ± 0.025 0.842 ± 0.032 *, ◊ 0.776 ± 0.044 *,  ◊ 
Lateral 0.774 ± 0.020 0.785 ± 0.018 0.742 ± 0.044 
Whole 0.828 ± 0.014 0.809 ± 0.015 0.755 ± 0.036 * 
BMD 
(mg HA/cm3 ± Std. Dev.) 
Medial 909.9 ± 22.12 885.5 ± 19.16 846.4 ± 33.64 * 
Lateral 836.8 ± 7.955 851.5 ± 15.6 ◊ 823.8 ± 23.84 ◊  
Whole 868.5 ± 7.04 865.6 ± 14.15 832.8 ± 26.27 
TMD 
(mg HA/cm3 ± Std. Dev.) 
Medial 937.9 ± 14.51 931 ± 12.31 914.1 ± 18.67 
Lateral 904.5 ± 4.999 921.9 ± 9.655 * 906.5 ± 15.15 
Whole 920.3 ± 8.66 925.9 ± 9.412 909.7 ± 16.36 
Tb.Th. Mean 
(µm± Std. Dev.) 
Medial 125.8 ± 12.05 115.1 ± 12.35 108.3 ± 10.69 
Lateral 105.3 ± 5.628 115.6 ± 8.188 108.3 ± 9.802 
Whole 115 ± 8.126 115.6 ± 9.468 108.3 ± 9.654 
Tb.Th. Std 
(µm± Std. Dev.) 
Medial 35.42 ± 3.453 37.95 ± 1.142 35.53 ± 3.751 
Lateral 36.02 ± 3.334 44.56 ± 6.068 * 39.98 ± 2.852 
Whole 37.32 ± 3.873 42.11 ± 3.793 38.32 ± 2.874 
Tb.Th. Max 
(µm± Std. Dev.) 
Medial 206.5 ± 20.61 204.1 ± 11.01 191.7 ± 11.54 
Lateral 194.1 ± 17.63 225.4 ± 27.8 207.7 ± 13.24 
Whole 229.4 ± 10.87 250.2 ± 15.53 245.3 ± 16.45 
 
* denotes significant difference to Control. ◊ denotes significant difference between Rupture and Transection.  
‡ denotes significant difference between 4 and 10 weeks. 
 
Table A2.4 – Tibial Subchondral Bone Morphology and Densitometry (10 weeks) 
 Control Rupture Transection 
BV/TV  
(Fraction ± Std. Dev.) 
Medial 0.937 ± 0.017 ‡ 0.873 ± 0.014 *, ◊ 0.803 ± 0.031*,  ◊ 
Lateral 0.891 ± 0.031 ‡ 0.871 ± 0.039 ‡ 0.834 ± 0.037 *, ‡ 
Whole 0.911 ± 0.022 ‡ 0.871 ± 0.024 ◊ ‡ 0.821 ± 0.030 *, ◊, ‡ 
BMD 
(mg HA/cm3 ± Std. Dev.) 
Medial 945.5 ± 18.18 ‡ 911.7 ± 19.79 *, ◊, ‡ 862.6 ± 26.1 *,  ◊ 
Lateral 901.5 ± 14.73 ‡ 903.5 ± 29.47 ‡ 870.1 ± 22.33 ‡ 
Whole 921.3 ± 15.6 ‡ 906.4 ± 24.79 ◊, ‡ 867 ± 22.03 *,  ◊, ‡ 
TMD 
(mg HA/cm3 ± Std. Dev.) 
Medial 962.8 ± 11.05 ‡ 948.1 ± 17.26 ◊ 920.5 ± 21.12 *, ◊ 
Lateral 927.8 ± 9.429 ‡ 944.4 ± 18.97 ◊, ‡ 917.2 ± 12.05 ◊ 
Whole 944 ± 9.915 ‡ 946 ± 17.88 ‡ 918.8 ± 15.41 
Tb.Th. Mean 
(µm± Std. Dev.) 
Medial 136.7 ± 6.793  125.6 ± 5.311 122 ± 8.888 *, ‡ 
Lateral 127.6 ± 3.889 ‡ 136.2 ± 4.632 ‡ 128.4 ± 8.347 ‡ 
Whole 131.8 ± 4.592 ‡ 132 ± 2.515 ‡ 125.9 ± 7.722 ‡ 
Tb.Th. Std 
(µm± Std. Dev.) 
Medial 38.02 ± 2.927  41.86 ± 2.126 ‡  45.07 ± 4.426 *, ‡ 
Lateral 43.66 ± 2.838 ‡ 51.23 ± 4.671  48.91 ± 4.918 ‡ 
Whole 41.5 ± 2.47  48.06 ± 2.395 *, ‡ 47.69 ± 3.73 *, ‡ 
Tb.Th. Max 
(µm± Std. Dev.) 
Medial 221.5 ± 15.1 1 218.6 ± 11.56 225.9 ± 17.04 ‡ 
Lateral 223.1 ± 9.234 ‡ 250.2 ± 15.53 * 243.7 ± 17.25 ‡ 
Whole 229.4 ± 10.87 ‡ 250.2 ± 15.53  245.3 ± 16.45 ‡ 
 
* denotes significant difference to Control. ◊ denotes significant difference between Rupture and Transection.  
‡ denotes significant difference between 4 and 10 weeks. 
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Table A2.5 – Femoral Epiphyseal Bone Morphology and Densitometry (4 weeks) 
 Control Rupture Transection 
BV/TV  
(Fraction ± Std. Dev.) 
Medial 0.622 ± 0.014 0.602 ± 0.03 0.59 ± 0.03 
Lateral 0.588 ± 0.02 0.6 ± 0.028 0.585 ± 0.02 
Trochlear 0.554 ± 0.021 0.492 ± 0.021* 0.482 ± 0.016* 
Whole 0.583 ± 0.014 0.548 ± 0.022* 0.539 ± 0.019* 
BMD 
(mg HA/cm3 ± Std. Dev.) 
Medial 767.7 ± 8.01 767.6 ± 29.03 749.6 ± 30.76 
Lateral 741.8 ± 13.15 759.7 ± 28.74 729.3 ± 17.82 
Trochlear 701.5 ± 18.73 662.4 ± 31.56* 641.2 ± 17.1* 
Whole 726.2 ± 12.3 711.1 ± 27.4 692.1 ± 20.85 
TMD 
(mg HA/ cm3 ± Std. 
Dev.) 
Medial 980.3 ± 17.03 981.9 ± 18.46 965.6 ± 22.14 
Lateral 968.4 ± 18.31 977.3 ± 15.59 954.8 ± 18.16 
Trochlear 961 ± 18.62 955 ± 19.12 935.8 ± 17.37 
Whole 975.5 ± 16.47 972.5 ± 15.47 954.2 ± 17.67 
Tb.Th. Mean 
(µm± Std. Dev.) 
Medial 132.4 ± 7.11 151.9 ± 13.14* 138.1 ± 7.36 
Lateral 130.8 ± 4.07 147 ± 10.54*, ◊ 134 ± 3.91 ◊ 
Trochlear 113.8 ± 7.79 116.1 ± 7.7 ◊ 104.2 ± 3.97 ◊ 
Whole 125.8 ± 5.67 137.8 ± 9.02*, ◊ 125.5 ± 3.71 ◊ 
Tb.Th. Std 
(µm± Std. Dev.) 
Medial 39.46 ± 3.91 68.76 ± 11.19*, ◊ 51.55 ± 4.64 *, ◊ 
Lateral 46.46 ± 1.85 61.42 ± 11.34* 55.21 ± 4.15 
Trochlear 36.29 ± 4.83 47.02 ± 7.64*, ◊ 37.62 ± 3.95 ◊ 
Whole 42.3 ± 3.14 62.94 ± 9.53*, ◊ 50.34 ± 3.81 ◊ 
Tb.Th. Max 
(µm± Std. Dev.) 
Medial 294.2 ± 22.64 385.1 ± 41.94* 334.4 ± 40.82 
Lateral 333.8 ± 26.95 373.1 ± 43.76 375.5 ± 25.28 
Trochlear 272.9 ± 39.21 316.9 ± 53.82 266.9 ± 30.51 
Whole 342 ± 18.05 401.9 ± 39.15* 371.9 ± 29.6 
 
* denotes significant difference to Control. ◊ denotes significant difference between Rupture and Transection.  
‡ denotes significant difference between 4 and 10 weeks. 
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Table A2.6 – Femoral Epiphyseal Bone Morphology and Densitometry (10 weeks) 
 Control Rupture Transection 
BV/TV  
(Fraction ± Std. Dev.) 
Medial 0.666 ± 0.03 ‡ 0.652 ± 0.024 ‡ 0.658 ± 0.015 ‡ 
Lateral 0.63 ± 0.023 ‡ 0.643 ± 0.012 ‡ 0.639 ± 0.014 ‡ 
Trochlear 0.581 ± 0.035 0.542 ± 0.012*,‡ 0.532 ± 0.011*, ‡ 
Whole 0.615 ± 0.021 ‡ 0.599 ± 0.013 ‡ 0.592 ± 0.011 ‡ 
BMD 
(mg HA/cm3 ± Std. Dev.) 
Medial 796.8 ± 28.39 ‡ 811.3 ± 22.18 ‡ 799.8 ± 16.78 ‡ 
Lateral 769.1 ± 17.28 ‡ 806.4 ± 12*, ◊, ‡ 780.6 ± 17.31 ◊, ‡ 
Trochlear 723.2 ± 32.35 703.5 ± 13.39 ‡ 686 ± 13.65*, ‡ 
Whole 745.9 ± 17.71 754.9 ± 15.07 ‡ 731.3 ± 15.2 ‡ 
TMD 
(mg HA/cm3 ± Std. Dev.) 
Medial 993.2 ± 11.02 1016 ± 13.43*, ◊, ‡ 991.9 ± 8.45 ◊ 
Lateral 985.9 ± 9.42 1012 ± 11.83*,◊, ‡ 987.3 ± 8.52 ◊, ‡ 
Trochlear 974 ± 10.67 984.9 ± 8.17 ◊, ‡ 965.6 ± 7.46 ◊, ‡ 
Whole 989.4 ± 9.71 1002 ± 11.55 ◊, ‡ 979.9 ± 6.91 ◊ 
Tb.Th. Mean 
(µm± Std. Dev.) 
Medial 126.9 ± 24.82 172.4 ± 17.4*, ‡ 162.5 ± 9.11*, ‡ 
Lateral 124.8 ± 21.75 149.6 ± 9.81* 149.7 ± 3.88*, ‡ 
Trochlear 118.4 ± 7.06 116.7 ± 5.89 117 ± 3.54, ‡ 
Whole 129.6 ± 4.48 146.7 ± 8.53* 142.8 ± 4.26*, ‡ 
Tb.Th. Std 
(µm± Std. Dev.) 
Medial 38.24 ± 3.95 86.54 ± 15.8*, ‡ 72.04 ± 7.93*, ‡ 
Lateral 44.24 ± 3.99 60.81 ± 10.49* 65.29 ± 5.48*, ‡ 
Trochlear 37.46 ± 4.09 45.76 ± 5.66* 49.52 ± 5.67*, ‡ 
Whole 41.57 ± 2.57 72.6 ± 10.56* 67.87 ± 4.26*, ‡ 
Tb.Th. Max 
(µm± Std. Dev.) 
Medial 278.9 ± 25.8 452.6 ± 49.28*, ‡ 404.8 ± 32.18*, ‡ 
Lateral 335 ± 43.89 371.3 ± 37.08 404.7 ± 41.51*, ‡ 
Trochlear 284.1 ± 15.09 316 ± 35.05 ◊ 375.4 ± 35.04*,◊, ‡ 
Whole 350.6 ± 20.89 462.1 ± 64.31* 445.5 ± 25.16*, ‡ 
 
* denotes significant difference to Control. ◊ denotes significant difference between Rupture and Transection.  
‡ denotes significant difference between 4 and 10 weeks. 
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Table A2.7 – Tibial Epiphyseal Bone Morphology and Densitometry (4 weeks) 
 Control Rupture Transection 
BV/TV  
(Fraction ± Std. Dev.) 
Medial 0.592 ± 0.021 0.567 ± 0.026 0.539 ± 0.025 * 
Lateral 0.552 ± 0.012 0.540 ± 0.015 0.518 ± 0.022 * 
Whole 0.571 ± 0.016 0.552 ± 0.020 0.528 ± 0.022 * 
BMD 
(mg HA/cm3 ± Std. Dev.) 
Medial 753.7 ± 13.17 747.5 ± 15.07 719.7 ± 22.58 
Lateral 726.8 ± 15.36 728.2 ± 12.3 ◊ 700 ± 17.49 *,◊ 
Whole 739.4 ± 12.37 736.4 ± 12.2 ◊  708.3 ± 19.2 *,◊ 
TMD 
(mg HA/cm3 ± Std. Dev.) 
Medial 975 ± 9.905 976.4 ± 9.566 959.3 ± 13.41 
Lateral 959.2 ± 13.7 969.4 ± 9.657 950.1 ± 12.88 
Whole 967 ± 10.86 972.4 ± 9.2 954.5 ± 12.97 * 
Tb.Th. Mean 
(µm± Std. Dev.) 
Medial 139.4 ± 6.8 144.4 ± 10.24 137.2 ± 12.8 
Lateral 124.7 ± 3.002 129 ± 5.638 125.9 ± 10.31 
Whole 132.6 ± 4.665 137.6 ± 7.871 132.4 ± 11.37 
Tb.Th. Std 
(µm± Std. Dev.) 
Medial 50.82 ± 3.282 60.88 ± 6.344 * 54.48 ± 6.206 
Lateral 43.58 ± 1.094 50.06 ± 5.308  50.28 ± 5.05 * 
Whole 48.4 ± 2.256 57.44 ± 5.741* 53.9 ± 4.859 
Tb.Th. Max 
(µm± Std. Dev.) 
Medial 317.4 ± 14.57 358.9 ± 36.11 328.6 ± 37.92 
Lateral 276.4 ± 5.141 333.8 ± 32.73 * 333.2 ± 36.47 * 
Whole 319.8 ± 14.87 362.4 ± 37.4 352.1 ± 29.77 
 
* denotes significant difference to Control. ◊ denotes significant difference between Rupture and Transection.  
‡ denotes significant difference between 4 and 10 weeks. 
 
Table A2.8 – Tibial Epiphyseal Bone Morphology and Densitometry (10 weeks) 
 Control Rupture Transection 
BV/TV  
(Fraction ± Std. Dev.) 
Medial 0.648 ± 0.010 ‡ 0.641 ± 0.014 ‡ 0.615 ± 0.025 *, ‡ 
Lateral 0.594 ± 0.010 ‡ 0.602 ± 0.020 ‡ 0.575 ± 0.043 ‡ 
Whole 0.617 ± 0.0082 ‡ 0.619 ± 0.016 ‡ 0.594 ± 0.034 ‡ 
BMD 
(mg HA/cm3 ± Std. Dev.) 
Medial 795.5 ± 12.79 ‡ 777.8 ± 12.8 ‡ 762.8 ± 13.78 *, ‡ 
Lateral 756 ± 15.35 ‡ 748.9 ± 18.94 ‡ 731.8 ± 26.52 ‡ 
Whole 773.3 ± 12.04 ‡ 762.5 ± 15.06 ‡ 746.9 ± 19.82 *, ‡ 
TMD 
(mg HA/cm3 ± Std. Dev.) 
Medial 990.2 ± 8.685 ‡ 984.2 ± 16.33 973.7 ± 15.49 
Lateral 970.4 ± 8.357  968.7 ± 10.25 959 ± 16.04 
Whole 980.3 ± 7.931 ‡ 977 ± 12.66 967.7 ± 14.58 
Tb.Th. Mean 
(µm± Std. Dev.) 
Medial 151.8 ± 3.075 ‡ 170.2 ± 5.538 *, ‡ 160.7 ± 13.18 ‡ 
Lateral 135.5 ± 3.446 ‡ 141.6 ± 6.409 ‡ 137.6 ± 17.85 
Whole 144.2 ± 3.037 ‡ 157.2 ± 4.255 ‡ 150.6 ± 15.04 ‡ 
Tb.Th. Std 
(µm± Std. Dev.) 
Medial 53.75 ± 3.75  82.01 ± 7.369 *, ‡ 76.06 ± 13.5 *, ‡ 
Lateral 49.34 ± 2.533 ‡ 60.96 ± 5.284 *, ‡ 59.66 ± 8.531 *, ‡ 
Whole 53.34 ± 2.394 ‡ 75.22 ± 5.152 *, ‡ 71.12 ± 11.01 *, ‡ 
Tb.Th. Max 
(µm± Std. Dev.) 
Medial 342.4 ± 25.14  428.6 ± 39.63 *, ‡ 411.5 ± 53.09 *, ‡ 
Lateral 319.9 ± 17.79 ‡  374.8 ± 19.67 *, ‡ 377.5 ± 52.53 * 
Whole 353.1 ± 22.19 ‡ 437 ± 33.44 *, ‡ 418.6 ± 50.77 *, ‡ 
 
* denotes significant difference to Control. ◊ denotes significant difference between Rupture and Transection.  
‡ denotes significant difference between 4 and 10 weeks. 
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A3. Comprehensive Femoral and Tibial Cartilage Morphology and Surface Roughness Data 
Table A3.1 – Femoral Cartilage Morphology and Surface Roughness by Compartment and Sub-
Compartment (4 weeks) 
 Control Rupture Transection 
Mean Height 
(µm± Std. Dev.) 
        Whole 74.95 ± 7.582 97.83 ± 3.221 * 100.5 ± 16.34 * 
Medial 
Whole 60.52 ± 8.384 84.03 ± 4.148 * 92.67 ± 24.94 
Medial 59.6 ± 8.536 102.4 ± 6.548 * 109.7 ± 26.44 * 
Lateral 61.48 ± 9.261 64.37 ± 4.225 74.16 ± 26.6 
Lateral 
Whole 55.94 ± 5.213 90.95 ± 6.276 * 93.9 ± 21.65 * 
Medial 56.88 ± 5.398 91.67 ± 5.659 * 93.72 ± 23.83 * 
Lateral 54.99 ± 5.328 90.23 ± 8.437 * 94.22 ± 20.35 * 
Trochlear 
Whole 86.1 ± 10.67 104.6 ± 4.673 * 105.6 ± 14.47 * 
Medial 80.2 ± 12.21 92.08 ± 4.453 97.97 ± 22.31 
Lateral 92.24 ± 9.529 117.6 ± 6.565 * 113.9 ± 10.6 * 
Peak-to-Valley 
(µm± Std. Dev.) 
         Whole 186 ± 33.73 266 ± 36.73 * 264 ± 39.44 * 
Medial 
Whole 144 ± 21.47 254 ± 45.8 * 256 ± 47.8 * 
Medial 124 ± 9.798 254 ± 45.8 * 236 ± 36.13 * 
Lateral 144 ± 21.47 206 ± 15.95 *  238 ± 55.99 * 
Lateral 
Whole 132 ± 16.97 210 ± 41.4 * 192 ± 46.16 * 
Medial 120 ± 7.589 206 ± 47.04 * 184 ± 50.15 * 
Lateral 126 ± 21.13 150 ± 39.98 160 ± 31.9 
Trochlear 
Whole 172 ± 29.07 224 ± 25.92 204 ± 26.29 
Medial 156 ± 30.36 204 ± 16.97 * 196 ± 23.6 * 
Lateral 170 ± 29.8 198 ± 42.09 198 ± 21.13 
Sa (µm± Std. 
Dev.)
 
        Whole 23.14 ± 4.329 30.32 ± 0.4788 * 31.78 ± 6.318 * 
Medial 
Whole 15.11 ± 2.555 48.27 ± 2.874 * 48.59 ± 8.809 * 
Medial 13.52 ± 2.224 50.56 ± 5.38 * 44.66 ± 12.65 * 
Lateral 16.24 ± 2.871 39.94 ± 3.461 * 46.19 ± 13.6 * 
Lateral 
Whole 13.43 ± 1.855 23.62 ± 2.65 * 23.09 ± 4.375 * 
Medial 14.88 ± 1.811 24.02 ± 3.295 * 23.12 ± 4.223 * 
Lateral 11.71 ± 2.242 22.89 ± 3.276 * 22.65 ± 6.073 * 
Trochlear 
Whole 23.03 ± 4.496 23.8 ± 1.17 25.32 ± 6.521 
Medial 21.76 ± 4.368 21.23 ± 1.788 25.55 ± 6.972 
Lateral 22.79 ± 5.054 21.57 ± 2.067 21.62 ± 6.364 
 
* denotes significant difference to Control. ◊ denotes significant difference between Rupture and Transection.  
‡ denotes significant difference between 4 and 10 weeks. 
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Table A3.2– Femoral Cartilage Morphology and Surface Roughness by Compartment and Sub-
Compartment (10 weeks)  
 Control Rupture Transection 
Mean Height 
(µm± Std. Dev.) 
        Whole 45.51 ± 6.361 ‡ 77.41 ± 6.117 *, ‡ 88.39 ± 9.964 * 
Medial 
Whole 38.97 ± 6.153 ‡ 77.07 ± 21.05 *,◊ 102.6 ± 17.88 *,◊ 
Medial 39.31 ± 6.512 ‡ 83.42 ± 31.55 * 107.8 ± 28.62 * 
Lateral 38.64 ± 6.475 ‡ 69.67 ± 17.59 *,◊ 96.75 ± 21.85 *,◊ 
Lateral 
Whole 35.4 ± 4.437‡ 73.95 ± 8.926 *, ‡ 84.41 ± 17.27 * 
Medial 35.41 ± 5.853 ‡ 77 ± 10.85 *, ‡ 91.74 ± 22.3 * 
Lateral 35.41 ± 3.428 ‡ 71.07 ± 8.078 *, ‡ 77.36 ± 14.55 * 
Trochlear 
Whole 49.05 ± 7.118 ‡ 79.23 ± 6.116 *, ‡ 86.05 ± 9.749 *, ‡ 
Medial 47.65 ± 6.337 ‡ 69.84 ± 5.969 *, ‡ 78.45 ± 8.399 * 
Lateral 50.51 ± 8.244 ‡ 89.05 ± 9.4  *, ‡ 94.18 ± 12.39 *, ‡ 
Peak-to-Valley 
(µm± Std. Dev.) 
         Whole 152 ± 23.6 282 ± 44.74 * 304 ± 39.19 * 
Medial 
Whole 112 ± 21.01 ‡ 262 ± 67.63 * 302 ± 42.54 * 
Medial 100 ± 28.06 248 ± 63.8 * 268 ± 60.56 * 
Lateral 100 ± 19.6 ‡ 232 ± 59.6 * 288 ± 44.25 * 
Lateral 
Whole 108 ± 36.4 180 ± 37.95 * 206 ± 39.01 * 
Medial 70 ± 20.67 ‡ 166 ± 29.8 * 178 ± 49.43 * 
Lateral 104 ± 39.19 174 ± 41.4 * 178 ± 48.84 * 
Trochlear 
Whole 142 ± 26.74 196 ± 39.92 198 ± 56.67 
Medial 122 ± 27.8 166 ± 32.57, ‡ 162 ± 39.25 
Lateral 130 ± 25.64 ‡ 190 ± 38.26 196 ± 52.4 * 
Sa (µm± Std. 
Dev.)
 
        Whole 17.68 ± 3.389 ‡ 31.07 ± 4.869 * 29.73 ± 5.332 * 
Medial 
Whole 12.35 ± 2.789 49.3 ± 15.99 *  55.71 ± 14.19 * 
Medial 11.51 ± 3.04 47.38 ± 17.25 * 49.06 ± 14.29 * 
Lateral 12.91 ± 2.536 46.03 ± 15.11 * 55.74 ± 13.95 * 
Lateral 
Whole 9.353 ± 1.405 ‡ 22.63 ± 4.995 * 23.98 ± 7.335 * 
Medial 10.7 ± 2.782 ‡ 27.93 ± 6.789 * 29.07 ± 10.54 * 
Lateral 7.967 ± 1.09 ‡ 17.22 ± 3.519 *, ‡ 16.51 ± 2.211 *, ‡ 
Trochlear 
Whole 19.73 ± 3.94 26.47 ± 3.282 * 25.92 ± 5.063 
Medial 19.3 ± 3.985 25.3 ± 2.478 ‡ 25.47 ± 4.934 
Lateral 19.79 ± 3.645 24.3 ± 4.913 24.33 ± 4.476 
 
* denotes significant difference to Control. ◊ denotes significant difference between Rupture and Transection.  
‡ denotes significant difference between 4 and 10 weeks. 
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Table A3.3– Tibial Cartilage Morphology and Surface Roughness by Compartment and Sub-
Compartment (4 weeks) 
 Control Rupture Transection 
Mean Height 
(µm± Std. Dev.) 
        Whole 109.7 ± 10.55 140.8 ± 6.765* 155.5 ± 17.9* 
Medial 
Whole 121.7 ± 10.67 158.5 ± 8.871* 174.3 ± 24.91* 
Medial 103.6 ± 11.32 131.7 ± 7.706 150.4 ± 29.07* 
Lateral 141.2 ± 12.13 184.2 ± 13.86* 198 ± 24.93* 
Lateral 
Whole 100.7 ± 10.09 128.4 ± 7.785* 142.6 ± 17.14* 
Medial 113.8 ± 7.18 159.9 ± 14.33* 167.9 ± 17.7* 
Lateral 87.8 ± 13.84 97.03 ± 8.484 115.5 ± 21.64* 
Peak-to-Valley 
(µm± Std. Dev.) 
         Whole 284 ± 22.34 350 ± 23.29* 382 ± 33.44* 
Medial 
Whole 282 ± 19.72 340 ± 27.01* 370 ± 40.46* 
Medial 222 ± 36.99 296 ± 28.06* 348 ± 40.87* 
Lateral 278 ± 14.03 338 ± 23.29* 364 ± 39.92* 
Lateral 
Whole 252 ± 30.36 314 ± 19.22*, ◊ 360 ± 33.08*, ◊ 
Medial 252 ± 30.36 312 ± 22.77*, ◊ 360 ± 33.08*, ◊ 
Lateral 222 ± 31.06 246 ± 28.14 ◊ 330 ± 39.25*, ◊ 
Sa (µm± Std.  
Dev.)
 
        Whole 46.43 ± 1.397 69.77 ± 2.182* 85.91 ± 12.33* 
Medial 
Whole 52.79 ± 1.493 73.29 ± 4.378* 88.34 ± 9.085* 
Medial 37.16 ± 2.707 60.28 ± 5.531*, ◊ 77.91 ± 10.69*, ◊ 
Lateral 64.84 ± 1.385 76.97 ± 6.845*, ◊ 93.64 ± 10.82*, ◊ 
Lateral 
Whole 40.46 ± 2.489 64.3 ± 2.388 *, ◊ 80.91 ± 15.92*, ◊ 
Medial 45.97 ± 1.158 67.87 ± 1.196* 83.92 ± 17.25* 
Lateral 30.93 ± 7.233 43.59 ± 7.959 ◊ 64.91 ± 19.84*, ◊ 
 
* denotes significant difference to Control. ◊ denotes significant difference between Rupture and Transection.  
‡ denotes significant difference between 4 and 10 weeks. 
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Table A3.4– Tibial Cartilage Morphology and Surface Roughness by Compartment and Sub-
Compartment (10 weeks) 
 Control Rupture Transection 
Mean Height 
(µm± Std. Dev.) 
        Whole 101.5 ± 5.383 131.6 ± 6.767*, ‡ 137.3 ± 13.95* 
Medial 
Whole 116.5 ± 7.663 145.8 ± 15.36* 149.6 ± 15.69* 
Medial 99.04 ± 4.959 118 ± 21.58 121.1 ± 16.49 
Lateral 134.9 ± 13.5 172.2 ± 13.16* 176.1 ± 19.99* 
Lateral 
Whole 90 ± 4.727‡ 122.7 ± 11.48* 128.7 ± 15.03* 
Medial 104.4 ± 7.644 146.9 ± 9.939* 157.5 ± 17.31* 
Lateral 75.16 ± 4.771 97.71 ± 21.44 95.46 ± 23.93 
Peak-to-Valley 
(µm± Std. Dev.) 
         Whole 284 ± 23.6 364 ± 23.6* 408 ± 25.17* 
Medial 
Whole 284 ± 23.6 354 ± 39.25* 390 ± 14.7* 
Medial 226 ± 9.033 288 ± 42.93* 322 ± 25.64* 
Lateral 282 ± 21.13 352 ± 40.63* 386 ± 11.8* 
Lateral 
Whole 230 ± 14.03 344 ± 9.798*, ‡ 380 ± 54.02* 
Medial 230 ± 14.03 338 ± 14.03* 378 ± 53.53* 
Lateral 196 ± 12.39 280 ± 50.72* 300 ± 67.46* 
Sa (µm± Std.  
Dev.)
 
        Whole 50.12 ± 4.083 67.85 ± 3.363*, ◊ 77.52 ± 8.642*, ◊ 
Medial 
Whole 58.55 ± 5.712‡ 72.12 ± 6.226* 75.38 ± 3.356* 
Medial 42.37 ± 2.579‡ 54.74 ± 2.796* 60.54 ± 6.834*, ‡ 
Lateral 71.79 ± 7.253‡ 80.73 ± 11.7 84.39 ± 4.636* 
Lateral 
Whole 41.21 ± 3.79 62.53 ± 3.269*, ◊ 77.51 ± 14.95*, ◊ 
Medial 48.44 ± 5.701 70.81 ± 2.837*, ◊ 89.02 ± 15.85*, ◊ 
Lateral 28.8 ± 2.818 42.93 ± 10.1 49.42 ± 19.27* 
 
* denotes significant difference to Control. ◊ denotes significant difference between Rupture and Transection.  
‡ denotes significant difference between 4 and 10 weeks. 
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A4. Comprehensive Femoral and Tibial OARSI Modified Mankin Grades 
Table A4.1– Femoral OARSI Histologic Grade by Subsection and Compartment (4 weeks) 
 Control Rupture Transection 
Articular Cartilage 
Structure  
(Mean ± Std. Dev.) 
Medial 0.6713 ± 0.359 7.245 ± 0.417* 7.25 ± 0.457* 
Lateral 0.7824 ± 0.375 3.278 ± 1.33* 2.699 ± 0.648* 
Whole 0.7259 ± 0.349 5.194 ± 0.844* 4.78 ± 0.451* 
Proteoglycan Content  
(Mean ± Std. Dev.) 
Medial 0.6898 ± 0.233 5.13 ± 0.282* 5.014 ± 0.529* 
Lateral 0.6389 ± 0.253 2.38 ± 0.874* 1.745 ± 0.557* 
Whole 0.6669 ± 0.231 3.668 ± 0.566* 3.222 ± 0.454* 
Cellularity  
(Mean ± Std. Dev.) 
Medial 0.4398 ± 0.223 2.87 ± 0.125* 2.838 ± 0.0903* 
Lateral 0.3843 ± 0.218 2.083 ± 0.23*, ◊ 1.292 ± 0.175*, ◊ 
Whole 0.4102 ± 0.207 2.459 ± 0.195*, ◊ 1.997 ± 0.123*, ◊ 
Tidemark Integrity  
(Mean ± Std. Dev.) 
Medial 0.2685 ± 0.0738 0.9722 ± 0.068* 1.000 ± 0.000* 
Lateral 0.3287 ± 0.117 0.7824 ± 0.125* 0.588 ± 0.234 
Whole 0.3016 ± 0.0853 0.873 ± 0.0981* 0.7789 ± 0.122* 
Total Score  
(Mean ± Std. Dev.) 
Medial 2.069 ± 0.477 16.22 ± 0.577* 16.1 ± 1.04* 
Lateral 2.134 ± 0.427 8.523 ± 2.50* 6.343 ± 1.3* 
Whole 2.105 ± 0.412 12.19 ± 1.66* 10.79 ± 0.935* 
 
* denotes significant difference to Control. ◊ denotes significant difference between Rupture and Transection.  
‡ denotes significant difference between 4 and 10 weeks. 
Table A4.2– Femoral OARSI Histologic Grade by Subsection and Compartment  (10 weeks) 
 Control Rupture Transection 
Articular Cartilage 
Structure  
(Mean ± Std. Dev.) 
Medial 1.31 ± 0.981 6.866 ± 0.823* 7.222 ± 0.76* 
Lateral 1.208 ± 0.332 2.866 ± 0.602* 2.657 ± 0.806* 
Whole 1.258 ± 0.623 4.741 ± 0.545* 4.934 ± 0.67* 
Proteoglycan Content  
(Mean ± Std. Dev.) 
Medial 1.468 ± 0.708 ‡ 4.889 ± 0.906* 4.991 ± 0.566* 
Lateral 0.9769 ± 0.535 2.181 ± 0.581* 1.931 ± 0.436* 
Whole 1.199 ± 0.538 3.45 ± 0.271* 3.449 ± 0.42* 
Cellularity  
(Mean ± Std. Dev.) 
Medial 0.6065 ± 0.255 2.653 ± 0.271* 2.875 ± 0.165* 
Lateral 0.3565 ± 0.179 1.926 ± 0.0989*, ◊ 1.356 ± 0.174*, ◊ 
Whole 0.4795 ± 0.185 2.265 ± 0.16* 2.109 ± 0.176* 
Tidemark Integrity  
(Mean ± Std. Dev.) 
Medial 0.2963 ± 0.139 0.9537 ± 0.0517* 1.000 ± 0.00* 
Lateral 0.2407 ± 0.156 0.838 ± 0.143* 0.6852 ± 0.135* 
Whole 0.2692 ± 0.134 0.8942 ± 0.0855* 0.8455 ± 0.0612* 
Total Score  
(Mean ± Std. Dev.) 
Medial 3.694 ± 1.76 15.36 ± 1.88* 16.09 ± 1.46* 
Lateral 2.796 ± 0.772 7.833 ± 0.978* 6.63 ± 1.30* 
Whole 3.22 ± 1.20 11.38 ± 0.925* 11.34 ± 1.20* 
 
* denotes significant difference to Control. ◊ denotes significant difference between Rupture and Transection.  
‡ denotes significant difference between 4 and 10 weeks. 
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Table A4.3– Tibial OARSI Histologic Grade by Subsection and Compartment (4 weeks) 
 Control Rupture Transection 
Articular Cartilage 
Structure  
(Mean ± Std. Dev.) 
Medial 0.7407 ± 0.218 3.269 ± 0.619* 3.051 ± 0.621* 
Lateral 0.8519 ± 0.303 3.236 ± 0.31* 2.593 ± 0.725* 
Whole 0.7836 ± 0.232 3.27 ± 0.347* 2.817 ± 0.503* 
Proteoglycan Content  
(Mean ± Std. Dev.) 
Medial 0.8611 ± 0.66 2.755 ± 0.462* 2.431 ± 0.803* 
Lateral 0.8565 ± 0.141 2.838 ± 0.246* 2.315 ± 0.716* 
Whole 0.8753 ± 0.447 2.784 ± 0.156* 2.38 ± 0.629* 
Cellularity  
(Mean ± Std. Dev.) 
Medial 0.6435 ± 0.188 1.843 ± 0.311* 1.662 ± 0.133* 
Lateral 0.4815 ± 0.427 1.759 ± 0.27* 1.519 ± 0.285* 
Whole 0.5728 ± 0.232 1.789 ± 0.198* 1.599 ± 0.129* 
Tidemark Integrity  
(Mean ± Std. Dev.) 
Medial 0.2083 ± 0.131 0.9722 ± 0.043* 0.9861 ± 0.034* 
Lateral 0.3981 ± 0.193 0.9861 ± 0.034* 0.8889 ± 0.272 
Whole 0.3032 ± 0.138 0.9782 ± 0.035* 0.9375 ± 0.153* 
Total Score  
(Mean ± Std. Dev.) 
Medial 2.366 ± 0.537 8.343 ± 1.18* 8.009 ± 1.48* 
Lateral 2.407 ± 0.893 8.579 ± 0.761* 7.116 ± 1.76* 
Whole 2.338 ± 0.482 8.049 ± 0.574* 7.094 ± 1.13* 
 
* denotes significant difference to Control. ◊ denotes significant difference between Rupture and Transection.  
‡ denotes significant difference between 4 and 10 weeks. 
 
Table A4.4– Tibial OARSI Histologic Grade by Subsection and Compartment (10 weeks) 
 Control Rupture Transection 
Articular Cartilage 
Structure  
(Mean ± Std. Dev.) 
Medial 0.9667 ± 0.496 3.236 ± 0.42* 3.62 ± 0.191* 
Lateral 1.204 ± 0.495 3.468 ± 0.927* 3.694 ± 0.481*, ‡ 
Whole 1.043 ± 0.441 3.258 ± 0.365* 3.666 ± 0.248*, ‡ 
Proteoglycan Content  
(Mean ± Std. Dev.) 
Medial 1.628 ± 1.37 3.083 ± 0.224* 3.634 ± 0.371*, ‡ 
Lateral 1.296 ± 0.85 3.157 ± 0.51* 3.5 ± 0.51*, ‡ 
Whole 1.422 ± 1.09 3.065 ± 0.186*, ‡ 3.541 ± 0.395*, ‡ 
Cellularity  
(Mean ± Std. Dev.) 
Medial 0.6389 ± 0.34 1.819 ± 0.226* 1.787 ± 0.234* 
Lateral 0.6528 ± 0.374 1.833 ± 0.284* 1.782 ± 0.239* 
Whole 0.6676 ± 0.312 1.802 ± 0.173* 1.791 ± 0.179* 
Tidemark Integrity  
(Mean ± Std. Dev.) 
Medial 0.3222 ± 0.398 0.9583 ± 0.0697 0.9815 ± 0.045 
Lateral 0.4167 ± 0.329 0.9074 ± 0.103 1.000 ± 0.00* 
Whole 0.3685 ± 0.347 0.9286 ± 0.0584 0.9907 ± 0.022* 
Total Score  
(Mean ± Std. Dev.) 
Medial 2.75 ± 2.29 8.833 ± 0.856* 9.500 ± 0.940* 
Lateral 3.157 ± 1.39 8.259 ± 1.13* 9.139 ± 1.12*, ‡ 
Whole 2.987 ± 1.61 8.006 ± 0.465* 8.73 ± 0.872*, ‡ 
 
* denotes significant difference to Control. ◊ denotes significant difference between Rupture and Transection.  
‡ denotes significant difference between 4 and 10 weeks. 
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A5. Abbreviations 
 
AC - articular cartilage 
ACL - Anterior Cruciate Ligament 
AMB - Anteromedial bundle 
ANOVA - Analysis of Variance 
BM- MSC - Bone marrow-derived mesenchymal stem cell 
C1,2C - type I and II degradation Col2 3/4 short assay 
C2C - collagen type II cleavage  
CD - cluster of differentiation 
CDC - Center for Disease Control 
CO2 - Carbon Dioxide 
Col - Collagen, gene 
CPII - procollagen II carboxy propeptide  
CRP - C-Reactive Protein 
CS846 - aggrecan chondroitin sulfate 846 epitope  
CT - computed tomography 
ECM - extracellular matrix 
ELISA - enzyme-linked immunosorbent assay 
EPIC - Equilibrium Partitioning of an anionic Contrast Agent 
GAG - glycosaminoglycan 
GFP - green fluorescent protein 
HA - hyaluronic acid 
HSC - Hematopoeitic Stem Cell 
IL - interleukin 
KOOS - Knee Injury and Osteroarthritis score  
LCL - Lateral Collateral Ligament 
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MCL - Medial Collateral Ligament 
MFC – Medial Femoral Condyle 
LFC – Lateral Femoral Condyle 
MMP - matrix metalloproteinase 
MRI  - magnetic resonance imaging 
MSC - Mesenchymal Stem Cell 
OA - Osteoarthritis 
PBS - phosphate-buffered saline 
PG - proteoglycan 
PLB - posterolateral bundle 
PTOA - Post-traumatic Osteoarthritis 
RBC - red blood cell 
ROI - region of interest 
Saf-O - safranin-O 
sCPII - procollagen II C-propeptide  
SD - Standard Deviation 
SDF-1 - Stromal Derived Factor -1 
sGAG - sulfated glycosaminoglycan 
snoRNA - serum-level small non-coding RNA  
TIMP - Tissue Inhibitor of Matrix Metalloproteinase 
TNF-α - tumor necrosis factor alpha 
uCTX-I -  type I collagen C-telopeptide 
uCTX-II -  type II collagen C-telopeptide 
WF6 - chondroitin sulfate epitope  
WHO - World Health Organization 
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Post-traumatic osteoarthritis (PTOA) is a prevalent condition following rupture of the 
anterior cruciate ligament (ACL). While numerous animal models of PTOA exist, most are based 
on surgical disruption of a stabilizing structure. In the rat, surgical ACL transection is the most 
commonly employed model, but it may introduce confounding biological factors due to surgery. 
The purpose of this dissertation was to utilize the tibial compression model of ACL injury to 
induce a noninvasive ACL rupture in the rat. First, a biomechanical characterization of four 
different loading protocols was undertaken, and a high-speed, high-displacement protocol was 
deemed optimal for inducing a repeatable, complete ACL injury. Tibiofemoral joint motion was 
found to be representative of motion during human injury. Next, a chronic, biological 
comparison of the noninvasive injury model to the surgical ACL transection model was 
performed. Results indicate that the two models both cause extensive degenerative joint changes, 
and articular cartilage degeneration was most profound in the medial compartment of the femur. 
The two models yield in a differential bony remodeling response, and surgical ACL transection 
causes more drastic degenerative changes of articular cartilage. Furthermore, the ACL 
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transection group had elevated biomarkers of cartilage breakdown compared to the noninvasive 
rupture group. Lastly, the acute response following noninvasive and surgical injury was 
investigated. Both injuries cause the systemic mobilization of mesenchymal stem cells (MSCs) 
and elevated stromal-cell derived factor (SDF-1) concentrations in the joint acutely. Biomarkers 
of cartilage breakdown and metabolism are elevated only slightly immediately after injury. In 
conclusion, while some studies may benefit from the more rapid onset of PTOA in the surgical 
ACL transection model, a noninvasive injury model avoids confounding biological factors and 
may be beneficial for future studies assessing pathology or potential treatment strategies. 
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